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ABSTRACT
This thesis provides the first scientific evidence on the cancer modulating properties of
two unique South African herbal teas, rooibos (Aspalathus Iinearis) and honeybush
(Cyclopia intermedia) utilizing in vitro as well as in vivo carcinogenesis assays by:
• Demonstrating the in vitro antimutagenic activity of aqueous extracts of the
herbal teas against the metabolic activated mutagens, 2-acetylaminofluorene (2-
AAF) and the mycotoxin, aflatoxin B1 (AFB,) as well as, to a certain extent,
against the direct acting mutagen, hydrogen peroxide, utilizing the Salmonella
typhimurium mutagenicity assay.
• Increasing the activity of hepatic drug metabolizing enzymes, glutathione S-
transferase alpha and UPD-glucuronosyl transferase, and reduced the oxidative
stress by stabilizing the level of reduced glutathione (GSH) resulting in an
increased hepatic reduced to oxidized glutathione ratio (GSG:GSSG). No toxic
effects were noticed in rats consuming the herbal teas for 10 weeks as their sole
source of drinking fluid.
• Demonstrating the ex vivo modulation of 2-AAF- and AFB1-induced mutagenesis
by sub- cellular hepatic fractions of rats consuming the herbal teas in the
Salmonella mutagenicity assay. Hepatic cytosolic fractions protected against
mutagenesis of both mutagens, while the microsomal fractions exhibited a
reduced capacity to metabolize AFB1 to its active mutagenic metabolite.
• Providing evidence for the in vivo modulation of tumour promotion using the liver
as well as the two-stage skin carcinogenesis animal models. The unprocessed
herbal teas arrested proliferation of the placental form of glutathione-S-
transferase (GSTP+) altered cells as well as reduced the total number of enzyme
altered foci in the liver of rats. Topical application of polyphenolic fractions of the
various herbal teas prior to 12-0-tetra-decanoylphorbol-13-acetate (TPA) tumour
promotion, reduced tumour formation in mouse skin initiated with 7,12-dimethyl-
benz[ajanthracene (DMBA). The protective effect was illustrated by a decreased
tumour incidence, a reduction in tumour volume as well as a delayed onset of
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tumour development. The f1avanol/proanthocyanidin content of the fractions
could playa major role in the protection against skin tumour promotion.
• Proposing possible mechanisms whereby rooibos and honeybush herbal teas
could exert their cancer modulating properties with respect to in vitro and ex vivo
antimutagenicity, in vivo oxidative status and reduced tumour promotion.
• Providing evidence that the herbal teas mimic the cancer modulating properties
of green and black teas although differences exist, presumably due to differences
in the polyphenolic constituents.
• Suggesting that rooibos and honeybush herbal teas may play an important role
as chemopreventive agents in the modulation of cancer.
IV
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UITTREKSEL
Hierdie tesis bevat die eerste ondersoek na die effek van waterige en polifenoliese
ekstrakte van rooibos (Aspalathus Iinearis) en heuningbos (Cyclopia intermedia) op
verskeie aspekte van kankerontwikkeling. Die twee kruietees is uniek aan Suid-Afrika
en kan 'n belangrike rol speel in die voorkoming van kanker. Verskillende in vitro so wei
as in vivo studies het die volgende getoon:
• Antimutageniese aktiwiteite teen die metabolies-geaktiveerde mutagene, 2-
asetielaminofluoreen (2-AAF) en die mikotoksien, aflatoksien B1 (AFB1) in die
Salmonella fyphimurium mutagenisiteitstoets. 'n Beperkte mate van beskerming
is ook verleen teen die oksidatiewe mutageen, waterstofperoksied, sonder
metaboliese aktivering.
• Verhoogde aktiwiteite van die fase II ensieme, glutatioon S-tranferase alfa en
UDP-glukuronidase, wat liggaamsvreemde verbindings metaboliseer. Die
kruietees verlaag die oksidasietoestand soos weerspieel word deur 'n toename
van gereduseerde glutatioon tot die geoksideerde vorm in die lewer van rotte wat
10 weke hierdie kruietees gedrink he!. Die kruietees het geen toksiese uitwerking
op die rotte gehad nie.
• Antimutageniese aktiwiteite van subselluiE~re fraksies van die lewer teenoor 2-
AAF en AFB1 in die Salmonella toets. Die sitosolfraksie van die rotlewer bied
beskerming teen die ge"induseerde mutagenese van beide mutagene, terwyl die
mikrosomale fraksie ook die metaboliese aktivering van AFB1 na die aktiewe
mutageniese metaboliet verminder.
• In vivo modulering van kankerpromosie met behulp van bekende rotlewer en
muisvel kankerontwikkelingsmodelle. In die lewermodel het die
ongeprosesseerde kruietees beide die ontwikkeling en getal van GSTP+ fokusse
onderskeidelik vertraag en verminder. In die geval van die velkankermodel het
aanwending van polifenoliese fraksies van die kruietees beskerming gebied teen
die ontwikkeling van velkankers by muise. Die aantal en grootte van die tumors
het afgeneem terwyl die verskyning daarvan ook vertraag is.
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• Verskeie meganismes waardeur rooibos- en heuningboslee moonllik kanker kan
moduleer word voorgeslel. Verskille in die polifenoliese sameslelling asook hul
onderskeie konsenlrasies kan 'n belangrike rol speel in die kankerveranderende
effekle van die lees.
• Oal gereelde inname van rooibos- en/of heuningboslee moonllik 'n belangrike rol
kan speel in die voorkoming van dieel- en omgewings-geYnduseerde kankers.
VI
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Chapter 1 1
General Introduction
Cancer is currently the second leading cause of death in the western world. More than
5.5 million cancer cases are diagnosed each year in developing countries (1) of which
approximately 50 000 are reported to the National Cancer Registry in South Africa. It is
estimated that one in every four South African males and one in every five South
African females will be affected by a cancer diagnosis in their lifetime (2). The five
leading cancers in South Africa in declining incidence in males are prostate, lung,
oesophagus, bladder and colorectal and in females are cervix, breast, colorectal
oesophagus and lung (Fig. 1).
Cervix
BreastProstate
BCC
o Males (n=54733) I!I Females (n=55113)
23.31 ••••••• 18.4
11.91 ~16.8
Lung 6.3 _._ __ _ : 15.5 BCC
SCC of skin 6.2c::=:J114.2 SCC of skin
Oesophagus 5.8~ 3.4 Colorectal
Bladder 3.9c:.3.0 Oesophagus
Colorectal 3.6L112.6 Uterus
Stomach 2.8C.2.5 Lung
Melanoma 2.5CI!l2.5 Melanoma
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Fig. 1. Percentage distribution of the ten most common cancers in South Africa
for period 1996 to 1997 (2).
Certain cancers are more common in certain geographic regions and population
differences also exist. In a quantitative analysis of avoidable risks for cancer in the
United States of America done by Doll and Peto (3), it was estimated that 35% of
cancer deaths were related to diet, 30% to smoking and 35% to other causes, e.g.
viruses, hormones, radiation, industrial carcinogens, etc. In the process of elucidating
the causes of cancer, research also focussed on identifying compounds that might
inhibit cancer development by interfering with one or more steps in carcinogenesis.
Michael Sporn defined the term chemoprevention already in the mid 1970s (4) and
research on chemoprevention started in all earnest in the early 1980s at the National
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Cancer Institute, USA. Preclinical efficacy of more than 140 potential chemopreventive
agents was evaluated during the 1980s and early 1990s and included agents such as
antioxidants, anti-inflammatories, glutathione-S transferases and glutathione enhancers,
phenolic compounds, etc. (5). Appropriate animal cancer models used to assess the
efficacy of these compounds showed inhibition of chemical induced tumours in many
organs and compounds having a high efficacy and low toxicity were selected for pre-
and clinical trials (6). At present, phase 1, 2 and 3 clinical trials are directed at various
cancers and include interventions with chemopreventive compounds or dietary
substances (7). Future studies are also directed towards developing reliable biomarkers
of exposure, determining bioavailability and reliable endpoints to be used in the clinical
trials.
One of the approaches used in chemoprevention includes the intake of tea.
Numerous reports indicate that the consumption of black and green teas (Camellia
sinensis) has several health benefits e.g. reducing risk for heart disease and strokes as
well as several lifestyle-related cancers (8-11). Apart from green and black tea, two
indigenous herbal teas, rooibos (Aspalathus linearis) and honeybush (Cyclopia
intermedia) have also been consumed in South Africa since the early 1700s. Anecdotal
evidence of the health promoting properties of these herbal beverages has been
accumulated. At present no scientific data are published on the biological activities of
honeybush tea, while limited data are available on rooibos tea. Thus, the objective of
this study was to substantiate some of the health claims and investigate the possible
chemopreventive properties of these unique herbal beverages. Aspects of chemical
carcinogenesis, chemoprevention and information about the chemical and biological
properties of the herbal teas are reviewed in chapter 2. The in vitro antimutagenic
activities and the ex vivo antimutagenic activities of rooibos and honeybush teas are
discussed in chapters 3 and 5, respectively, while the ex vivo modulation of certain
hepatic drug metabolizing enzymes and oxidative status are presented in chapter 4.
The cancer modulating properties of rooibos and honeybush teas against cancer
promotion in rat liver and mouse skin are provided in chapters 6 and 7, respectively.
The key results of this study is summarised in chapter 8 which also includes some
proposed future research directions.
http://scholar.sun.ac.za
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Chapter 2
1. INTRODUCTION
Coronary heart disease and cancer are important disorders that cause alarming
mortality and morbidity in humans (1). Both epidemiological and experimental
carcinogenesis studies showed that more than 90% of cancers are associated with
exposure to environmental mutagens and mitogens (2). Environmental factors
implicated in cancer development in humans include cigarette smoke, physical
carcinogens such as ultraviolet radiation, infectious agents such as pathogenic
bacteria (He/icobacler pylon) and viruses (Human Hepatitis Band C virus) as well as
dietary contaminants such as the mycotoxin, aflatoxin B1 (3). The degree to which
environmental factors effect tumour formation in humans will depend on the
individual's susceptibility and defence mechanisms, e.g. DNA repair enzymes,
antioxidant status and the level of detoxification enzymes (4-6). Some cancers (5-7%
of total cancers), attributed to genetic factors rather than environmental factors, e.g.
familial retinoblastoma, will not be discussed in the context of this review.
The discovery of the structure of DNA (7), contributed to our understanding of
carcinogenesis at several levels. Cells divide and regenerate continuously and
background or spontaneous mutations occur in approximately 1 in every 1,000,000
cells. Cells have the ability to repair damaged DNA, or to commit "suicide", referred
to as apoptosis or programmed cell death, but when these protective mechanisms
fail, tumours develop. Thus, damage of cellular DNA is essential to the process of
cancer development and progression towards invasive cancer is characterised by
accumulation of mutations and increased cell proliferation. The constitutive features
of cancer include the ability of autonomous growth, to invade and metastasize. The
process of carcinogenesis is usually prolonged, requiring one third-to-two thirds of
the human lifespan to develop. Treatment of cancer is far more likely to succeed
when diagnosed whilst still in the early stages.
Research efforts of the past four decades provide strong evidence that
changes in dietary habits and lifestyles may reduce the risk for important diseases
such as cancer. There is a growing interest in identifying natural occurring
compounds capable of reducing the incidence of cancer, especially those caused by
environmental factors Tea is one of the most widely consumed beverages in the
world today and its medicinal properties have been widely explored. Tea polyphenolic
compounds have unique structures and activities for treatment of various
7
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abnormalities and diseases in humans such as cancer, cardiovascular disease,
dermatological problems, dental caries and even memory loss as shown by some
epidemiological studies (8). Most of the information on the antimutagenic and
anticarcinogenic activity of green and to a lesser extent black tea and their
polyphenolic constituents is obtained from epidemiological and experimental studies.
However, as mentioned, in South Africa, herbals teas derived from two endemic
plants, Aspalathus Iinearis (rooibos tea) and Cyclopia intermedia (honeybush tea),
are also consumed on a daily basis. These teas differ from green and black teas as
they are naturally caffeine free, with a low tannin content and their phenolic
composition differs not only from one another but also from that of green and black
teas. The health promoting effects of these two endemic teas are mostly based on
anecdotal evidence and sound scientific evidence is needed to substantiate these
claims.
8
The present review mainly deals with the process of cancer development,
polyphenolic compounds that may playa role in chemoprevention, some health benefits
of green and black tea and the possible health promoting properties of the two unique
South African herbal beverages, rooibos and honeybush teas.
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2. Carcinogenesis
Percival POlt, an English surgeon is regarded as the father of carcinogenesis studies
as he recognised that an environmental agent was responsible for the high incidence
of scrotal cancer among chimney sweeps in London in the 1700's (9). Legislation
then required bathing for removal of the soot and protective clothing for chimney
sweeps resulted in the elimination of scrotal cancer as an occupational hazard. It was
only in the early 1900's that scientists had developed an animal model to test the
hypothesis that certain chemicals may cause tumours. Yamigawa and Ichikawa (10)
demonstrated that skin carcinomas are induced by the chronic application of coal tar
to the ears of rabbits. Cook and his co-workers (11) extracted the substance
responsible for the carcinogenicity of coal tar on rabbit skin, called benzo[ajpyrene
(BP). This substance has been studied extensively while numerous other
occupational or environmental chemical carcinogens have been identified (Table 1).
Table 1 Chemical carcinogens identified by the National Toxicology
Programme, United States of America
Eronite
Diethylstilbestrol
Chemical carcinogens
CyclophosphamideAflatoxins
Arsenic
Asbestos
Azathioprine
Analgesic mixtures containing
phenacetin
Benzene
Benzidine
Bis(ch loromethyl )ether
1,4-butanediol dimethyl-sulfonate
Methoxsalen with ultraviolet light
Mustard gas
2-naphthylamine
Chlorambucil
2-ch I0 roethy 1-3-(4-methyl-
cyclohexyl)-1-nitrosourea
Chromium
Conjugated estrogens
Table modified from Perantoni et al. (9).
Radon
Thorium dioxide
Vinyl chloride
"
'-J'
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Chapter 2
2.1 A multistage process
Cancer researchers today share views that cancer development is a multistage
process with the accumulation of genetic changes a function of time (6,12,13).
Carcinogenesis is often characterised by the following sequential stages: initiation,
promotion, progression and malignant conversion (Fig. 1). Initiation is described as
an irreversible consequence of the interaction of a carcinogen with tissue causing
DNA damage, either through strand breaks or the formation of adducts (14-16).
When a round of cell replication occurs before the DNA damage is repaired, the
lesion is "fixed" and alterations can either be neutral or cause an error in the
sequence, producing cells that are potential precursors of neoplastic growth. This
step is often not recognisable as a pathological entity as the initiated cell may not be
phenotypically different from the other parenchymal cells in the specific organ.
Spontaneous initiation may also occur whereby the agent responsible for the initiating
event is unknown, e.g., when cellular DNA is changed at one or more sites in the
genome as a result of incorrect action of DNA polymerases during cell division or
during DNA repair. These changes represent a mutational event that may be
hereditary. In different model systems, initiated cells exhibit certain characteristics,
when compared with the surrounding non-initiated cells including increased
proliferative capabilities, resistance to apoptotic stimuli and inducers of cell
cytotoxicity resulting in an increased lifespan (17). Initiation alone does not result in
tumour formation as the development into a clinically detectable neoplasm requires
several additional events.
The next stage, referred to as cancer promotion, is defined as the step where
specific agents known as promoters selectively enhance the development of
neoplasms from a background of initiated cells (18). Promotion is suggested to be
reversible as withdrawal of the agent usually results in the disappearance of the
expanding clones of initiated cells, e.g. the regression of polyps in the colon. Thus,
the promotion process facilitates the expression of the initiated phenotype and is not
considered to be genotoxic (19). Promoters are generally not mutagenic and may be
agents of exogenous origin, such as therapeutic drugs and plant products, or
endogenous origin, including hormones or chronic inflammation (18). These agents
do not directly interact with the host cellular DNA but influences the expression of
genetic information encoded in the cellular DNA, referred to as epigenetic
mechanisms. Certain promoters produce their effect by interaction with receptors in
10
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the cell membrane, cytoplasm or nucleus and others are mitogenic by stimulating
DNA synthesis and enhancing cell proliferation (20). Promoters also appear to have
relatively high tissue specificity, e.g. phenobarbital functions as a promoter for rodent
liver neoplasia but not in the urinary bladder (21). Similarly, the phorbol ester, 12-0-
tetra-decanoylphorbol-13-acetate (TPA), is a potent skin and forestomach cancer
promoter but has no appreciable activity in the liver (18). Some promoters cause
inflammation and this is particular relevant in skin initiation-promotion studies using
the phorbol esters. Tumour promotion may be modulated by several factors such as
age, sex, diet and hormone balance (18,22).
A second genetic event and/or series of events proposed to increase the
probability of a cell to become malignant; occur during the third stage referred to as
progression. The DNA changes involved could arise from additional exposure to
carcinogens, spontaneous mutations or genomic instabilities resulting in an
irreversible change in the phenotype of a cell (6,12,23).
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Fig. 1. Sequential stages of carcinogenesis (24).
Progression is used to signify the stage whereby a benign proliferation
becomes malignant or whereby a neoplasm develops from a low grade of malignancy
to a higher grade (9,17). During progression, neoplasms show increased
invasiveness, develop the ability to metastasize and alter biochemical, metabolic and
morphological characteristics. Tumour cell heterogeneity is an important
characteristic of tumour progression (18). Associated with progression is the
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development of an increased degree of karyotypic instability as well as chromosomal
rearrangement. Malignant conversion may be considered the final step in
progression. Distinction between tumour promotion and tumour progression is not
clear when performing a routine histopathological evaluation of neoplasms. In both
situations though, the critical event is accelerated growth (19). Emerging
technologies offer promise to help distinguish various stages of progression.
A complete carcinogen is an agent capable of providing initiation through
single or multiple exposures, promoting a growth advantage to selective altered cells
resulting in lesions generated during progression that have the potential to undergo
malignant transformation.
2.2 Short-term in vitro mutagenesis and in vivo carcinogenesis models
2.2.1 In vitro mutagenesis testing
Prior to performing carcinogenesis assays in animal models numerous in vitro
test systems exist to evaluate the carcinogenic potency of various synthetic
chemicals and/or natural compounds. The predictive power of in vitro mutagenicity
assays to identify potential carcinogens is then often evaluated through comparison
with carcinogenic assays in rodents. Short-term assays include bacterial tests, e.g.
Salmonella typhimurium mutagenicity or Ames assay; mammalian DNA mutagenesis
and repair tests, e.g. COMET assay; and chromosome integrity tests, e,g.
micronucleus and sister chromatid exchange assays. Table 2 lists some of the most
widely used in vitro assays. Some chemicals exhibit their carcinogenic effects by
mechanisms that do not involve DNA damage and are referred to as non-genotoxic
carcinogens, e.g. estrogens, metals (12,25). There are a few in vitro methods to
detect non-genotoxic carcinogens but none of these has been validated for regulatory
usage. Chemicals that prove to be non-genotoxic in vitro and in vivo may still be
subjected to a rodent bioassay, especially if a high level of human exposure is
anticipated.
12
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Table 2 Principal short term assays in assessing genotoxic effects
Type of assay Evaluating endpoint
Gene mutations
Mammalian germ cell assays
Other indicators of genetic
damage
Gene mutations
Chromosome damage in vivo
= hypoxanthine-guanineHPRT
Cytogenesis in cultured hamster
or human cells
Other
assays
Main
assays
• Sa/manella/AMES assay
• Micronucleus assay in rodent
bone marrow
• E. coli WP2 tryptophan reversion
assay
• TK or HPRT forward mutation
assay in cultured mammalian
cells
• Drosophila sex-linked recessive
lethal assay
• Chromosome aberrations and
micronuclei assays
• Aneuploidy assays
• Mitotic recombination in yeast
and Drosophila
• Unscheduled DNA synthesis in
cultured hepatocytes and rodents
• Mouse visible/electrophoretic
specific-locus tests
• Skeletal or cataract mutation
assays
• Cytogenetic analysis and
heritable translocation assays
• DNA damage and repair in
rodent germ cells
• Dominant lethal assay
Abbreviations: E .coli = Escherichia coli; TK = thymidine kinase;
phosphoribosyltransferase. Table modified from Hoffmann et al. (26).
The percentage of chemical agents positive in the Sa/monella mutagenicity
assay that have been shown to be carcinogenic is approximately 83 to 89% (27,28).
Therefore in addition to bacterial assays, the impact of mutagenesis in human health
should encompass additional tests including gene mutations, chromosome
aberrations and aneuploidy, in other test systems. A few of these short term in vitro
and in vivo assays will briefly be discussed.
2.2.1.1 Salmonella mutagenicity assay
The study of mutations in bacteria has played a very important role in the science of
genetics. The Sa/monella mutagenicity assay developed by Bruce Ames (29) is the
best-studied short-term predictive test for carcinogenicity and has been validated in
studies by the National Cancer Centre Research Institute of Tokyo as well as the
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International Agency for Research on Cancer (30,31). A range of Salmonella
fyphimurium strains with well-defined mutations in known genes became available
(29). Each of the strains carries one of a number of mutations in the operon coding
for histidine biosynthesis. The mutations can be reverted either by base-pair
substitutions or frameshifts referred to as point mutations. For these commonly used
strains the DNA sequence at the site of the original mutation in the histidine
biosynthesis gene has been determined. Apart from these mutations in the histidine
operon, the tester strains also contain other mutations that increase their ability to
detect possible mutagens, e.g. the rta mutation to increase membrane permeability to
larger molecules and the uvrB mutation coding for the DNA excision repair system. A
mutant strain is treated with a compound to determine whether a second mutation will
directly reverse or suppress the original mutation in the histidine gene.
The standard tester strains normally used are TA 97, TA 98, TA 100 and TA
102. TA 97 and TA 98 are used for detecting various frameshifts, TA 100 for
detecting base pair substitutions (adenine-thymine base pairs) and TA 102 containing
the ochre mutation to efficiently identify other oxidative mutagens not detected or
poorly detected by the other strains, e.g. various hydroperoxides, UV light, X rays
and cross linking agents (27). These strains also contain the R-factor plasmid,
pKM101 making them more susceptible to detect certain mutagens. Additional tester
strains are available that do not contain pKM101, e.g. TA 1535 and TA 1538 that
have a lower spontaneous mutation frequency than TA 100 but detect mutagens that
do not revert TA 100. An enzyme component representing mammalian drug
metabolism is also included.
Methods as well as revised methods for detecting mutagens and carcinogens
using the Salmonella mutagenicity assay are described in detail in the literature
(27,32).
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2.2.1.2 Micronucleus assay
The use of micronucleus formation as a measure of chromosome damage in
peripheral blood lymphocytes was first proposed by Countryman and Heddle (33)
and has subsequently led to the development of the cytokinesis-block micronucleus
method. The bone marrow of rodents is routinely used in this test since polychromatic
(immature) erythrocytes are produced in this tissue. The measurement of
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micronucleated immature erythrocytes in peripheral blood is equally acceptable in
species in which the inability of the spleen to remove micronucleated erythrocytes
has been demonstrated. The micronuclei are small membrane bound DNA fragments
and originate from acentric fragments (chromosome fragments lacking a centromere)
or whole chromosomes that are unable to migrate with the rest of the chromosomes
during the anaphase of cell division. Micronuclei can be distinguished by a number of
criteria, but the frequency of polychromatic erythrocytes is the principal endpoint.
Cells are exposed to a test substance both with and without metabolic activation.
Following exposure, cytochalain B is added to block cytokinesis and the cells are
grown for a sufficient time to allow chromosomal damage and the formation of
micronuclei in bi- or multinucleated interphase cells. The harvested and stained cells
are analysed microscopically for the presence of micronuclei.
This assay can be applied to both in vitro as well as in vivo experimental
conditions. The mammalian in vivo micronucleus assay is especially relevant to
assess mutagenic hazards, as it allows consideration of factors of in vivo metabolism,
pharmacokinetics and DNA-repair processes (34,35). This short term assay was also
used in the Human MicroNucleus (HUMN) project to establish a database of "normal"
baseline frequencies of DNA damage in human populations (36).
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2.2.1.3 COMET assay
The COMET assay, also known as the single cell gel electrophoresis assay (SCGE),
was developed in 1984 for identifying agents exhibiting genotoxic activity by detecting
DNA damage at the level of the single cell (37). The original method was performed
under neutral conditions, but subsequently a COMET assay performed under alkaline
(pH >13) conditions was developed (38). In the COMET assay the cells are
embedded in a thin agarose gel on a microscope slide and lysed to remove cellular
proteins. The DNA is then allowed to unwind under neutral or alkaline conditions
where after it is electrophoresed and stained with a fluorescent dye. The electric
current causes migration of the broken DNA fragments or relaxed chromatin away
from the nucleus, thus the COMET assay essentially measures the sizes of the
various DNA fragments within that cell. The types of DNA damage detected by the
COMET assay include double strand breaks at neutral conditions, single strand
breaks at pH 12.1 and alkali labile sites at pH >13. Breaks can also be introduced at
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specific sites with specific glycosylases and endonucleases. The COMET assay is
also applied as a simple DNA repair assay suitable for use in biomonitoring. In an in
vitro cellular assay cells are embedded in agarose, treated with a DNA-damaging
agent and immersed in culture medium at 37"C to initiate repair in the gel (39). The
applications of this technique include genetic toxicology, radiobiology, clinical
investigations as well as environmental biomonitoring (40).
It is important to note that the use of the COMET assay for human
biomonitoring is still controversial as single strand breaks are not the major form of
damage induced by most genotoxins, and if they are, these breaks are rapidly
repaired. However, the assay is regarded as a good addition to the existing test
systems used in human biomonitoring studies.
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2.2.1.4 Sister chromatid exchange assay
The sister chromatid exchange (SCE) assay provides a highly sensitive means of
evaluating cy10genetic damage caused by chemical or physical mutagenic agents.
SCE means a reciprocal interchange of the two chromatid arms within a single
chromosome. The exchange is visualised during the metaphase of the cell cycle by
differential staining and presumably requires the enzymatic incision, translocation
and ligation of at least two DNA helices (41). Evidence of such exchanges appears
as a banding effect. An increase in the number of exchanges obselVed in the test
cells is an indication of a genotoxic effect. This assay can also be applied in vivo, e.g.
in peripheral blood lymphocy1es cell cultures from study animals (42).
2.2.2 In vivo carcinogenesis assays
The use of experimental animals as models for human disease has been
indispensable in understanding the causes, biology and prevention of cancer and
plays a crucial role in the preclinical testing of new anti-cancer drugs and treatments
(43). Rodents are the most commonly used animals for modelling human tumours as
they have several advantages in medical research. Their physiology and genetics are
well characterised and understood, they are relatively easy and cheap to maintain,
are mammals and readily develop cancer in response to chemical carcinogens over a
short time period (44). Animal models also have their disadvantages when they are
used to study human cancers. Extensive inbreeding has made rodent strains
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genetically similar, whereas humans are genetically diverse and might respond
differently when subjected to the same circumstances. Animals and humans have
important metabolic, physiological and hormonal differences which will affect the type
of carcinogens metabolised, the resultant metabolites as well as the subsequent
repair of DNA damage (45). The practical limitations on the design of the animal
experiments can make the findings difficult to apply to humans e.g. animals are
usually exposed to higher levels of carcinogens than levels encountered by humans.
The accepted design thus for carcinogenicity testing is to expose a statistically
acceptable number of rats or mice to the highest dose they will tolerate without
reducing their lifespan for reasons other than tumour development (46). A number of
specific "short term" in vivo rodent carcinogenesis models have been developed to
assess the carcinogenic potential of chemicals. A few of these models relevant to the
present study will be briefly discussed.
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2.2.2.1 Hepatocarcinogenesis in rats
A variety of carcinogenesis treatment protocols have been proposed in rat liver and is
especially useful to identify potential liver tumour initiators and promoters (21,47-53).
The first experimental models were developed by Peraino et a/. (21) where the rat
liver was initiated with 2-acetylaminofluorene (2-AAF) and exposed to phenobarbital
(PB) to develop preneoplastic and neoplastic lesions. Subsequently, Pitot et a/. (47)
combined the partial hepatectomy and diethylnitrosamine (PH/DEN) method of
Scherer and Emmelot (48) with the PB-promoting method of Peraino et al. (21) to
clearly distinguish the stages of initiation and promotion. Foci of enzyme altered
hepatocytes and/or hepatic nodules were used as the endpoint. The resistant
hepatocyte model was developed by Farber et a/. (49) and is based on the
hypothesis that carcinogens induce "resistant" hepatocytes during initiation which are
stimulated to develop into foci and nodules by brief exposure to carcinogens such as
2-AAF coupled with a mitogenic stimulus. This assay consists of 3 components, an
initiator (e.g. DEN), a selective growth inhibitor, 2-AAF and a growth stimulus (e.g.
PH). Male Fischer 344 rats are given a single dose of 200 mg/kg body weight DEN
(intraperitoneally), after a 2 week recovery period from the initial cell damage, rats
were fed a basal diet containing 0.02% 2-AAF for two weeks including a 67% PH
after the first week (49). Within 7-10 days foci and/or nodules occurred randomly
throughout the liver. The number of foci and/or nodules of enzyme altered (gamma-
http://scholar.sun.ac.za
Chapter 2
glutamyl transpeptidase -GGT; glutathione-S-transferase placental form -GSTP)
hepatocytes visualized histochemically, varied with the dose of DEN administered.
Other models, including the choline-deficient model developed by Sells et al. (51) and
the orotic acid model developed by Sarma et al. (53), have also been described in
the literature. Subsequently, numerous chemicals have been identified and used as
cancer initiators andlor promoters in these models, e.g. aflatoxin B, (AFB,), and
fumonisin B, [FB,] (54-59).
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2.2.2.2 Two-stage mouse skin carcinogenesis model
The initiation-promotion developed protocol in mouse skin carcinogenesis has been
widely used for studies on mechanisms involved in chemical carcinogenesis and to
evaluate the carcinogenic or anticarcinogenic properties of compounds (60,61).
Initiation is accomplished by a single topical application of a sub carcinogenic dose of
a carcinogen e.g. 7,2-dimethylbenz(aj-anthracene (DMBA) inducing a permanent
genetic alteration in some epidermal cells (62). Repeated application of the phorbol
ester, 12-0-tetradecanoylphorbol-13-acetate (TPA) to mouse skin, leads to sustained
proliferation resulting in hyperplasia in non-initiated skin and papilloma development
in initiated skin. A fraction of these papillomas progresses to carcinomas through the
acquisition of additional genetic changes (63). The progression stage is generally a
spontaneous process (62,64).
2.2.2.3 Other models
Several other organ specific models have been developed in rats and mice for
studying cancer development. Azoxymethane (AOM) is highly effective in causing
colon and rectal cancers in rats (65). Male Fischer rats are injected subcutaneously
with AOM and depending on the experimental design the aberrant crypt foci or other
types of cancerous lesions are manifested in the colon (66-68). AOM-induced
tumours were shown to share many histopathological characteristics with human
tumours (69). Animal models have also been developed to study oesophageal
carcinoma. Among the most potent inducers of oesophageal tumourigenesis in the
rat is N-nitroso-benzylmethylamine (NBMA) and which is injected subcutaneously 3
times a week for 5 weeks (70-72). Induction of papillomas is monitored after 20-40
weeks.
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Fig. 2. The three major groups of chemical carcinogens (9).
The reactive metabolite is suggested to be a diol-epoxide, generated by two
metabolic cycles involving P450. The epoxide intermediates are stable to allow
movement to the cell nucleus where they react with DNA (79).
2.3.1.3 Arylhydroxylamines
The carcinogenic activity of the aromatic amines has been suggested from
epidemiological studies of workers occupationally exposed to aniline dyes and the
subsequent development of bladder cancer (80). One of the aromatic amines, 2-
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acetylaminofluorene (2-AAF) was identified and listed as a known carcinogen in 1987
under the Safe Drinking Water and Toxic Enforcement Act of 1986 -Proposition 65
(81).
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2-AAF induces tumours in the liver of male rats, mammary gland in female rats and
ear duct gland and small intestine in both male and female rats (82).
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It is N-hydroxylated in the rat liver by CYP1A2 to N-hydroxy-2-acetylaminofluorene
(Fig, 4) which can either be esterified to yield the sulphuric acid ester (N-S04-2-AAF)
catalysed by the sulfotransferase system or be subjected to an intramolecular
transfer of the acetyl group via acetyltransferase to N-acetoxy-2-AAF (83), All these
metabolites may form adducts with DNA resulting in damage (84),
2.4 Metabolism of xenobiotic compounds
After a xenobiotic, e,g, chemical carcinogen, has been absorbed into a biological
system it may undergo a biotransformation, The products of metabolism are usually
more water soluble to facilitate their excretion via the kidneys or bile, If the compound
is highly lipophilic, e,g, polychlorinated biphenyls and thus not suited for excretion, it
will remain in the biological system for long periods of time (85,86), Metabolism of
xenobiotics is generally divided into two phases: phase I and phase II (Fig, 5), with
phase I altering the compound by adding a functional group which can be conjugated
with endogenous polar constituents during phase II (85,87), Some xenobiotics
already possess a functional group, e,g. hydroxyl groups and therefore simply
undergo a phase II reaction, The products of phase II may be further metabolised
involving both phase I and phase II enzymes,
The xenobiotic/foreign compound enters the body via the gastrointestinal tract
and goes directly to the liver, the major organ involved in carcinogen metabolism via
the portal blood supply, The metabolising enzymes are generally localised in
particular subcellular fractions, e,g, in the endoplasmatic reticulum, in the cytosol and
in other organelles such as mitochondria, The metabolic reactions produce unstable
positively charged intermediates (electrophiles) which are chemically reactive. The
reactivity of the metabolic intermediates may determine the toxicity of the parent
compound,
23
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Fig. 5. The potential metabolism of xenobiotic/foreign compounds by phase I
and phase II reactions.
2.4.1 Phase I reactions
Phase I reactions include oxidation, reduction, hydrolysis and hydration. The major
types of oxidation reactions catalysed by P450 are divided into aromatic
hydroxylation, heterocyclic hydroxylation, N-,S- and Q-dealkylations, N-oxidations, N-
hydroxylation, S-oxidation, desulphuration and deamination.
The principal function of P450 is the mono-oxygenation of various substrates
which requires molecular oxygen and reducing equivalents from reduced
nicotinamide adenine dinucleotides or dinucleotide phosphates (NADH or NADPH).
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The P450-containing monooxygenase system primarily falls into two major classes,
bacterial or mitochondrial (type I) and microsomal (type II) or alternatively can be
classified according to the number of their protein components. The electron carrier
proteins differ with subcellular location with both microsomal and mitochondrial
P450s in eukaryotic cells using NADPH as electron donor while bacterial P450s use
NADH.
The mitochondrial or bacterial P450 systems have 3 components, a FAD-
containing flavoprotein (NADPH- or NADH-dependant reductase), an iron-sulphur
protein and P450 (88) with the eukaryotic microsomal system containing two
components, a flavoprotein containing both FAD and FMN (NADPH-cytochrome
P450 reductase) and P450 (89). The P450 system consists of a group of enzymes
located predominantly in the smooth endoplasmic reticulum of mammalian cells (90).
Upon subcellular fractionation of the cell, the P450 enzyme system is
concentrated in the centrifugally-derived microsomal preparations (91). Although
found in other tissues as well, the liver has the highest concentration of P450. The
P450s have an iron-haem centre at their active site and in the reduced state these
proteins form complexes with carbon monoxide to exhibit a maximum absorbance of
light at 450 nm (92). Due to the flexibility in the ligand-binding pocket, each P450 has
the capacity to oxidise a variety of different substrates. Exposure of P450s to a
particular chemical and/or compound often leads to transcriptional activation of one
or more P450 genes, resulting in the induction of enzymes involved in the
metabolism and excretion of the ingested compound (91). Substances that may
cause enhanced or induced activity of the P450 enzymes include caffeine, alcohol,
dioxin, saturated fats, organophosphorous pesticides, paint fumes, sulfonamides,
exhaust fumes and barbiturates (93). Based on sequence similarities, a standardized
nomenclature has been adopted that categorises the individual P450s into respective
families and subfamilies (94). Currently more than 700 P450s have been
characterized, of which 50 are known to occur in humans. Table 3 summarizes the
major P450 families and their isoforms.
P450s do not catalyse all Phase I reactions as other oxidative enzyme
systems also exist. Epoxides may undergo hydration catalysed by the enzyme
epoxide hydrolase located in the smooth endoplasmic reticulum near to the P450
system that produces the epoxides. This reaction can be regarded as a detoxification
25
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reaction as the dihydrodiol products are less chemically reactive than the epoxide.
However, the products, the trans diols, are further metabolised into more toxic
metabolites (87). Another phase I reaction that may take place is reduction, utilising
NAOH or NAOPH and is catalysed by either microsomal or cytosolic reductases and
gut bacteria that possess reductases (Fig. 6). The most commonly found reaction is
the reduction of nitro and azo groups. Reduction of nitro groups is an important route
of biotransformation for e.g. nitrobenzene.
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Table 3 Major cytochrome P450 families and their isozymes
Family Subfamily Isoform Substrate activated Induced by:
CYP1 CYP1A, 1B CYP1A1 Polyaromatic Cruciferous
hydrocarbons, e.g. vegetables,
benzo[aJpyrene cigarette smoke
CYP1A2 Heterocyclic amines, Cruciferous
Aromatic amines e.g. 2- vegetables,
AAF and AFB1 cigarette smoke
CYP1B1 Metabolism of
endogenous estrogens,
biotransform heterocyclic
amines from broiled meats
CYP2 CYP2A, 2B, CYP2A1, A2,
2C, 20, 2E A3
(Expressed
in rats)
CYP2A6, A7 Aflatoxin B1, N- Barbiturates,
(Expressed nitrosod iethyl-ami ne, Coumarin
in humans) nicotine
CYP2B1, Amphetamines, Phenobarbital,
B2(rats) benzodiazepines barbiturates
CYP2B6, 6-aminochrysene, Phenobarbital
(humans) Cyclophosphamide
CYP2C8, C9, S-mephenytoin, S- Rifampin
C19, C18, warfarin, non-steroidal
(humans) anti-inflammatory agents
CYP2E1 Acetami nophen ,ethanol, Ethanol, acetone,
acetone, benzene isoniazid,
starvation in
animal models
CYP3 CYP3A CYP3A4, Aflatoxin B1, Phenobarbital
acetaminophen,
benzo[aJpyrene-7,8-
dihydrodiol
Hydrolysis of esters and amides by carboxyl-esterases and amidases occurs
in a variety of tissues but these enzymes are usually found in the cytosol of cells.
Esterases can have amidase activity as well. Hydrazides and carbamates may be
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hydrolysed by amidases (87) as amidases play an important role in the metabolic
activation of certain drugs, e.g. isoniazid and phenacetin.
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Fig. 6. The cytochrome P450 reduction reaction with NADPH and NADH as
electron donors (95).
A number of compounds can also initiate redox cycling (cyclic reduction and
re-oxidation) which may lead to the formation of reactive oxygen species [ROSJ (96).
These compounds are reduced by taking up an electron from NADPH to form a
radical which is then oxidised by molecular oxygen. The ROS include hydrogen
peroxide, hydroxyl radicals, singlet oxygen molecules and lipid peroxides and are all
powerful oxidising agents that have the ability to initiate a wide range of responses
including mutagenesis and carcinogenesis. Oxygen radicals interact with all cellular
macromolecules, not only DNA. In particular, the polyunsaturated fatty acid residues
of the phospholipids are extremely sensitive to oxidation (97). The resultant lipid
hydroperoxides are relatively short lived as they are either reduced by glutathione
peroxidases to non-reactive fatty acid alcohols or they react with metals to produce a
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variety of reactive products, including epoxides and aldehydes. Malondialdehyde
(MDA) and 4-hydroxynonenal (HNE) are the main products of lipid peroxidation (98).
MDA reacts with DNA to form adducts to dC, dA, dG and was shown to be mutagenic
in bacterial and mammalian cells and carcinogenic in rats (99,100).
The oxidant/antioxidant balance is highly regulated and oxidative stress
induced by the overproduction of ROS lead to a disruption of cellular functions. The
cell eludes injury caused by free radicals via a system of small molecule endogenous
antioxidants, e.g. glutathione, vitamin E, C and enzymes e.g. superoxide dismutase
(SOD), catalase and glutathione peroxidase.
2.4.2 Phase II reactions
Phase II reactions are known as conjugation reactions and involve the addition of a
polar endogenous metabolite to a substrate molecule being either the parent
compound and/or reactive metabolites resulting from phase I reactions (75). The
polar moiety renders the substrate molecule more water-soluble facilitating excretion
from the body via the kidneys or bile. The endogenous compounds include
carbohydrate derivatives, amino acids, glutathione and sulphate. Phase II enzymes,
such as uridine-5'-diphospho-a-D-glucuronic acid glucuronosyltransferases (UPD-
GT), sulfotransferases and glutathione S-transferases (GSTs) catalyse these
conjugation reactions and cofactors are essential as they provide the "donor"
molecule.
Glucuronosyl transferases (UDP-GTs) are microsomal enzymes found mainly
in the liver, intestinal mucosa and kidneys. The addition of glucuronic acid, a polar
carbohydrate molecule, to hydroxyl, carboxylic acid, amino and thiol groups is a
major route of phase II metabolism. Glucuronic acid is donated by a cofactor, UDP-
glucuronic acid yielding an organic acid that can be readily excreted by specific
transporters (87). This multigene family has been shown to participate in the
conjugation of potentially harmful oxidative compounds (101). One class of
compounds that contain candidates for the formation of oxidative derived mutagens
is the aromatic and heterocyclic amines (Fig. 7). In the presence of the intermediate,
N-hydroxy-2-AAF, glucuronidation is capable of providing sufficient protection against
mutagenesis and is generally a detoxification reaction, but may occasionally be
involved in increased toxicity ofaxenobiotic (102).
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Fig. 7. Glucuronidation of phenol and benzoic acid to form ether and ester
conjugates, respectively (95).
Sulfotransferases are cytosolic enzymes found mainly in the liver, but also in a
variety of other tissues. They catalyse the conjugation of lipophilic chemicals with a
sulfate moiety (Fig. 8) involving the cofactor, 3'-phosphoadenosine-5'-phosphosulfate
[PAPS] (87). The water-soluble sulphate conjugate is an ester that is excreted in
urine.
Sulfation is the main metabolic pathway for the elimination of steroid and
thyroid hormones. Many factors may influence the activity of the sulfotransferases as
a diet low in methionine and cysteine has been shown to reduce sulfation. Sulphate
conjugation may also be involved in the metabolic activation of compounds such as
the carcinogen 2-AAF (103).
+ 3' -Phosphoadenosine-5'-phosphale
OH
o
Phenol
+ PAPS
Sulphotransferase
O-S03H
-0
Phenyl sulphate
Fig. 8. Conjugation of an aromatic hydroxyl group with sulphate (95).
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The GST enzymes catalyse the reaction of electrophilic compounds with glutathione
(GSH) rendering the products more water-soluble (104). The cytosolic GST family is
grouped into 3 classes of cy1osolic isoenzymes, alpha (a), mu (fl) and pi (ll) and a
microsomal membrane bound (theta) form (105). This conjugation is irreversible and
an important phase II reaction as it is involved in the active removal of reactive
intermediates. Detoxification of the ultimate carcinogen, AFB,-8,9-epoxide, through
GSH conjugation is a key mechanisms in reducing AFB,-induced
hepatocarcinogenesis in rats (106). After the addition of GSH and the subsequent
removal of two amino acids, the cysteine conjugate is acetylated to yield the N-
acetylcysteine conjugate (Fig. 9).
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Fig. 9. Glutathione conjugation of benzo[a]pyrene-7,B-diol-9,10-epoxide
(107).
As a cellular nucleophile, GSH may react chemically via the sulfhydryl groups
that attack electrophylic sites. GSH is a sulphur-containing tripeptide consisting of the
amino acids y-glutamic acid, cysteine and glycine (Glu-Cys-Gly) and found in many
mammalian tissues, specifically the liver. Glutathione exists in both a reduced state
(GSH) and an oxidised state (GSSG) and GSSG is usually less than 1% of the GSH
content. In healthy cells, normal cellular glutathione homeostasis is maintained
through regeneration from GSSG via glutathione reductase (Fig. 10) and/or through
GSH uptake from exogenous sources (108). Reduced glutathione is vital to a broad
range of cellular functions including quenching of ROS and free radicals,
detoxification of xenobiotics and the maintenance of a reduced cellular status.
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Acetylation involves an activated cofactor, acetyl coenzyme A (acetyl CoAl
and may yield a compound that is less water-soluble e.g. when an amine is
converted into an amide. The acetyl transferases involved in acetylation reactions
occur in the cytosolic fraction of liver, gastric mucosa and white blood cells.
Acetylation is an important route of metabolism for aromatic amino compounds,
sulfonamides, hydrazines and hydrazides (87). Amino acid conjugation is the second
type of acylation reaction in which the xenobiotic compound is metabolized resulting
in the formation of an amide bond to an amino acid. The reaction is catalysed by
amino acid acyl transferase enzymes and is dependent on thiamine, pantothenic acid
and vitamin C. Glycine is the most common conjugating amino acid in mammals.
Methylation is a common, but generally minor pathway of xenobiotic
metabolism and involves the transfer of methyl groups to substrate molecules. It
differs from most other phase II reactions because it generally decreases the water
solubility of a compound. Methylation is mediated by three groups of enzymes, the 0,
N, and S-methyltransferases.
Most of the methyl groups utilised in the phase II reactions originate from the
cofactor S-adenosylmethionine (SAM) that is synthesized from the amino acid
methionine, a reaction requiring choline, vitamin 812 and folic acid. Hormones such
as estrogens are inactivated through methylation using SAM (87).
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Fig. 10. The glutathione cycle (108).
2.4,3 Phase III reactions
A possible phase III detoxification system with antiporter activity (Fig.11) has
recently been described (109). The antiporter is an energy-dependent efflux pump,
transporting xenobiotics out of the cell and resulting in a decreased intracellular
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3. Cancer chemoprevention
"He is a better physician that keeps diseases off us, than he that cures them being on
us; prevention is so much better than healing because it saves the labour of being
sick. "
Thomas Adams, 1618
"Chemoprevention is the use of pharmacological or natural agents that inhibit the
development of invasive cancer either by blocking the DNA damage that initiates
carcinogenesis or by arresting or reversing the progression of premalignant cells in
which such damage has already occurred. The word chemoprevention includes
prevention of initiation, promotion and progression of carcinogenesis to cancer. "
Michael Sporn, 1976
3.1 General
33
Controlling cancer involves the prevention of a complex series of genetic and epigenetic
events that result in invasive and metastasised malignancy. The "chemo-prevention
strategy" was founded in the mid 1970s by Michael B. Sporn (116) who defined it as
using one or several chemical compounds (natural or synthetic) to prevent, inhibit or
reverse the process of cancer development.
The National Cancer Institute (NCI) in the United States of America has made
chemoprevention research a top priority and more than 400 compounds are currently
under investigation as potential chemopreventive agents (117). These agents can either
prevent and/or stop mutations or the processes leading to excessive cell replication that
may lead to cancer development of genetically damaged cells. Ideally such agents
should be inexpensive, easily administered, highly effective, showing minimal short term
and no long-term toxicity (117). Chemopreventive compounds generally exhibit three
major activities: 1) inhibiting the uptake, formation or activation of carcinogens by
enhancing the deactivation of ultimate carcinogen thereby preventing DNA-carcinogen
adduct formation; 2) antioxidant scavenging of reactive electrophiles, oxygen radicals or
inhibiting the formation of eicosanoids; and 3) interfering with cell proliferation of
transformed cells to modulate signal transduction pathways, inducing apoptosis or
inhibiting angiogenesis (118). Identification of such chemopreventive compounds,
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biomarkers of risk, biomarkers of efficacy and suitable cohorts for clinical intervention
are critical for the progression of chemoprevention. Successful implementation of
chemopreventive strategies also depends on the mechanistic understanding of
carcinogenesis at molecular, cellular and tissue level.
The credibility of chemoprevention as a serious and practical approach to the
control of cancer has been enhanced by the publication of clinical trials. Tamoxifen,
raloxifene and 4-hydroxyphenylretinamide (synthetic retinoid) have been shown to be
effective agents for prevention of breast cancer in women with varying degrees of risk
(119-121).
3.2 Human intervention trials
Potential chemopreventive compounds have to pass through several testing phases in
humans before they are rendered "safe and effective" to be prescribed to the population
at large (122). During these phases the effectiveness, toxicity and possible side effects
of the compounds are determined, as preclinical toxicity screening in animals does not
always accurately reflect toxicity in humans. The individuals targeted for
chemoprevention trials include the following persons: those with lifestyle risks, such as
smoking or high fat diet, persons with a family history of cancer, persons at high risk of
cancer development because of the presence of precancerous lesions and persons at
risk of developing a second primary cancer.
Performing phase 1 trials is the first step in evaluating new compounds for
toxicity and to determine the dose-related safety and pharmacokinetics in normal
subjects or subjects with pre-malignant lesions (123). This dose escalation scheme in
phase 1 trials determines the dosages for phase 2 trials. The latter usually involves 25-
100 people, lasts less than 12 months and also focuses on possible side effects of the
compounds in humans. In phase 2 trials the efficacy of the compound against
intermediate endpoints of cancer risks (e.g. precancerous lesions) is assessed and
involves 100-1000 human subjects and last 1-5 years. The majority of phase 3 trials
target the reduction of precancerous lesions and therefore cancer incidence as primary
endpoints, usually last 5-10 yrs and involves 1000-10 000 human subjects. These
studies also focus specifically on long term side effects the chemopreventive agent
might have (123).
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Currently the NCI does not recommend supplements of vitamins, minerals or any
other compound for the prevention of certain cancer(s) as many short and long term
effects of these possible chemopreventive compounds are still unknown. Recently,
many studies produced contradictory results. The outcome of three randomized 0-
carotene intervention trials, started in the 1980s, had lowered the enthusiasm for using
~-carotene in chemoprevention studies against lung, oral cavity and pharyngeal cancers
(124-126). In the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC), a
double blind trial was used to evaluate high daily dosages of vitamin E (a-tocopherol),
~-carotene or a combination of both on reducing the incidence rates of particularly lung
cancer or other cancers among male smokers (127). Alpha-tocopherol had no effect on
the incidence of lung cancer, while the men who received ~-carotene presented with a
higher incidence (>16%) of lung cancer. This trial was the first to support the possibility
that 0-carotene may also be harmful. Since then, two other big intervention trials using
~-carotene were conducted. The Beta-Carotene and Retinol Efficacy trial (CARET), a
multicenter randomized chemoprevention trial designed to test a combined lung cancer
prevention agent in heavy smokers and asbestos workers, reported a 28% increase in
lung cancer and 17% more deaths in the active intervention group receiving a daily
dose of 30 mg of ~-carotene and 25,000 IU of retinyl palmitate (125,128). On the other
hand, the strongest evidence of a benefit of vitamin and mineral supplementation arises
from the large Linxian general population trial that indicated patients receiving a
combination of ~-carotene, Vitamin E and Vitamin A showed a significant reduction in
stomach cancer mortality (129). The process of chemoprevention is complex, but the
potential to increase the general health of a population and reduce cancer incidence
rates in high risk individuals does exist (130). Improved knowledge of the level of these
chemopeventive agents, their metabolites that prevent cancer in rodent models and
levels achievable in human tissue are needed (131).
3.3 Animal studies and chemoprevention
Animal models playa significant role in cancer prevention investigations. Hypothesis
resulting from human epidemiological studies can be tested in animal models, as they
not only provide a system to identify potential chemopreventive agents but also help to
elucidate the protective mechanisms involved. These animal models are also used as a
tool to establish and/or verify the use of biomarkers for specific cancer types and to
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determine non-toxic dose ranges. Potential chemopreventive compounds are screened
in a series of preclinical tests, including in vitro antioxidant, antimutagenicity assays and
in vivo experimental animal cancer models to monitor any protective effect. Data
generated from these investigations as well as from animal toxicology tests to evaluate
drug safety and pharmacokinetic characterisation, are utilized to identify compounds to
be used in human trials. The development of transgenic rodents has been of great
advantage in studying the prevention of oestrogen receptor (ER)-negative breast cancer
in addition to the well established ER-positive breast cancer rat models (132).
The evaluation of a chemopreventive agent in a relatively small number of
animals where the controls show a 100% tumour incidence within a short latency period
is suggested to be the preferred method for laboratory studies (133). However, the
latency period in humans can be up to 20 years and the incidence of invasive cancer is
low, thus chemopreventive agents that double the latency period for human
carcinogenesis would have a great impact on increasing the quality of life for millions of
people. Over 2000 compounds of at least 20 structural and pharmacological activity
classes have been shown to possess chemopreventive activity, but less than 10% of
these compounds have been subjected to in vivo testing using animal carcinogenesis
models. However, it is still unclear whether the effects in animals can be readily
extrapolated to humans as the dose used is often higher in animal models. Certain
agents such as phytochemicals are fermented by colonic bacteria, altering the
compound absorbed from the gut from that which was originally consumed. The original
phytochemical may, in fact, not be detectable in the blood at all (134).
3.4 Phytochemicals and chemoprevention
There is strong scientific evidence, both epidemiologically and experimentally, that
modifications in diet such as increased intake of fruits and vegetables, can prevent a
range of human disease, including cancers (135,136). Vegetables and fruits are a rich
source of a variety of nutrients, including vitamins, trace elements, dietary fibre and
many other classes of biologically active compounds (Table 4). The cancer inhibitory
action of dietary components derived from plants, referred to as phytochemicals, has
been confirmed in various animal cancer and/or carcinogenesis models (137,138).
Studies in cell culture systems have provided a wealth of information on the
mechanisms by which a diet high in fruits and vegetables may lower the risk for chronic
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diseases in human. In recent years, the isolation, identification, characterization and
quantification of phytochemicals and their potential health benefits to humans have
become an important area of scientific research.
Table 4 Dietary plant sources of possible chemopreventive compounds
Phytochemicals (non-
nutrient
chemopreventers)
Fiber
Carotenoids
Allium compounds
Dith iolth iones/g Iucosinolates
Isothiocyanates
Terpenoids
Phytoestrogens
Protease inhibitors
Phytic acid
Flavonoids
Phenolic compounds
Plant sterols
Saponins
Dietary source
Cereals (grains, fruits,
vegetables)
Yellow/orange vegetables,
fruits, dark leafy vegetables
Onion, garlic, chives, leeks
Cruciferous vegetables
Cruciferous vegetables
Oil of citrus peel
Cereals, pulses, sorghum,
millets, soyabeans, fruits,
berries
Cereals, barley, wheat, oats,
rye, soya beans, kidney
beans, chick peas
Cereals, nuts, seeds, sesame
seeds, lima beans, peanuts,
soyabeans
Fruits, vegetables, tea
Fruits vegetables, tea
Vegetables
Soyabeans, yams, colacasia
Approximately 30 classes of phytochemicals including flavonoids, isoflavonoids,
isothiocyanates, indoles, dithiolthiones, coumarins, isoprenoids and organosulphides
have been isolated and tested for their potentially anticancer activity (130,139).
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3.4.1 Flavonoids and tannins
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Flavonoids are low molecular weight compounds found in all vascular plants, e.g. fruits,
vegetables, nuts, seeds, herbs, spices, stems, flowers, red wine as well as tea (140) and
are recognised as pigments responsible for the many shades of yellow, orange and red.
These phytochemicals cannot be synthesized in the human body (141). More than 5000
different flavonoids have been described and have been classified into more than 10
chemical groups (141,142). The structure of flavonoids is based on the flavonoid nucleus
(Fig. 11) consisting of three phenolic rings, A being the benzene ring which is condensed
with C, a six-member ring which carries at position 2 a phenyl benzene ring, B.
R3,
HO
Re
Rs
o
1
c
R4
R3
./OR4
I
Rs'
Fig. 11. The generic structure and numbering pattern for common food f1avonoids
(143).
The flavonoids are classified into subgroups according to substitution patterns in
the A, Band C rings and include flavanols, flavanones, flavonols, flavones, isoflavones
and anthocyanidins [Fig. 12] (144,145). Flavonoids primarily exist as 3-0-glycosides
(flavonoid molecules linked to sugar moieties) and polymers in food, as glycosylation
Increases the polarity of the flavonoid molecule necessary for storage in plant cell
vacuoles (146-148).
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Fig. 12. The structures of the major classes of f1avonoids (143).
Various dietary sources of flavonoids are shown in Table 4 and it is important to
note that the flavonoid content is strongly influenced by variation in plant type, growth,
season, climate, degree of ripeness, food preparation and food processing (148). The
dietary intake of flavonoids (based on only a subset of the flavonoids, quercetin,
kaempferol, myricetin, apigenin and luteolin) in various populations has yielded estimates
of 3-68 mg, but tea drinkers may have an intake up to 430 mg per day based on the
intake of 3.3 cups of tea per day (149,150).
Tannins are natural occurring plant polyp henoIs and are made up of flavonoid
units (151) responsible for the astringent or bitter taste of plant products such as wine,
unripe fruits and various teas. Tannins can be divided into three types, the non-
hydrolysable or condensed tannins that are polymerised forms of flavonoids, the
hydrolysable tannins that are gallic acid esters of simple sugars like glucose and the
derived tannins that are complex compounds formed primarily during the processing of
plants (152). The condensed tannins are also referred to as proanthocyanidins (153).
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Table 4 Dietary sources of subclasses of flavonoids
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Class Flavonoid Dietary source
Quercetin, Myricetin, Kaempherol
Rutin, Luteolin, Apigenin, Chrysin
Flavonols
Flavones
Flavanols
Onions, Apple skin, Tea, Berries, Black grapes
Onions, Apple skin, Berries, Black grapes, Tea,
Broccoli, Celery, Parsley, Lemon, Olive
Catechins, Epicatechins, Epigallocatechins, Black grapes, Teas
Epigallocatchin gallates, Epicatechin
gallates
Flavanone Naringenin, Hesperidin, Hesperetin,
Taxifolin, Narirutin
Anthocyanins Cyanidin, Oenin, Delphinidin
Isoflavones Genistein, Daidzein, Biochanin A,
Formononetin, Coumesterol
Citrus fruit, Orange juice, Grape fruit
Black grapes, Grapes, Raspberries, Strawberries,
Aubergine skin
Soybeans, Black beans, Green split peas, Clover
sprouts, Lima beans, Sunflower seeds
Adapted from Peterson and Dwyer (141) and Rice-Evans et a/. (146).
Tannins have the ability to form complexes with proteins, starch and digestive
enzymes and reduce the nutritional value of foods. Tannin-protein interactions are mostly
based on the formation of hydrophobic and hydrogen bonds. The phenolic group of
tannin is an excellent hydrogen donor forming strong hydrogen bonds with the carboxylic
groups available on the protein (154). Of importance to oolong and black teas are the
f1avanol-derived theaflavins. These tannins reduce the bioavailability of non-heme iron
when tea is consumed with meals by forming insoluble complexes within the
gastrointestinal tract, rendering the iron unavailable for absorption (155,156). Other
condensed type of tannins have also been reported to inhibit digestive enzymes,
including pectinase, amylase, lipases, proteolytic enzymes, ~-galactosidase, cellulase
and those microbial enzymes involved in fermenting cereal grains (153).
3.4.1.1 Absorption, metabolism and bioavailability of flavonoids
The absorption and subsequent distribution, metabolism and excretion of flavonoids in
human and animal studies are of great importance to better understand their health
benefits. Bioavailability is defined as the amount or percentage of an ingested
nutrient/compound that is absorbed and thus available for metabolic use (157). Various
factors may influence the bioavailability such as isomeric form, processing methods, type
of compound and matrices surrounding the compounds. Many studies have reviewed the
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bioavailability and health effects of dietary flavonols in humans indicating that quercetin
glycosides were more readily absorbed than the pure aglycone suggesting that the
glycosides may be absorbed via the intestinal sugar uptake route (158). However, the
question still remains as to which form is actually absorbed from the gut, the aglycone,
the glycoside or both. The hydrophobic flavonoid aglycones are transported across
membranes by passive diffusion, while with the addition of a glycoside moiety, the
flavonoid molecule becomes more hydrophilic, thereby reducing the possibility of passive
transport. A theory has been proposed whereby the flavonoids are absorbed via active
transport, but this has not been proven (159). A study by Walle et al. (160) could not
detect any quercetin glucosides in the ileostomy fluid, but identified substantial amounts
of the aglycone form. It was suggested that quercetin glucosides are efficiently
hydrolysed to the aglycone in the small intestine by [l-glucosidases and then absorbed.
Further evidence is required to establish the possible role of sugar transporters in
flavonoid glycoside uptake.
Deglycosylation of flavonoid glycosides has been proposed to be the first step in
the metabolism during the absorption process whereafter the liver seems to be the main
organ involved although the intestinal mucosa and/or kidneys cannot be ignored.
Flavonoids are either methylated, sulphated, glucuronidated or hydroxylated (144) after
absorption. Conjugation with glucuronic acid and/or sulphate seems to be the most
common type of metabolic reaction in the liver to increase the molecule's polarity and
facilitates its excretion (141,161) via the urine or bile. Flavonoids that are not absorbed in
the small intestine can be metabolised by colonic microflora into aglycones and phenolic
acids. In the presence of intestinal microflora ring scission may occur, accounting for the
subsequent demethylation and dehydroxylation of the involved phenolic compounds.
Intestinal bacteria also possess glycosidases capable of cleaving sugar residues
resulting in aglycones that can then either be absorbed or further metabolized to more
simple phenolic acids (162,163). Evidence is increasing to confirm that human intestinal
bacteria have a selection of hydrolytic enzymes capable of degrading various dietary
flavonoid glycoside compounds.
Improved analytical methods have enabled the detection of flavonoid
concentrations as low as 10 nM in human plasma samples (164). In a study conducted
by Das (165) the oral administration of 83 mg/kg bodyweight of (+)-catechin to humans
resulted in rapid absorption, metabolism and excretion of the flavonoid within 24 hr.
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Using more updated analytical techniques, peak plasma levels of the flavonoid,
quercetin, were measured after 2.9 h of ingesting fried onions containing quercetin
glycosides (166). A study in animals showed that rats fed a 0.2% quercetin diet exhibited
an increased plasma antioxidant status when compared with control animals (167).
Adverse reactions to f1avonoids in humans appear to be minimal (168) and safe
with a wide range of biochemical and pharmacological activities. These findings imply
their possible role as health promoting and disease preventing dietary supplements.
Although flavonoids exhibit various biological activities as mentioned above, for the
scope of this review, only those properties that may playa role in cancer prevention will
be discussed.
3.4.1.2 Biological properties of flavonoids
The mechanisms of action of most chemopreventive agents are complex and classified
according to the site of action or by the specific type of action. It appears that the
flavonoids act primarily as antioxidants, antimutagens, immunomodulators and
anticarcinogens (169-172).
(i) Antioxidant activity. Oxidative stress may lead to the damage of many biological
molecules such as structural proteins, membrane lipids, DNA, and RNA. An effective
antioxidant is defined as a compound, that when present at low concentrations relative to
an oxidizable substrate, can suppress, delay or prevent oxidation of these
macromolecules (173). The antioxidant properties of flavonoids have been investigated
since the mid 1960s with quercetin and rutin receiving the most attention (174).
Flavonoids act as natural antioxidants by functioning as metal chelators and reducing
agents, scavengers of reactive oxygen species, chain-breaking agents, quenchers of the
formation of singlet oxygen and stabilization of endogenous antioxidants (146,147). The
antioxidant potential of flavonoids is predicted by the chemical structure and the relative
positions of the hydroxyl groups (175).
Human cells are constantly exposed to reactive oxygen species (ROS) and
increased exposure may cause damage of cellular molecules leading to the development
of cancer and cardiovascular diseases. The term ROS is used for oxygen-centered
radicals e.g. superoxide (02') and hydroxyl (OH) as well as non-radical species derived
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from oxygen, e.g. hydrogen peroxide (H202), singlet oxygen C02) and hypochlorous acid
(HOC I). These radicals also have the ability to initiate and promote carcinogenesis (145).
Both enzymatic as well as non-enzymatic systems exist in the cell to detoxify ROS.
Endogenous enzymatic defences include superoxide dismutase, catalase, glutathione
peroxidase and glutathione-regenerating systems, but are not completely efficient
especially under certain diseases conditions (176). Other endogenous and exogenous
antioxidants are needed to assist in the body's defences against oxidative damage.
Flavonoids are known to be effective scavengers of ROS and other free radicals, as
epidemiological studies identified inverse associations between flavonoid consumption
and risk for cancer and cardiovascular disease (177-181). Ishige et 81. (181) showed that
flavonoids protect cells from oxidative stress by altering glutathione (GSH) metabolism,
resulting in a 30-80% increase in the basal level of total GSH. Lipid peroxidation is also
of biological importance, whether being a primary event produced by oxidative stress or a
consequence of tissue damage, as products originating from dying cells can have a
cancer promoting effect (98). Flavonoids such as quercetin have been reported to
suppress lipid peroxidation in several biological systems, e.g. mytochondria,
microsomes, and erythrocytes by acting as strong oxygen radical scavengers (145),
Another study indicated flavonoids to exert prooxidant activities, The presence of
EDTA (pH 7.4) containing ferric iron (Fe'+) and 100/lM quercetin enhanced hydroxyl
radical formation from hydrogen peroxide (H202) in the deoxyribose assay (182), From
this study and various others, the prooxidant activity appears to require the presence of
Fe3+ and high flavonoid concentrations and has been suggested that both are not likely
to occur in physiological systems.
(ii) Anticarcinogenic activity. The relationship of flavonoid intake and cancer
prevention has been well documented (183). Various studies indicated the antimutagenic
and/or anticarcinogenic activity of different flavonoids when tested in bacterial
mutagenicity assays and carcinogenesis models (184). Quercetin inhibits the mutagenic
activity of benzo[ajpyrene (BP) in bacterial mutagenicity studies as well as BP-induced
DNA damage in mice colonic epithelial cells (185,186). Topical application of quercetin to
mouse skin has been reported to protect mice against DMBA-, BP-, N-methyl-N-
nitrosourea-, and BP-7,8-dihydrodiol- and IQ-epoxide-induced skin tumourigenesis
(61,187). When quercetin was fed to rats in their diet over a period of weeks, the number
of hepatocellular carcinomas in rats treated with the liver tumour promoter phenobarbital
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was significantly decreased (188). Several possible mechanisms exist in the inhibition of
carcinogenesis by flavonoids and include: 1) inhibiting the metabolic activation of the
carcinogen to its reactive intermediate; 2) inducing the enzymes involved in the
detoxification of the ultimate carcinogen; and 3) scavenging of free radicals, thereby
preventing their interaction with cellular targets (115). Inhibition of the isoenzyme CYP1A
family by quercetin, myricetin and anthraflavic acid has been shown, and suggested to
be, an inhibitory mechanism as discussed above (189,190). However, induction of the
P450 system by natural and/or synthetic flavonoids has also been reported (191,192).
Controversies in the literature do exist with regard to compounds operating via the
induction of P450 enzymes, as some scientists suggest that it increases susceptibility to
some classes of carcinogens and that compounds inducing the conjugating phase II
enzymes are less likely to be potentially hazardous. Siess et at. (176) studied the effect
of flavone, flavanone and tangeretin on the induction of various drug metabolising
enzymes in rats fed a diet containing 20-2000 ppm. The flavone and flavanone showed a
dose dependent induction of GST as well as UDP-GT, while tangeretin showed a slight
stimulating effect on UDP-GT. The effect of various flavonoids in the diet of rats on AFB1-
induced hepatocarcinogenesis was investigated in a subsequent study (193). The non
polar flavonoid, flavanone, exhibited an anti-initiating effect while delaying the promotion
phase. Tangeretin and quercetin induced a less protective and no protective effect,
respectively. The induction of phase II enzymes (UDP-GT and GST), increased formation
of AFB1-GSH conjugates in the liver cytosol as well as a significant decrease in AFB1-
DNA adduct formation by the flavonoid attributed to the protective effects obtained in this
study.
(iii) Other diverse activities. Various flavonoids, e.g. hesperidin, luteolin and quercetin
exhibit anti-inflammatory activity by inhibiting cycloxygenase-2 (COX2) and inducible
nitric oxide synthase [iNOS] (145). Nitric oxide (NO.) is a free radical with a single
unpaired electron, not very reactive, but when overly produced is involved in chronic
inflammatory diseases and initiation of lipid peroxidation (194). In the presence of
molecular oxygen (02), NO autooxidizes to produce a variety of nitrogen oxides, referred
to nitrosating species, such as nitrogen dioxide, nitrite and dinitrogen trioxide. Nitrosation
of secondary aromatic amines may produce potentially carcinogenic nitrosamines. These
promote mutagenesis and carcinogenesis via their ability to alkylate specific sites in
DNA. In the absence of superoxide (02-), NO will nitrosate certain primary and secondary
amines forming potentially mutagenic nitrosamine intermediates promoting the nitrosative
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deamination of DNA bases, while in the presence of both NO and superoxide, N-
nitrosation may be suppressed but oxidation reactions may dominate (195). Depending
upon the fluxes of each radical (NO or O2") either nitrosation or oxidation will dominate.
Flavonoids suppress the oxidation of NO to nitrite and scavenge the reactive nitrogen
species (RNS) formed from NO such as peroxynitrite (196,197). NO metabolism in the
vascular endothelium appears to be an important target explaining the beneficial effects
of dietary flavonoids.
Flavonoids also affect cell signalling and cell cycle progression via induction of cell
cycle arrest and apoptosis (198). Disregulation of cell proliferation is implicated in an
increased susceptibility to neoplasia, thus cancer prevention is generally associated with
inhibition, reversion or retardation of cellular hyperproliferation. Many flavonoids and
isoflavonoids inhibit cellular proliferation in various human cancer cell lines (199).
Tumour cell lines exposed to quercetin showed appropriate morphological changes, DNA
laddering and condensation of nuclear chromatin, characteristic of apoptosis (199,200).
In addition, quercetin also exerts growth-inhibitory effects on several tumour cell lines in
vitro (200) which may be due to its interaction with nuclear type II oestrogen binding sites
(EBS) as the relative binding affinity correlated well with growth inhibition (201,202).
Certain checkpoints of the cell cycle in cultured cancer cell lines, 81/S and 821M have
been shown to be disrupted by flavonoids such as genistein, quercetin, silymarin and
apigenin. Although antiproliferative effects of flavonoids have been well established In
vitro, relatively little data exists on the in vivo antiproliferative effects.
Recently, Zang et al. (203) showed that flavonoids interact with the aryl
hydrocarbon receptor (AhR) in vitro. This receptor is the same through which 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD), a toxic halogenated aromatic industrial by-product,
exerts its toxic and mutagenic effects. Certain flavonoids were shown to be AhR
agonists, mimicking TCDD's action while other flavonoids, e.g. luteolin were antagonists,
blocking the stimulation of the AhR by TCDD. This study suggested that the effect of
dietary flavonoids should be taken into account when assessing TCDD-induced
biochemical and toxic responses in humans, but it is likely that the dietary intakes of most
phytochemicals would be below the levels required for an AhR agonist, based on the in
vitro cell culture studies (203).
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3.5 Summary
There is a great variety of dietary flavonoids and it seems unlikely that one particular
compound is responsible for all the associations described between plant components
and cancer prevention. Although multiple biological actions for dietary flavonoids
against cancer have been identified, it is not clear whether these effects would also be
present at physiological concentrations and/or for the flavonoid metabolites. More data
is needed before any of the possible inverse associations between flavonoid intake and
various cancers be used to support specific health recommendations (204). A better
understanding of synergisms and antagonisms between various flavonoids present in
our daily diet is needed.
Chemopreventive compounds mainly act as enzyme modulators, antioxidants,
inhibitors of carcinogen-adduct formation, inhibitors of oncogene activation or
modulators of signalling cascades associated with carcinogenesis (204). These
compounds are not only expected to interfere with the carcinogenesis process, but also
with the normal homeostatic processes in the body. Side effects may include
enhancement of carcinogenicity under certain conditions. Evaluation of potential
toxicological effects of these compounds should be thorough and elucidation of the
mechanisms involved is imperative.
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4. Tea and herbal beverages as possible tools for chemoprevention
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"Bodhidharma, the first Zen Buddhist legend around the 6th century A.D. tried to keep
himself awake during meditation by cutting off his eyelids. The eyelids grew as the first
tea plants and the tea has been used since to fend off sleep and clear the soul (8). The
Chinese emperor, Shen Nung, while on a journey, had a few leaves from a wild tea tree
fall into hot water producing a yellow brownish beverage that he tasted and liked. He
declared it gave vigour of body, contentment of mind and determination of purpose.
Gautama Buddha is said to have discovered tea when a leaf fell into his cup while
meditating in the garden (http://www.nationmaster.com/encyclopedia/tea) ...
Herbal teas are not regarded as true teas as they are not derived from Camellia
sinensis, but from other sources such as blossoms, leaves, stems and fruits of various
other plants (205). Herbal teas are more properly referred to as infusions or tisane. In
addition to being a safe, enjoyable and inexpensive beverage, tea also provides a
natural source of compounds that protect against various diseases (206-209). During
the past 7-8 years research from across the world yielded increasing scientific evidence
of the health benefits of tea to animal and man.
4.1 Camellia sinensis
4.1.1 History and processing
Tea derived from the evergreen shrub, Camellia sinensis belonging to the Theaceae
family, is used as a daily beverage worldwide and is second only to water in popularity.
Tea is usually prepared by infusing green or black tea leaves in a proportion of 1 g leaf
to 100 mL freshly boiled water for approximately 3 minutes. Tea has been consumed
socially and habitually by humans for more than 4000 years and the first accepted
reference is found in a Chinese dictionary from 350 A.D. stating the beverage was used
as a medicine for various illnesses (210). Tea was first cultivated in China and in the
late 1ih century, Japanese Zen priest, Eisai, brought the seeds of Camellia sinensis to
Japan (208). Tea is a perennial crop, with the bushes reaching maturity after 7 years
and maintaining steady yields for up to 100 years (211). Tea can be cultivated in many
regions with a high humidity, fair temperature and acidic soils from sea level to
mountainous areas (212). Based on the leaf features, two intra-specific varieties have
been identified, the China variety, referred to as C. sinensis var. sinensis (Fig. 13) and
the Assam variety referred to as C. sinensis var. assamica (213).
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Fig.13. Camellia sinensis plantation and picking of tea leaves
(http://www.dal.ca/-dp/vigs/tea.html).
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The China variety is a slow growing, dwarf shrub with small, narrow serrated and
dark green leaves, while the Assam variety is a quick growing tree with large, broad,
mostly non-serrated and light green leaves (211). Commercial cultivation has now
expanded and the major exporting countries include China, India, Kenya, Sri Lanka,
Argentina, Indonesia and Japan. India is the world's largest tea producing as well as tea
consuming country. In 1996 the annual world tea production was 2 610 569 metric tons
(214). Americans, Europeans, Africans and Indians typically prefer black tea, while
Japanese and Northern Chinese prefer green tea, with oolong and paochong tea (semi
fermented) favoured in Taiwan and parts of China (215).
The teas differ only according to the different degree of "fermentation" or
chemical oxidation involved in their manufacture. Black tea (Fig. 14) is made by
maceration of fresh tea leaves after withering to effect "fermentation" before drying. The
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crushing and maceration of the tea leaves partially destroys the cell structure to allow
enzymatic oxidation of the flavanols in the presence of oxygen (216). During the
"fermentation", when endogenous enzymes catalyse aerobic oxidation, oligomeric
flavanols e.g. theaflavins and thearubigins are formed to provide the characteristic
flavour and colour of black tea (215). After "fermentation" the teas are fired by hot air
dryers to stop the enzymatic fermentation and reduce the moisture content to about 3%.
During the firing process the flavour and aroma is further developed (216) where after it
is sorted into the appropriate grades. Green tea (Fig.14) is prepared from fresh leaves
that are rapidly subjected to heat treatment after harvest to prevent any oxidative
fermentation. This is done by either steaming (Japanese style) the leaves or roasting
them in a pan referred to as Chinese style (217). The leaves are then pressed, rolled,
dried and sorted into various grades. The composition of the teas also varies with the
species, season, age of the leaf, climate and horticultural practises (215,218).
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Fig. 14. Commercially available black (left) and green tea (right).
Another tea that has received little attention for its health benefits is white tea.
White tea is amongst the rarest and most expensive varieties of tea and is exclusively
produced in China, mainly in the Fukien province and represents the least processed
form of the teas. This tea is made from the new growth buds shielded from the sunlight
to prevent the formation of chlorophyll. Little data is available on the phenolic
constituents and biological properties of this tea (219).
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4.1.2 Major phenolic constituents
4.1.2.1 Tea f1avonoids
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The major polyphenolic fraction in green tea is the group of flavonoids made up of
flavanols, i.e. the catechins (215,220). In addition to caffeine, the phenolic acid, gallic
acid and the purines, theobromine and theophylline are also present as minor
constituents. Partially "fermented" teas (oolong and paochong) contain both green tea
catechins and black tea theaflavins (221). The principal catechins (Fig. 15) in fresh tea
leaves and green tea are (-)-epigallocatechin-3-gallate (EGGG), (-)-epigallocatechin
(EGG), (-)-epicatechin-3-gallate (EGG), (-)-epicatechin (EG), (+)-gallocatechin (GG) and
(+)-catechin (G).
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Fig. 15. Major green tea catechins (222).
EGGG is the most abundant catechin accounting for 6-16% on a dry weight basis
(223). EG contains an orlho-dihydroxyl group in the B-ring at carbons 3' and 4' and a
hydroxyl group at carbon 3 on the G ring while EGG has a gallate moiety esterified at
carbon 3 of the G ring. EGG has a trihydroxyl group at carbons 3', 4', and 5' on the B
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ring while EGCG has an added gallate moiety esterified at carbon 3 on the C ring
(207,214,215,220). Catechins are colourless, water-soluble compounds lending
bitterness and astringency to green tea infusions. The taste, colour and aroma of
manufactured tea are associated with modifications to the catechins (224).
The main flavonols in tea leaves are quercetin, kaempferol and myricetin and
they rnake up 2-3% of the water-soluble extract (214). Flavonols are predominantly
present as glycosides with the sugar moieties consisting of glucose, rhamnose,
galactose, arabinose and fructose and mono-, di- and tri-glycosides. Variable values for
flavonol glycosides content in teas are reported which could be ascribed to different
sources of tea and varying processing procedures (225).
In the preparation of black teas, catechins are oxidised yielding the typical colour
and flavour. The pigments of black tea have been divided into orange-red coloured
theaflavins and brownish thearubigins (Fig. 16). Theaflavins are formed from
polymerization of catechins during fermentation (226). There are four main theaflavins,
theaflavin, theaflavin 3-gallate, theaflavin 3'-gallate and theaflavin 3,3'-digallate. The
thearubigins are a heterogeneous group of phenolic pigments with relative higher
molecular mass and are the major contributor to the black tea polyphenols (227).
Theaflavins contain benzotropolone rings with dihydroxy or trihydroxy substitutions, with
the thearubigins even more extensively oxidised and polymerised as illustrated in figure
17. A typically brewed black tea beverage contains approximately 3-10% (w/w)
catechins, 2-6% theaflavins and >20% (w/w) thearubigins of the tea soluble solids per
dry weight (214,215,228).
Quantitative and qualitative analyses of white tea identified nine of the major
constituents found in green tea. EGCG was present at equally high levels in white tea
when compared with levels in green tea. Higher levels of gallic acid, theobromine, ECG
and caffeine were also found in white tea (219).
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Fig. 17. Generic structure of thearubigins in black tea (215).
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4.1.3 Metabolism of tea polyphenols
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The metabolism of green tea catechins has been studied in various animals and
humans showing that orally administered catechins are absorbed, metabolized and
rapidly excreted within 24 hr in humans and 6-10 hr in experimental rats (229,330).
Studies conducted in rats indicated that EGCG is mainly excreted through bile, while
EGC and EC are excreted mainly through urine and bile (207,229). These studies are in
agreement with another carried out by Chen et al. (231) where EGCG was absent from
human urine samples, while EGC and EC was recovered. Metabolism and
bioavailability of tea constituents are dependent on several factors including their
structure, purity, dosage and route of administration. When green tea extract was
consumed by healthy individuals, EGCG, EGC and EC were found in the plasma in
concentrations varying from 0.2% to 2% of the ingested amount within 1.4 to 2.4 hr after
ingestion (207). Saliva was found to have catechin esterase activity, suggesting that
EGCG may be degalloylated in the mouth and oesophagus (230). A study conducted in
rats suggested that catechins are either glucuronidated in the intestinal mucosa,
sulphated in the liver and/or methylated in the liver and kidney. The major metabolites
detected were the glucuronidated catechins (232). Human plasma also contains 0-
methylated and glucuronidated catechin metabolites and the authors suggested that the
profile of conjugated metabolites may change at higher doses due to the saturation of
specific metabolic pathways (232,233). EGCG is also absorbed by the skin when
applied topically in a hydrophilic ointment (234). Information regarding the bioavailability
and tissue levels of the tea constituents should feature prominently in future mechanistic
studies, as only activities displayed by tea constituents at concentrations achievable in
human tissues are of importance.
4.1.4 Biological activity of tea polyphenols
Due to the unique structures and activities of tea polyphenols they have a broad utility
for treatment of various diseases or modulate many risk factors associated with
common medical ailments. These include cardiovascular disease, cancer, oral health,
bone health, thermogenesis, cognitive function, iron status, kidney stones, diabetes,
immune responses, antibacterial activity, antiviral activity, dermatological therapy and
various other (8,235). Many of these benefits are ascribed to the antioxidant properties
and free radical scavenging ability of green and black teas. The catechins interact with
numerous structurally unrelated molecules and may alter cellular membranes, proteins,
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lipids, nucleic acids as well as cellular factors important for normal and abnormal cell
growth which are the key to cancer development and metastasis. Some of these
interactions could be responsible for the anticarcinogenic and antimutagenic properties
of green and black teas (236,237). Despite all these findings, the understanding of the
mechanisms involved in the biological effects of green and black teas are far from
complete. However, these mechanisms are important to design strategies for prevention
and treatment of cancer.
4.1.4.1 Antioxidant activity
(i) In vitro studies. A number of studies, using different assays, have reported on
the in vitro antioxidant activity of green, black and oolong teas as well as their
respective phenolic constituents (238). Each assay differs in its measurement of
antioxidant activity depending on the nature of the radical generating system and assay
conditions applied. Some of these assays include (i) the FRAP (ferric reducing ability of
plasma) assay, based on the reduction of ferric ions (Fe3+) to ferrous ions (Fe2+), (ii) the
TEAG (Trolox equivalent antioxidant capacity) assay based on the formation and
scavenging of the ABTS+ [2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid)] radical
cation, (iii) the TRAP (total radical-trapping parameter) assay measuring the total
peroxyl radical trapping capacity, (iv) the ORAG (oxygen radical absorbance capacity)
assay measuring the decrease in fluorescence of phycoerythrin in the presence of the
radical generator, AAPH [2,2'-azobis(2-amidinopropane) dihydrochloride] that generates
aqueous peroxyl radicals at a constant rate and (v) the DPPH radical assay measuring
the ability to donate a hydrogen atom to the stable free radical, 2,2-diphenyl-1-
picrylhydrazyl (DPPH") (239). Using the ORAG assay, green and black teas displayed a
much higher antioxidant activity against peroxyl radicals when compared to garlic, kale,
spinach and Brussels sprouts (240). In the FRAP assay green tea is more potent than
black tea (241). A study done by Vinson and Dabbagh (242) showed that phenolic
constituents of black and green teas are responsible for its antioxidant activity and that
the pure catechins and phenolic acids were found to be more powerful than vitamins G,
E and f)-carotene in an in vitro lipoprotein oxidation model. The antioxidant activity of
the catechins using the Rancimat method varies in the order EGGG > EGG> EGG> EG
with EGGG being the single strongest antioxidant as well as the major catechin
component of green tea (243,244). The linkage of gallic acid to the epicatechin or
epigallocatechin structure via esterification at the 3 position increases the antioxidant
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potential (146). The antioxidant effectiveness of purified tea components inversely
correlated (r " -0.999) with the % polyphenol content which was not the case for
aqueous extracts prepared from the various green, black and oolong teas. Tea
flavonoids have also been shown to directly quench reactive oxygen species in vitro as
well as chelate metal ions to prevent their participation in Fenton reactions (246). The
ability of a compound to scavenge free radicals is partly ascribed to its reduction
potential (hydrogen or electron donation). EGCG and EGC have a lower reduction
potential than vitamin E, suggesting they are superior electron donors (246). The in vitro
antioxidant capacity of the various teas and their constituents is dependent on the type
of assay used and does not reflect factors such as bioavailability and metabolism. The
fact that catechins are metabolised could play an important role in the in vivo antioxidant
activity.
(ii) In vivo studies. Most animal studies utilise the thiobarbituric acid reacting
substances (TBARS) assay to assess the effect of tea consumption on lipid
peroxidation in vivo. Plasma TBARS were decreased in hamsters fed a diet containing
1% tea catechins, and Wistar rats consuming black tea (243,247). New Zealand white
rabbits did not show any difference in the plasma TBARS after consuming green or
black tea in their drinking water (248). A study conducted by Kim et al. (249) indicated
that topical application of EGCG to guinea pigs protected against UV-B light induced
oxidative damage by reducing the TBARS in the skin. Serafini et al. (250) were one of
the very first groups to show an in vivo effect that both green and black teas increased
the plasma antioxidant activity in humans. Since then, numerous other studies have
been conducted to demonstrate that a single dose of tea enhances the plasma
antioxidant capacity of healthy adults. Using the FRAP assay, a significant increase in
the plasma antioxidant capacity was detected in humans consuming three cups of
green or black tea, while in another study, subjects consuming 300 mL of green tea
showed a significant increase in their plasma antioxidant activity, using the ABTS assay
(251-254). Biomarkers of oxidative damage such as oxidized deoxynucleosides (8-
hydroxydeoxyguanosine), thiobarbituric reactive substances (TBARS) or
malondialdehyde (MDA), micronuclei formation, sister chromatid exchange and low-
density lipoprotein (LDL) are often utilised as surrogate markers for in vivo antioxidant
activity (215). In studies examining the effect of tea consumption on some of these
biomarkers in humans, one study indicated a significant 22% decrease in plasma
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TSARS after the consumption of approximately 10 cups/day of green tea for 4 weeks,
while another study showed no significant changes in volunteers consuming 2-3
cups/day for 7 days (255,256). However, in a study conducted in 1999 where healthy
volunteers consumed six cups of black tea per day, their plasma was not protected from
lipid peroxidation ex vivo (257). The discrepancy between the powerful in vitro
antioxidant efficacy and the lack thereof in vivo could be ascribed to the insufficient
bioavailability of tea polyphenols in humans.
4.1.4.2 Prooxidant activity
Although plant polyphenols are good antioxidants that act as radical scavengers
protecting the cell against oxidative damage, polyphenols also exhibit prooxidant activity
under certain conditions, generating hydroxyl radicals especially in the presence of Fe
(II or III), Ag (I) or Cu (II) [258,259]. Purified tea polyphenols, EGCG and ECG induce
apoptosis in various cancer cells which is associated with the generation of H202. Yang
et a/. suggested that EGCG may serve as a prooxidant, but the relevance of this
mechanism still needs to be studied in vivo (260) as transition metals found in vivo and
in plasma are complexed by proteins and are unlikely to catalyse the autoxidation of
polyphenols significantly (261).
4.1.4.3 Metal ion chelation
Dietary iron is available in two valence states, ferrous (Fe2+) and ferric (Fe3+) and the
majority of Fe2+ is found in haem iron whereas the majority of Fe3+ is in non-haem iron.
Tea consumption mainly influences the absorption of non-heme iron and the reduction
of non-heme iron absorption in the presence of tea flavonoids suggests that chelation of
iron are one of the mechanisms of antioxidant action in vivo (262,263).
The iron chelating activity of tea flavonoids may affect the function of various
heme- or metalloproteins that are dependent on metal ions for activity (264). Tea
polyphenols chelate metal ions such as iron and copper thus preventing their
participation in free radical generating reactions (146,245,265). Iron and copper playa
major role in the production of the very reactive hydroxyl radical (HO') through the
Fenton and Haber-Weiss reactions (266) and chelation of these metals will decrease
the oxygen toxicity to cells. Green and black tea polyphenols bind ferric iron (Fe3+) to
form a redox-inactive Fe-polyphenol complex (265). The gallate esters, EGCG and
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ECG, have greater chelating activity than EGC and EC and are active in vivo as
consumption of green and black tea lowers absorption of dietary iron (266).
Glycosylation at any of the functional hydroxyl positions would decrease the metal
chelating activity of that particular flavonoid (175.)
4.1,4,4 Antimutagenic activity
In the mid 1980s Japanese and Chinese investigators reported that water extracts of
green tea exhibited antimutagenic effects in bacterial test systems (267,268). Since
then many in vivo studies in rodents were conducted with water extracts or phenolic
fractions of green and black tea to investigate the possible protective effects of tea
against cancer development. These studies show that tea protects against many types
of cancers in skin, lung, oesophagus, stomach, liver, small intestine, pancreas, colon,
bladder, prostate and mammary glands (269-276).
(i) Salmonella mutagenicity studies. In vitro studies using the Salmonella
mutagenicity assay indicated that tea and tea components display antimutagenic activity
against the major classes of dietary, environmental and occupational mutagens and/or
carcinogens. These include heterocyclic amines, polycyclic aromatic hydrocarbons and
their ultimate carcinogens, nitrosamines and other aromatic amines, pyridoindols and
pyridoimidazols as well as UV light (55,277-281). Comparison of the antimutagenic
activities of aqueous extracts of green, black and decaffeinated black tea conducted at
concentrations customarily used for human consumption showed no major differences
in the antimutagenic potential against three different metabolic activated mutagens
(282). In a study conducted by Weisburger et al. (278) similar protective effects were
observed for green and black tea polyphenols against groups of carcinogens or
mutagens representing aromatic and heterocyclic amines, polycyclic aromatic
hydrocarbons and N-nitrosamines, with no effect on the mutagenicity of 1-nitropyrene
and 2-chloro-4-methylthiobutanoic acid. Apostolides et al. (283) showed that purified
black tea polyphenols have slightly better protective effects against PhlP-induced
mutagenicity than green tea polyphenols.
Relatively fewer reports are found on studies comparing black tea with green tea
with regards to antimutagenicity (284). A common finding though was that the inhibition
of mutagenesis is associated with the polyphenol fraction of both green and black teas.
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Many studies attempt to identify the active component(s) responsible for green and
black tea's good antimutagenic and/or anticarcinogenic activities (280,285). These
studies suggest that different degrees of tea fermentation might produce different types
of antimutagenic compounds effective against different mutagens (286).
It is apparent from the available data that the cancer chemopreventive activity of
green and black tea is a combined effect of several active components, as shown by
Suganama et al. (287) where the action of EGCG in the presence of EC and that of a
whole green tea infusion showed better protective activity than EGCG alone in lung
cancer cells.
Recently a study conducted by Santana-Rios et al. (219) reported on the potent
antimutagenic activity of white tea against a number of heterocyclic amines compared
with green tea in the Salmonella assay. The greater inhibitory effect exhibited by the
white tea was proposed to be related to higher concentrations of several of the major
phenolic constituents and a possible synergistic effect with the minor constituents to
prevent mutagenicity, presumably via multiple mechanisms.
(ii) Animal studies. Tea and its constituents inhibit chemically-induced
carcinogenesis in various animal models. Yoshizawa et al. (288) were the first to use
the two stage skin carcinogenesis mouse model to demonstrate that the topical
application of the green tea flavonoid, EGCG inhibited tumour promotion in DMBA-
initiated, teleocidin-promoted mouse skin while Katiyar et al. (62) showed an inhibition
of TPA promotion utilizing the same mouse skin model. Since then many studies
demonstrated that topical application or oral feeding of phenolic extracts and individual
catechin derivatives of green and black tea has anticarcinogenic activities in animal skin
studies (274,289-291). To elucidate the mechanisms involved, various studies showed
that the tea inhibits DNA synthesis and enhances apoptosis. A study conducted by
Saha and Das (292) indicated the activation of several detoxification enzymes,
decreased cellular damage, inhibition of cell proliferation and induction of apoptosis in
the liver of DMBA-initiated, croton oil-promoted mice consuming aqueous black tea,
black tea polyphenols and EGCG. Topical application of black tea polyphenols also
inhibits markers of inflammatory responses such as epidermal edema, hyperplasia,
leukocyte infiltration, induced activity of epidermal ornithine decarboxylase and
cyclooxygenase (207).
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In addition to preventive effects against skin carcinogenesis, studies indicated
that green and black tea polyphenols are also effective against chemically induced
carcinogenesis of various internal organs. Oral consumption of green or black tea water
or phenolic extracts demonstrated a protective effect against N-nitrosodiethylamine and
benzo[a]pyrene-induced forestomach and lung tumourigenesis in A/J mice (274,293).
When the tobacco smoke carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
(NNK) was used to induce lung tumorigenesis in mice and rats, green, black tea
extracts and EGCG and theaflavins afforded effective protection (153,276,293). Tea
consumption and digestive tract cancers have also been studied and recently Morse et
al. (294) reported that theaflavin significantly reduced NMBA-induced oesophageal
tumour formation, while other studies showed high doses of theaflavin, black or green
tea polyphenols or EGCG reduced the tumour multiplicity but not the oesophageal
cancer incidence when orally administered to rats (272,295). Oral feeding of EGCG also
resulted in a reduction of N-ethyl-N'-nitro-N-nitrosoguanidine (ENNG)-induced
duodenum tumourigenicity in C57BL/6 mice (296). Different studies also reported on the
effects of black and green tea on azoxymethane (AOM)-induced colon cancer in rats,
with one study reporting on the inhibition of AOM-induced carcinogenesis following oral
feeding of green tea polyphenols in drinking water of Fischer rats (297). The oral
feeding of a tea infusion with or without the addition of milk during the period of
carcinogen administration significantly decreased the production of aberrant colon
crypts (298). When heterocyclic amines obtained from grilled and/or cooked meat, were
used in animal studies green tea, EGCG and black tea polyphenol fractions also
inhibited the formation of aberrant crypts in the colon with a synergistic effect between
green tea and phylic acid (299,300). Beneficial effects of tea have also been observed
in rats, mice and hamsters in the inhibition of liver carcinogenesis. The administration of
green tea leaf in the diet of rats prior to and after DEN and AFB1 treatment resulted in a
significant inhibition of X-glutamyl transpeptidase-positive foci in the liver (272,301). Tea
catechins, black tea and oolong tea extracts significantly decreased the number and
area of preneoplastic GST-P positive foci in the liver of DEN-initiated, PB-promoted liver
carcinogenesis (302). Recently, the protective effect of tea on the development of
mammary gland and prostate cancer has also been investigated. Black and green
catechins had no significant inhibitory effect on 7,12-diemethylbenz[ajanthracene
mammary gland carcinogenesis in rats, while EGCG, administered via intra peritoneal
route, inhibited the growth and reduced the size of tumours initiated by human prostate
and breast cancer cell lines inoculated into mice and rats (303,304). Results from these
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studies indicated that tea is active against carcinogenesIs In animals for skin, lung,
colon, liver, oesophagus, forestomach and hormonal-dependant cancers.
(iii) Studies in humans. Epidemiological studies on the relation between tea
consumption and altered cancer risk have been inconsistent. This could be ascribed to
the lack of proper study design as most of the studies were not specifically designed to
assess the effect of tea consumption on minimising the risk factors for cancer
development. Differences in lifestyle habits, type of tea and duration of tea consumption
in the different study populations and potential confounding factors could also be
contributors to the inconsistent findings (180,305,306). One Japanese cohort study
found a significant inverse association between total cancer risk and green tea
consumption in women who consumed more than 10 cups per day (307). In a study
designed to determine the tea intake patterns in an older south western United States
population, a significantly lower risk of squamous cell carcinoma (SCC) of the skin was
associated with hot black tea consumption (306). The consumption of black tea was
shown to reduce the risk of rectal cancer in women and men in a Russian population
based case-control study (308). In China, a case control study indicated an inverse
association with ovarian cancer, concluding that an increased frequency and duration of
green tea consumption may reduce the risk of ovarian cancer, while further
investigations are required for black and oolong teas (309). A more recent nested case-
control study conducted in Japan to evaluate whether green tea consumption provides
protection against development of stomach cancer also showed no inverse association,
which is in accordance with four other prospective studies (310). These results confirm
the need for future studies with the goal of examining green and black tea intake in
relation to the reduction of cancer risk in humans in much more detail.
4.1.5 Proposed protective mechanisms
Anticarcinogenic compounds have been classified into three categories according to
their proposed mechanisms of action i) compounds inhibiting the formation of mutagenic
and/or genotoxic metabolites from precursor molecules, ii) "blocking" compounds
inhibiting the reactions of carcinogens or scavenging radicals and iii) "suppressing"
compounds which inhibit the expression of the malignant characteristics at cellular level
(311,312). Multiple mechanisms seem to exist whereby tea and its phenolic constituents
elicit their inhibitory effects against mutagenesis and/or carcinogenesis and these
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include inhibition of the metabolic activation of carcinogens, increased detoxification via
the induction of phase II enzymes; inhibition of oxidative damage to DNA and proteins,
inhibition of enzymes involved in the formation of reactive oxygen species and radicals
and influencing cellular and molecular events (313). Other mechanisms relating to
antiviral activity and enhancement of immune functions have also been suggested but
their relevance to carcinogenesis still needs to be elucidated.
4.1.5.1 Modulation of drug metabolising enzymes and oxidative stress
Both phase I and phase II enzymes are induced by rats consuming green or black tea
extracts (314). A variety of green tea polyphenols have been shown to alter rat liver
microsomal mono-oxygenase activities. Exposure of rats to sub-chronic doses of green
and black teas caused an induced activity of specific classes of P450, e.g. 1A1, 1A2,
and 2B1 with no effect on the other phase I enzymes (300,314,315). Green tea
catechins inhibited aryl hydrocarbon hydroxylase (AHH) activity in liver and in epidermal
microsomes as well as tissue enzyme-mediated binding of tritiated B[aJP to DNA. These
results all suggest that the antimutagenic potential of green tea polyphenols may be in
part, related to their ability to inhibit P450-dependent metabolic activation of PAHs,
which would result in the inhibition of PAH-DNA adduct formation (237). The inhibition of
P450-dependent bio-activation may be due to impairment of the electron flow from
NADPH (222).
The enhanced generation of reactive carcinogen metabolites is not necessarily to
a cell's disadvantage, as tea polyphenols also increase the detoxification rate by
simultaneous induction of phase II detoxifying enzymes. Chronic feeding of mice with
green tea extracts in their drinking water significantly enhanced the activities of phase II
enzymes such as glutathione-S-transferase, glutathione peroxidase, catalase and
NADPH-quinone oxidoreductase in the bowel, lung and liver (316), while Bu-Abbas and
co-workers showed stimulation of hepatic UDP-glucuronosyl transferase activity (317).
A study conducted by Sohn et al. (314) indicated a significant increase in the activity of
UDP-GT as well as increased levels of GSH in the plasma of male Fischer rats
consuming aqueous extracts of green and black teas. Oral feeding of green tea leaves
in the diet of male Wistar rats resulted in significant increases in the activities of the
antioxidant enzyme, catalase and the phase II detoxifying enzyme, GST-a. Also noted
were elevated levels of GSH in the liver (318). Various in vitro studies have confirmed
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the protective effect green tea polyphenols have against oxidative injury by minimising
the generation of ROS, decreasing lipid peroxidation and stabilising the endogenous
antioxidant GSH, thus enhancing the ability of the cells to cope with oxidative stress.
(319-320).
Other mechanisms hypothesized include induction of DNA repair and binding
with activated carcinogens. The antimutagenic and/or anticarcinogenic effect of teas
may be partly due to changes in hepatic drug metabolizing enzymes (222).
4.1.5.2 Cell cycle regulatory effects
Many studies indicate an association between cell cycle regulation and cancer via the
modulation of cell proliferation and apoptosis (322). In eukaryotes regulation of the cell
cycle is partly controlled by a family of protein kinases complexes. These complexes
consist of a catalytic unit, the cyclin-dependent kinase and an activating unit, the cyclin,
which are activated at specific intervals during the cell cycle. Exogenous factors have
been suggested to induce and regulate these complexes (322). EGCG irreversibly
causes GO/G1-phase arrest of the cell cycle in A431, a human epidermoid carcinoma
cell line (322). EGCG and EGC also inhibit the proliferation of various cancer cell lines
as measured by [3H]thymidine incorporation, with some cells requiring higher
concentrations while other are more sensitive to lower concentrations. EGCG is the
most active inhibitor of proliferation of certain breast cancer, colon cancer and
melanoma cancer cell lines, whereas EGC is more active against a lung carcinoma cell
line (323). Fujiki et a/. (324) reported that tea polyp henoIs cause a G2/M cell cycle
arrest and growth inhibition in a human lung cancer cell line. Green and black tea
polyphenols also strongly inhibit DNA synthesis in DS 19 mouse erythroleukemia cells
and cell growth in four human tumour cell lines (323,325).
The inhibitory activities of tea and tea polyphenols may also be due to their ability
to inhibit growth-related signal transduction pathways. AP-1 (activator protein), an
oncogene, is involved in cell transformation and progression of cancer, and NFKB
(nuclear factor kappa B) is an anti-apoptotic factor which promotes survival in cancer
cells. The inhibition of AP-1 dependent transcriptional activity occurs via the inhibition of
a c-jun NHrterminal kinase-dependent pathway. EGCG, EGC and theaflavin-3,3'-
digallate have been shown to inhibit AP-1 activation and the phosphorylation of c-jun
and an extracellular signal-related protein kinase (Erk). Inhibition of the transcription
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factors, NF-K8 and AP-1 as well as the reduced activity of protein tyrosine kinase and c-
jun mRNA expression by EGCG may also contribute to the anticarcinogenic effect of the
tea and its polyphenols (224,326). Recently, another mechanism by which EGCG
induced apoptosis was reported, suggesting that EGCG specifically binds to Fas, also
known as APO-1 or C09S, presumably on the cell surface, triggering the cascade of
Fas-mediated apoptosis in U937 cells (327).
Cell cycle inhibitors are viewed as being the new generation of anticancer drugs
and some synthetic compounds are already being investigated in clinical trials. Natural
occurring agents like tea polyphenols could therefore play an important role as potential
chemopreventive agents (322).
4.1.5.3 Anti-inflammatory activity
An association between chronic inflammation and increased cancer risk has been
demonstrated by various epidemiological studies (328). Phagocytes secrete chemically
reactive oxidants, radicals and electrophillic compounds during the process of
inflammation which can damage surrounding tissue leading to DNA adduct formation
and somatic mutations resulting in malignant transformation. Reactive oxygen species
(ROS) and reactive nitrogen species (RNS) are considered as major bio-determinants in
the process of cancer development (328,329). In this regard, the formation of nitric
oxide (NO) is increased during infection and inflammation, possibly promoting
carcinogenesis.
Tea polyphenols react with nitrosating species, inhibiting nitrosation (330,331).
Humans consuming green and black tea also demonstrated the inhibition of N-
nitrosoproline formation and it was estimated that the consumption of 3-S g of tea per
day may effectively block nitrosation reactions in humans (332). Green tea polyphenols
also inhibit both in vitro and in vivo nitrosation reactions (333) which are regarded as a
major source for the endogenous formation of secondary and tertiary amines in
humans. There exists a two-edged situation similar to the antioxidant and/or prooxidant
activities of tea, as tea polyphenols at low concentrations can also be nitrosated to form
C-nitroso derivatives which can act as potential catalysts of other nitrosation reactions
(272)
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The green tea catechin, EGCG was shown to block the induction of nitric oxide
synthase (iNOS) by down-regulating the activity of transcription factor NFKB (nuclear
factor kappa B) in macrophages (326). Another study by Paquay et al. (334) confirmed
the protective effects of green and black tea against NO toxicity in a pulmonary
macrophage cell line. The tea and tea components not only scavenged NO and
peroxynitrite, but also inhibited the activity as well as the induction of iNOS. In mouse
skin the induction of inflammation is mediated by chronic topical application of the
phorbol ester tumour promoter, TPA. Topical application of black tea polyphenols
significantly inhibited the markers of inflammation, e.g. induction of epidermal ornithine
decarboxylase (ODC), cytokine IL-1a mRNA expression and cyclooxygenase activity
(335).
4.1.6 Tea tannins and human health
Hurrel and co-workers showed that black tea, when consumed simultaneously, inhibits
the bioavailability of non-heme iron by 79 to 94% (336). Consumption of green tea
extracts with a meal also reduces the non-heme iron absorption by 25% (263). Iron
deficient anaemia among children in Saudi Arabia and the United Kingdom, may be
aggravated by the regular consumption of tea with meals (337,338). Tea is not likely to
cause iron deficiencies in healthy individual consuming a well balanced diet that
includes readily available sources of heme-iron. Vegetarians and other people at risk for
iron deficiency anaemia, e.g. infants, young children and pregnant women, should be
encouraged to drink tea between meals and with added milk or lemon juice, limiting the
chelating activity (339,340).
Obtaining significant effects through diet supplementation with polyphenol
extracts seem to be very difficult without decreasing the nutritional value of diets,
especially the reduction in digestibility and protein efficiency. This was shown in a study
conducted by Zdunczyk et al. (341) where the addition of large amounts of catechin
extracts (0.8%) effectively reduced the total cholesterol and LDL fraction in the serum,
but also caused a reduction in protein digestibility and protein efficiency. It was
mentioned that catechin extracts from green tea leaves and flavones from skullcap
exhibited more favourable biological properties compared to anthocyanins and
condensed tannins.
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4.1.7 Caffeine and human health
Caffeine (1,3,7-trimethylxanthine), a natural alkaloid is probably the most frequently
ingested pharmacological substance in the world, as it is found in coffee, tea, soft
drinks, cocoa products and certain medications. Tea contains between 20-73 mg/100
mL (342) and variation of the content is dependant on preparation as well as the type of
tea. Upon ingestion, caffeine is absorbed from the gastrointestinal tract into the
bloodstream and can also pass the blood-brain barrier and placenta (343). Caffeine is
primarily metabolised in the liver. Infants up to the age of 8-9 months have a reduced
ability to metabolise this alkaloid (344). People differ in sensitivity to caffeine and need
to be aware of possible adverse effects such as altered calcium balance in bones,
increased anxiety, increased time to fall asleep, reduced fertility and interference with
foetal growth (345). In growing children it is unknown if long-term daily consumption of
caffeine would produce effects such as hyperactivity and anxiety as no study has been
designed to test for potential chronic effects. The nervous system, including the brain,
continues to develop and mature throughout childhood and it is possible that the
delayed development of the nervous system may render children more sensitive to any
adverse effects of caffeine. In healthy adults, the moderate consumption of caffeine has
not been associated with any major adverse effects. Based on data from many studies,
a dose level of 6 mg per kg bodyweight per day caffeine for healthy adults was
established without adverse effects and children should not exceed an intake of 2.5 mg
caffeine per kg bodyweight per day (346).
4.2. Aspalathus Iinearis (Rooibos tea)
4.2.1 History and processing
Rooibos (pronounced "roy boss") tea has been used as herbal beverage and to a lesser
extent, as herbal medicine, in South Africa since the 1800's (347). The indigenous Khoi
people were the first to use rooibos tea as a herbal beverage and in 1904 a Russian
immigrant, Benjamin Ginsberg, began trading it from the San tribe. Just before the
Second World War, his son, Charles Ginsberg started what is considered today as the
"heritage" rooibos brand, Eleven O'Clock Rooibosch Tea. It was in the 1930's when a
local medical doctor and nature lover, Dr P.F. Le Fras Nortier, realised its commercial
potential and initiated cultivations in plantations by various local farming communities
(hltp:l/www.rooibosltd.co.za/storvof.htm). Ceylon tea was in short supply during the
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Second World War, while production levels of rooibos grew steadily. However, after the
war the rooibos market collapsed and in an effort to rescue the industry the producers
established the Clanwilliam Tea Cooperative in 1948. In 1954, the cooperative became
the Tea Control Board with the goals being regulation of marketing, stabilization of
prices and standardization of the quality. In 1993, the governmental Tea Control Board
was privati sed and the company Rooibos Ltd was established
(http://www.rooibosltd.co.za/storvof.htm) owned largely by rooibos producers.
Fig. 18. - Map of Western Cape Province, South Africa with Clanwilliam region
indicated in red (Rooibos Ltd, Clanwilliam, South Africa).
Today rooibos is cultivated on over 23 000 hectares of land and includes over
350 commercial farmers in the Clanwilliam region of the Western Cape Province (Fig.
18) and less than 200 small-scale farmers located in the town Wupperthal in the
Cedarberg mountain area of the Western Cape Province and in Southern Bokkeveld, an
area south of Nieuwoudtville in the Northern Cape (http://www.qem.orq.za;
http://wwwwesqro.orq.za). The popularity of this herbal tea, both locally and abroad can
be ascribed to the low tannin content and absence of caffeine (348,349). The annual
quantity rooibos tea produced in 2003 was -9500 tons, with total sales for 2003 being
10500 ton of which 62% was exported (Personal communication, Arend Redelinghuys,
Rooibos Ltd). The European market, mainly Germany and the Netherlands, accounts
for the highest export volumes from South Africa, followed by Japan and the United
Kingdom. About 30% of exported rooibos teas are flavoured varieties. There is also an
increasing demand for organic and "green" or unprocessed rooibos tea and many farms
are In the process of converting to organic production
(http :www.emg.org.za/Documenls/rooibos. pdf).
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Aspalafhus linearis (Fig. 19), belonging to the Fabaeeae family (Leguminosae), is
endemic to the Cedarberg region of the Western Cape, a mountainous area 250 km
north of Cape Town. Only here can one find the unique combination of soil, altitude and
climate necessary for the plant to grow.
Fig. 19. The rooibos plant, Aspalathus linearis (Courtesy of Rooibos Ltd,
Clanwilliam, South Africa).
A closely related species, A. pendula Dahlg., as well as several wild types of A.
linearis are used to prepare rooibos tea but on a non-commercial scale. Rooibos
requires sandy soil with high acidity and sparse but consistent rainfall, is seeded
between February and March and harvested 18-24 months later. The field can be
harvested three more times, where after the land is ploughed and left for five years
before it can be replanted. During this time the farmers fertilize the soil with other crops
such as wheat or potatoes. The plant is a shrub-like bush with a central, smooth barked
main stem and divides into a number of strong offshoots near the soil, followed by side
branches bearing the needle-like leaves and stems that are used to manufacture
rooibos tea (hltp:/Iwww.rooibosltd.co.za). The plant's height varies from 1 to 1.5 m in its
natural state. Branches are cut either by hand with a sickle or by machine. Two types of
rooibos tea can be produced depending on the processing methods. Manufacturing
processed rooibos tea entails cutting the leaves and stems into uniform lengths of 3-5
mm, thoroughly wetting the cut leaves and stems before it is bruised between rollers to
induce chemical oxidation or "fermentation" in heaps (Fig. 20).
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Fig. 20. Processing steps in the manufacturing of rooibos tea (Courtesy of
Rooibos Ltd, Clanwilliam, South Africa).
During the oxidation step, the distinctive red colour, aroma and flavour of rooibos
tea are developed. After the oxidation process, which lasts from 12-24 hrs depending on
the temperature of the heap, the cuttings are thinly spread out in hot sunlight to dry.
Further processing is then accomplished at the factory and includes sieving. grading,
steam pasteurisation and drying over a hot air-bed dryer. Rooibos tea is subjected to
strict microbiological tests before it is made commercially available. The rooibos is then
weighed, packed, either in bags or in loose leaf form, and marketed under various brand
names (personal communication, Arend Redelinghuys Rooibos Ltd).
Another type of herbal tea is the unprocessedl"unoxidised" or "green" form of
rooibos tea which is manufactured by immediately drying the harvested plant material in
an oven before cutting it into pieces and sieving it, preventing chemical oxidation to take
place. During the oxidation step when preparing the processed rooibos tea, a
substantial loss of the major flavonoid, aspalathin, occurs as well as a decrease in
antioxidant activity (350,351). This warranted the development of a minimally oxidised
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product, the "green" rooibos (353). Unprocessed rooibos tea has only recently come
onto the South African and overseas markets.
4.2.2 Phenolic constituents
The phenolic constituents of rooibos tea (Fig. 21) differ from that of green and black
teas, and are unique as rooibos tea contains aspalathin, only isolated from rooibos and
nothofagin, another rare il-hydroxydihydrochalcone (353). The dihydrochalcone content
of rooibos decreases substantially during processing, with less than 7% of the original
aspalathin content remaining in the processed tea (354).
Apart from the aglycone, quercetin, other flavonols present in rooibos, is the
quercetin glycosides, rutin and isoquercitrin (353). According to Toyoda et al. (355)
rooibos contains the flavonol, kaempferol, but this identification is based only on HPLC
analysis. The flavones comprise orientin, iso-orientin, vitexin, chrysoeriol, 5,7,4'-
trihydroxy-3-methoxyflavone and luteolin (353). The flavanol, (+)-catechin (356) is
present, which together with (-)-epicatechin, form the chain-extending units of the
rooibos procyanidin type tannin (357). A cup of processed rooibos tea (150 ml) is
estimated to contain 1.4 mg of aspalathin (354) and 1.5 mg quercetin (358). Recently a
HPLC method, using a C18 reverse phase column with mass spectrometric analyses,
was developed that allows for sensitive and reproducible quantitation of the main
flavonoids in rooibos tea (359). With growing interest in the unprocessed rooibos tea,
Schulz et al. (351) developed a near-infrared spectroscopy (NIRS) method to rapidly
discriminate between processed and unprocessed rooibos tea while predicting the
aspalathin content in the unprocessed form. The aspalathin content of the unprocessed
rooibos samples was estimated at 35 to 68% of the total phenolic content.
4.2.3
4.2.3.1
Biological activities of rooibos
Anecdotal health claims
South African consumers and physicians use rooibos tea for a wide range of ailments,
such as digestive disorders, skin allergies, loss of appetite, nervous tension, and
insomnia. In 1968 a young South African mother, whose baby was allergic to milk and
suffered with colic, fed her baby rooibos tea and was astonished at the results: the baby
gained weight, and was cured of the chronic restlessness, vomiting and stomach
cramps. She published all her observations in a book: Babas, Allergiee en Rooibostee,
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(translated "Babies, Allergies and Rooibos tea") in 1974 and communicated the findings
through the press and other public forums (348). The antispasmodic activity of the tea
was later suggested to be ascribed to two components isolated from processed rooibos
tea, quercetin and luteolin (358).
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Fig. 21. Structure of the main polyphenolic constituents of rooibos tea (356).
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One of the earliest references to the antioxidant activity of rooibos tea was the study
conducted by Yoshikawa et aI, (360) who assessed the antioxidant activity of rooibos
tea by measuring reactivity to various reactive oxygen species using electron spin
resonance (ESR) spectrometry. Aqueous extracts of rooibos tea (processed form)
effectively scavenged the superoxide anion radicals and hydroxyl radicals,
Subsequently, Ito et aI, (361) reported that aqueous extracts of rooibos tea (processed
form) could protect mouse leukaemic cells against H202-induced oxidative stress,
Rooibos tea extracts also inhibited the growth of the primary cells, myoblasts and
fibroblasts, in tissue culture, The authors suggested that this inhibitory effect could be
due to the potent scavenging activity of rooibos tea, but other compounds having
cytostatic properties were not excluded (362),
The antioxidant properties of specific rooibos tea fractions, e,g, ethyl acetate
soluble and insoluble fractions of an aqueous extract, were determined in a study by
Von Gadow et aI, (363). The ethyl acetate soluble solids were more effective
antioxidants than the insoluble fraction containing polymeric solids on a mass basis,
Extraction of the water soluble fraction with ethyl acetate removed the phenolic acids
and flavonoids and these compounds have been shown to be potent antioxidants,
Selective extraction is important when a maximum antioxidant potential of rooibos tea
solids is required. The aspalathin content in commercial unprocessed rooibos tea
samples was shown to correlate well (R2=0,812) with the total antioxidant activity using
the ABTS-scavenging method (351), Aspalathin showed a higher ability to scavenge the
DPPH radical when compared with BHT and ex-tocopherol, but offered less protection
against lipid peroxidation (364), The hydrogen donating and superoxide radical
scavenging abilities were also conducted with the ethyl acetate and crude aspalathin
fractions being the most effective radical scavengers, followed by the aqueous extracts,
crude polymeric fractions and tannin showing the weakest effects (365,366).
When comparing the antioxidant activity in three model lipid systems, sunflower
oil-in-water emulsions, linoleic acid emulsion and methyl linoleate micelles, aqueous
extracts of both processed and unprocessed rooibos tea, crude fractions and tannin
possess antioxidant activity, The processed and unprocessed aqueous rooibos extracts
were the most consistently effective in all the lipid systems used, suggesting these
extracts are better equipped to handle oxidation in these various lipid systems (365),
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The antioxidant activity of an aqueous extract of rooibos tea was determined using the
Rancimat and p-carotene bleaching methods to assess the effect of extraction time and
additional exposure to heat. The additional heat treatment and increased time during
extraction increased the antioxidant activity (367).
Rooibos tea extracts contain less antioxidant activity than green, oolong and
black teas on a cup for cup basis (363). As black and green teas have twice as much
soluble solids as rooibos tea, the serving of rooibos tea to be consumed could be
increased to obtain the same antioxidant benefit as measured by DPPH method (363).
The results from the scavenging abilities correlated well with the total polyphenol
content of the extracts and fractions. Tea processing reduces the antioxidant activity of
rooibos tea (350).
4.2.3.3 Anti-HIV activity
Alkaline extracts (1% sodium carbonate) of processed rooibos tea suppress the HIV-
induced cytopathic effect of HIV-1 infected MT-4 (Human T Iymphotropic virus type 1
infected T cell line) cells in vitro (368). The polysaccharide isolated from the alkaline
extract also exhibited very low cytotoxicity to the cells. The proposed mechanism(s)
involved in the anti-HIV activity was the inhibition of the virus binding to the cells.
Substances inhibiting the binding of the virions to the conserved region of the CD4
antigen are desired as it is active at a very early stage of the viral infection. The authors
suggested that an extract like this should be a good candidate drug and will add new
dimension to the therapeutic weapons against AIDS.
4.2.3.4 "Anti-ageing" properties
Aqueous extracts of processed rooibos tea were fed to Wistar female rats for 21
months and the damage to the central nervous system (CNS) assessed by
thiobarbituric acid levels (TBA) and the level of lipidperoxides in the brain by magnetic
resonance imaging (MRI). When compared with rats consuming water for 21 months,
the TBA content was significantly lower in the rats consuming rooibos tea as well as in
the young (5 weeks old) control group of rats. The MRI scans showed similar results for
the rooibos tea treated rats and young rats when compared with the rats consuming
water. Age-induced deterioration of the CNS is partly due to the cytotoxic effect of
reactive oxygen species (ROS) generated in the brain. As rooibos tea exhibits potent
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antioxidant activities by scavenging oxygen, hydroxyl and DPPH radicals (360,366), the
results suggested that tea flavonoids suppressed the accumulation of lipid peroxides in
the brain associated with the aging process (369).
4.2.3,5 Antibody production and cytokine generation
Impaired immune responses are known to cause allergies, along with other autoimmune
diseases. A study was conducted to verify rooibos teas' control of allergic diseases, as
many antioxidants inhibit histamine release from mast cells (370). Female Wistar rats
and BALB Ic mice were injected with ovalbumin (OVA) and fed aqueous extracts of
rooibos tea. Cyclopsorin A was administered to the Wistar rats intravenously before
OVA challenge while murine splenic B cells were cultured with various concentrations of
aqueous rooibos tea extracts. Rooibos extracts increased the antibody responses and
improved cell survival via the stimulation of IL-2. The authors suggested that phenolic
compounds of rooibos tea were responsible for these biological activities, as removal
thereof diminished the antibody production (370).
4,2,3,6 Antihemolytic properties
The anti hemolytic activity of rooibos and black tea on Japanese quail erythrocytes was
studied. Peroxide and hypotonic haemolysis of the red blood cells of quails, either fed
with rooibos tea supplemented food or fed without tea, was performed. Long-term
consumption of rooibos tea did not change the erythrocyte fragility to either peroxide or
hypotonia induced haemolysis. However, rooibos and black teas decreased peroxide
induced haemolysis of erythrocytes but not haemolysis induced by a hypotonic NaCI
solution. An increased inhibition of haemolysis was been obtained when a boiled water
extract of rooibos tea was used, The degree of inhibition was comparable with the effect
of ascorbic acid (371).
4.2.3,7 Antimutagenic activities
The protective effect of rooibos tea against BP, mytomycin C and y-rays were
investigated. Aqueous extracts of processed rooibos tea administered (via drinking
water or gastric intubations) to male ICR mice, subsequently treated with
benzo(ajpyrene (BP), mytomycin C or y-rays reduced the frequency of micronuclei in
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peripheral blood reticulocytes. Chromosome aberrations were also suppressed in
rooibos tea treated Chinese hamster ovary cells after exposure to BP and mytomycin C.
The suppressing effects of rooibos tea were better when cells were treated with a
combination of the extract and BP and mytomycin C, than when cells were treated
separately (373,373). Komatsu et at. (374) also reported a protective effect of rooibos
tea extract using x-ray-induced cell transformation of C3H10T1/2 mouse cells. The
suppression was dependent on the duration of treatment. Green tea, at an equivalent
concentration, displayed no detectable effect on the transformation incidence (374).
4.2.3.8 Hepatoprotective effect
The hepatoprotective effect of an aqueous extract of commercially obtained rooibos tea
on cirrhosis development by carbon tetrachloride (CCI.) intoxication in male Wistar rats
was investigated (375). Reactive metabolites of CCI. cause lipid peroxidation, producing
hepatocellular damage and enhancing the production of fibrotic tissue. Administration of
rooibos tea protected the rats against liver damage, as indicated by the histological
regression of steatosis and cirrhosis in the liver tissue as well as a significant inhibition
of the increase of liver tissue concentration of malondialdehyde (MDA), triacylglycerols
and cholesterol. The plasma markers for liver function, aminotransferases, alkaline
phosphatases and bilirubin concentrations were all significantly suppressed by rooibos
tea supplementation. The authors suggested that the natural antioxidants and
scavenging agents in rooibos tea might be the hepato-protectors and could be included
in the diet of patients with hepatopathies (375).
4.3 Cyclopia intermedia
4.3.1 History and processing
Honeybush tea (Cye/opia intermedia) is a traditional indigenous herbal beverage from
South Africa. The plant belongs to the Cape fynbos biome grows only in the coastal
districts of the Western and Eastern Cape Provinces from Darling to Port Elizabeth
surrounded in the north by various mountain ranges. The earliest mention of the
honeybush plant in botanical literature was in 1705 (376). It was also recognised by the
Dutch and British colonists in the Cape as a suitable substitute for black tea, probably
based on native practises for the treatment of coughs and other upper respiratory
symptoms. The plant is a shrub of the Fabaeeae family (Leguminosae) and is easily
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recognised by its trifoliate leaves, single-flowered inflorescences and sweetly scented
bright yellow flowers with prominent grooves on the standard petal. The honeybush
plant has woody stems and a relative low ratio of leaves to stems with the leaf shape
and size differing among the species. The name Cyclopia is derived from the Greek
words cyclos, a circle and pous, a food, which allude to the intrusive base of the calyx
(http://www.rooibos.ch/honeybush.html). Honeybush tea is prepared from the leaves,
stems and flowers (Fig. 22) of several species of Cyclopia, including C. sessiliflora, C.
genistoides, C. subternata and C. intermedia.
Commercial supplies of honeybush are mainly from C. intermedia, also referred
to as "bergtee", meaning mountain tea, and to a lesser extent from C. subternata (377).
The production of honeybush has grown in the past few years, from approximately 30
tons harvested in 1997 to 160 tons in 2000, with an estimate of 300 tons for 2004
(http://www.itmonline.org/arts/honeybush.htm). Although there has been a substantial
growth in local consumption of honeybush tea, this increase mainly reflects the
development of the international market as 90% of the annual honeybush production is
exported (http://www.wesgro.org.za/-uploads/ssnatura Iproducts 0800. pdf).
C. geni$toide$
C. $ubtemata
C. intennedia
Fig. 22. Species of Cyclopia (Courtesy of Cape Natural Tea Products,
Brackenfell, Cape Town, South Africa).
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The honeybush industry is only in a developmental stage and consists mainly of
processed Cyclopia infermedia harvested from natural plant populations. Cultivation
has, however, become necessary. In 2000 the first large scale South African plantation
dedicated to honeybush, began operation in the town of Haarlem, a subsistence farming
community in the Langkloof, Eastern Cape Province. Due to its success, a second
community at Ericaville, established a plantation in 2001 (Personal communication,
Dawie de Villiers, Cape Natural Tea Products, South Africa). In response to the growing
demand of honeybush tea, role players in the Honeybush Industry formed a
representative body, SAHTA (South African Honeybush Tea Association) in 1999.
Members include both growers as well as marketers.
Fig.23. Map of Southern and Eastern Cape Provinces in South Africa
illustrating the regions were honeybush is grown
(http://www.itmonline.org/arts/honeybush.htm ).
Traditionally, the bushes are harvested every two to three years during the
flowering period which included September to October for C. infermedia and May to
June for C. sessiliflora, with C. subfernafa being harvested annually. Due to the
increasing demand, some of the producers are forced to extend their harvesting period.
The bushes are often cut to the ground to reduce the occurrence of stems that die after
harvesting (personal communication, Dawie De Villiers, Cape Natural Tea Products,
South Africa). Two types of tea are manufactured, processed and unprocessedl"green"
honeybush tea. The manufacture of the processed tea includes 4 steps, harvesting,
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cutting, oxidation or "fermentation" and drying (Fig. 24). Mechanised fodder cutters are
used to increase productivity and to deliver a more uniform product of plant material as
it can vary between 6 mm to 3 cm. The cutting of the plant material is done to disrupt
cellular integrity to facilitate the oxidation process.
Currently there are two methods for honeybush oxidation, e.g. "heap
fermentation" and "oven fermentation". Heap fermentation is the traditional method used
where cuttings of "green" honeybush material (1.5 to 2.5 tons) is firmly packed in a oval
shaped heap (4 m by 1.5 m), covered with canvas bags and left for 3 days to allow
spontaneous heat generation and oxidation. During this oxidation process the plant
material changes from a green to dark brown colour and develops a sweet aroma. From
the 3rd day onwards the heap is turned every 12 hrs and inspected after 3-5 days. After
this oxidation process the heap is spread in a thin layer on canvas and allowed to dry in
the sun. Oven oxidation is the preferred method as it yields a better and more
consistent quality product. A preheated oven is used and a shorter oxidation period (24-
36 hrs) is needed to obtain the processed form of the tea. The baking oven allows for
reheating of about 385 kg of plant cuttings during the oxidation process without having
to remove the plant material. Although sun drying is believed to enhance the final
product's appearance, oven drying has been implemented by the bigger producers. The
dried product is then sieved to remove all the undesirable bigger pieces, steam
pasteurised and bulk packed in woven plastic bags for local and overseas markets.
A small portion is also packed in smaller sized bags for local sales. Honeybush
tea is traditionally a very coarse product with the finer tea material used for teabags and
the coarser material for brewing loose tea.
The unprocessed form is prepared by immediate drying of the cut plant material
in a drying tunnel (40°C for 12 hr), sieving and pulverization (378). The unprocessed
honeybush tea only recently became part of the herbal tea market in South Africa
(personal communication Elizabeth Joubert, Agricultural Research Council,
Stellenbosch, South Africa) and its use for the preparation of an extract for the
cosmeceutical market based on its antioxidant properties is under investigation.
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Fig. 24. Processing of honeybush plant material (Courtesy of Cape Natural Tea
Products, Cape Town, South Africa).
4.3.2 Phenolic constituents
The major constituents in the leaves of various Cyclopia species were
investigated by De Nysschen et al. (379). Honeybush tea differs from rooibos in the
major classes of phenolic compounds, and three major constituents were identified in
methanol extracts from the leaves of 22 Cyclopia species which include the xanthone,
mangiferin and glycosides of the f1avanones, hesperitin and isosakuranetin. A
combination of these three compounds is a unique character for Cyclopia species and is
present in varying quantities in the 22 species that were screened but no precise
quantitative data could be obtained from the study (379).
As Cyclopia intermedia is the main resource for local as well as export use,
studies were conducted to identify phenolic compounds from this species (380,381). A
methanol extract from the leaves and stems contained a phenolic acid, isoflavones,
flavanones, coumestans and xanthones (Fig. 25). The phenolic acid was identified as 4-
hydroxycinnamic acid, the isoflavones comprised of formononetin, afrormosin,
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calycosin, pseudobaptigen and fujikinetin, the flavanones of hesperetin, hesperidin,
eriodictyol, and naringenin, the coumestans of medicagol, flemichapparin and
sophoracoumestan B and the xanthones of mangiferin and isomangiferin. The flavone
luteolin and the inositol (+)-pinitol was also identified to be present in C. infermedia
(380). Recently, a reversed-phase HPLC method was devised for the separation of the
flavonoid fractions of four species of unprocessed Cyclopia in order to quantify the
mangiferin, isomangiferin and hesperidin content in these plants (382). C. infermedia
and C. genisfoides contained the highest levels of mangiferin (3.6 % w/w) , isomangiferin
(0.54% w/w) and hesperidin (1.74% w/w). Harvesting dates, geographical location and
processing, influences the phenolic composition of these plant extracts, e.g. chemical
oxidation in the manufacturing of processed honeybush tea resulted in a significant
decrease in mangiferin, isomangiferin, hesperidin (378,382).
4.3.3 Biological activities
4.3.3.1 Anecdotal health claims
As for rooibos tea, honeybush tea also has very low tannin content and contains no
caffeine (383,384) rendering it well suited for a night time beverage and for those
experiencing nervousness. Several health benefits have been associated with regular
consumption of this herbal tea, but these are mostly anecdotal. Traditionally honeybush
tea is used as a diuretic, appetite stimulant, preventer of stomach ulcers, stimulator of
milk production in lactating woman, treatment for colic babies and as a cough syrup
(385-388). Researchers have shown high levels of (+)-pinitol to be present in
honeybush (380,381). Pinitol has been used as an expectorant (389) and is known to
possess anti-diabetic activity (390). Phytoestrogenic activity is also associated with
isoflavonoids, coumestans, and the flavonoid groups, flavones and flavanones
(391,392). These compounds have been shown to be present in Cyclopia infermedia.
Phytoestrogens are used in the treatment of menopausal symptoms in women (393).
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Fig, 25, Major classes of phenolic constituents in Cyclopia intermedia (380).
4.3.3.2 Antioxidant activity
Thus far, very limited scientific data exist on the biological activities of this herbal tea,
One such activity that has been established though is the in vitro antioxidant activity of
various extracts as well as purified compounds (378,394), The oxidation process, during
the manufacturing of processed tea, decreases the antioxidant activity of honeybush tea
(378,394,395).
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Antioxidant activity of honeybush tea has been demonstrated for aqueous
extracts for several of the Cyclopia species in vitro. Hubbe (395) reported on the
superoxide anion radical (02.) scavenging activity as well as the hydrogen donating
ability of four Cyclopia species, C. intermedia, C. sessiliflora, C. genistoides and C.
subternata. Unprocessed C. sessiliflora was the most effective scavenger of both the
DPPH radical as well as the superoxide anion radicals. This species was also shown to
have the highest polyp henoI content. Using a linoleic acid buffer system, the inhibitory
effect of the various honeybush species on lipid peroxidation was also determined. The
processed and unprocessed counterpart of C. genistoides exhibited the highest
protection in this assay (395). Subsequent to this study, Richards (378) further
investigated the antioxidant activity of the various honeybush species using ABTS and
FRAP assays for radical scavenging ability and a microsomal lipid peroxidation model,
measuring the inhibition of MDA formation in vitro. Overall, unprocessed C. intermedia
and C. sessiliflora showed the highest antioxidant activities, with C. genistoides being
the most potent for the processed honeybush plant material (378).
Further in vitro investigations into the antioxidant activity of various honeybush
tea extracts and purified compounds are currently under investigation at ARC Infruitec-
Nietvoorbij, Stellenbosch under leadership of Dr E Joubert.
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ABSTRACT
The antimutagenic properties of South African herbal teas were investigated using the
Salmonella typhimurium mutagenicity assay. Aqueous extracts of fermented and
unfermented rooibos tea (Aspalathus linearis) and honeybush tea (Cyclopia intermedia)
both possess antimutagenic activity against 2-acetylaminofluorene (2-AAF) and
aflatoxin B1 (AFB1)-induced mutagenesis using tester strains TA 98 and TA 100 in the
presence of metabolic activation. A far less inhibitory effect was noticed against the
direct acting mutagens, methyl methanesulfonate (MMS), cumolhydroperoxide (CHP),
and hydrogen peroxide (H202) using TA 102, a strain designed to detect oxidative
mutagens and carcinogens. Depending on the mutagen used, the unfermented tea
exhibited the highest protective effect. A similar response regarding the protection
against mutagenesis was obtained when utilizing different variations of the double layer
Salmonella assay. The double layer technique proved to be more effective to detect the
protective effect of the different tea preparations against the direct acting mutagens.
With respect to indirect mutagens, the highest protection was noticed when the
carcinogen was metabolically activated in the presence of the tea extract as compared
with when the tea extract was incubated in a separate layer with the bacteria. The
current data suggest that two mechanisms seem to be involved in the antimutagenicity
of the tea extracts towards carcinogens that require metabolic activation: (i) the tea
components may interfere with cytochrome P450-mediated metabolism of these
mutagens and (ii) the direct interaction between the tea constituents, presumably the
polyphenolic compounds, with the promutagens andlor the active mutagenic
metabolites. However, the mild andlor lack of protection and in some cases even
enhancement of mutagenesis induced by direct acting or oxidative mutagens, provide
new perspectives regarding the role of the polyphenolic compounds known to exhibit
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antioxidant properties, in the protection against mutagenesis in the Salmonella assay.
The present study provides the first evidence on the antimutagenic activity of
honeybush tea and further evidence on the antimutagenicity of rooibos tea.
KEYWORDS: Rooibos tea; Honeybush tea; Antimutagenicity; Salmonella assay.
INTRODUCTION
Epidemiological data suggest that more than 80% of cancers are attributable to lifestyle,
of which at least one third is diet-related [1]. Diets containing substances that can
modulate or prevent cancer may playa role in the general health of humans, especially
if they are inexpensive and easily available. Tea is a widely consumed beverage
throughout the world while the popularity of herbal health teas increased significantly
during the past twenty years [2]. The anticancer properties of tea are well known, and
the tumour inhibition potential of certain polyphenolic compounds from green and black
tea has been well documented [3-7).
Both rooibos tea (Aspalathus linearis) and honeybush tea (Cyclopia intermedia),
two South African herbal teas, have been shown to contain a complex mixture of
polyphenolic compounds, of which aspalathin, a dihydrochalcone, is unique to rooibos
tea while luteolin is one of the most important f1avones in honeybush tea [8-10].
Processing of these teas include the following steps, fermentation of leaves and stems,
followed by sun-drying and sieving and in the case of rooibos tea, steam pasteurization
of the dried product before packaging [11,12]. Rooibos tea is popular as a health
beverage, as it contains no harmful stimulants and no caffeine with only trace amounts
of tannins [13,14]. Extracts of rooibos tea have been found to decrease the number of
chromosome aberrations when treating Chinese hamster ovary (CHO) cells with
benzo[a]pyrene (B[a]P) in the presence of metabolic activation [15]. An in vivo study in
male ICR mice indicated that the number of micronucleated reticulocy1es (MNRET)
induced by single dosage of mitomycin C (MMC) was significantly reduced by daily
ingestion of rooibos tea. However, a single gavage treatment of rooibos tea 24 h before
MMC injection did not reduce MNRET frequency [15]. Suppression of oncogenic
transformation of mouse CH310T1/2 cells induced by X-rays in the presence of rooibos
tea was also shown in a study by Komatshu et al. [16]. However, green tea extracts at
an equitoxic concentration did not show any detectable suppression [16]. In a study
done by Standley [17], it was reported that water soluble fractions of both fermented
and unfermented rooibos tea possess antimutagenic activity against 2-
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acetylaminofluorene (2-AAF)-induced mutagenesis using strain TA 98 in the Salmonella
mutagenicity assay. Apart from these studies on rooibos tea very little is known about
the antimutagenic and anticarcinogenic properties of the two South African herbal teas.
Most of the research regarding the antimutagenicity and anticancer properties of tea, as
well as chemoprevention and epidemiological studies in humans to date has focused on
green and black teas [18-24]. Most of these studies indicated that polyphenol
preparations and/or water extracts from green and black tea dramatically decreased the
mutagenicity of a variety of genotoxic carcinogens. As damage to DNA is likely to be a
major cause of cancer and other chronic diseases [25,26], the protective effect of
naturally occurring dietary constituents could effectively reduce the onset and/or
progression of cancer.
The Salmonella mutagenicity assay has been extensively used to monitor the
mutagenic potential of a variety of compounds that either occur naturally or are
introduced artificially into the environment by various means [19,22,27,28]. In the
present study, this test system was utilized to monitor the antimutagenic properties of
aqueous extracts of fermented and unfermented rooibos and honeybush tea against a
variety of direct-acting mutagens as well as two indirect mutagens that required
metabolic activation.
MATERIALS AND METHODS
Chemicals and media. The mutagens, 2-AAF and aflatoxin B1 (AFB1) were purchased
from Sigma Chemical Co. (SA) at the highest available purity. Cumolhydroperoxide
(CHP) was purchased from Merck (Schuchardt, Germany), hydrogen peroxide (H202)
from Saarchem (SA) and methyl methanesulfonate (MMS) from Aldrich Chemical Co.
(SA). Stock solutions of the different carcinogens were freshly prepared on the day of
the experiment in dimethyl sulfoxide (DMSO) purchased from BDH Laboratory Supplies
(Poole, UK). All other solvents used were of analytical grade. Agar and Nutrient Broth
No. 2 were purchased from the Difco Laboratories (Detroit, USA) and Oxoid
(Hampshire, UK), respectively.
Antimutagenicityassay
Standard plate incorporation assay. Antimutagenicity of the tea extracts against
different mutagens was assessed using the standard plate incorporation assay as
described by Maron and Ames [29]. Salmonella Iyphimurium strains TA 98, TA 100 and
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TA 102 were kindly provided by Dr. B.N. Ames (Berkely, CAl. For the plate
incorporation inhibition assay, 0.1 ml of each mutagen, 0.1 ml of the various tea
extracts, 0.5 ml 89-mix and 0.1 ml of an overnight bacterial culture were carefully mixed
with 2 ml of molten top agar, containing 0.05 mM biotin-histidine and dispersed onto
minimal glucose agar plates. A liver 89 homogenate (0.72 nmol cytochrome P450/mg
protein) was prepared by inducing male Fischer rats (200 g) with aroclor-1245 as
described by Maron and Ames [29]. The 89 homogenate was incorporated into the 89-
mixture at a level of 2 mg protein per ml. The mutagenicity of 2-AAF (5 fIg per plate)
and AFB, (10 ng per plate) were monitored against TA 98 and TA 100 in the presence
of the 89 mixture, respectively. The direct acting mutagens were tested against strain
TA 102: MM8 (10 11M per plate), CHP (400 I1g per plate) and H202 (1.81 mg per plate)
in the absence of the 89 mixture. A series of control plates containing only the tea
extracts and the bacteria in the absence and presence of the 89 mixture were also
included to screen the different tea preparations for mutagenic effects. Control plates
containing only DM80, which was used as the solvent vehicle, were also included to
obtain the background or spontaneous revertant counts.
Double layer assay. A modification of the double layer technique described by Glatt
and Oesch [30] was also performed using two direct acting mutagens, MM8 and CHP
and one requiring metabolic activation (2-AAF). Two variations of the technique were
used, one where the carcinogen and the tea preparation were included in the lower top
agar layer, with the bacterial suspension in the upper top agar layer (referred to as a)
and another where the carcinogen was included in the lower top agar layer with the tea
preparation and bacterial suspension in the upper top agar layer (referred to as ~). Two
concentrations of the tea extracts (5 and 10% (w/v)) were used with MM8 W technique)
while only a 10% (w/v) concentration was used with CHP and 2-AAF (a technique).
All plates were incubated at 37°C for 48 h. Thereafter, the histidine revertants
were counted using a Quebec Colony Counter (American Optical Corp., Buffalo, New
York). All the experiments were repeated once, and five replicates were included for
each sample.
Preparation of tea extracts. Fermented and unfermented rooibos and honeybush tea
were used. Aqueous extracts of the teas were prepared by the addition of freshly boiled
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water to the tea leaves and stems to a concentration of 2 g/100 ml for rooibos tea and 4
g/100 ml for honeybush tea. These concentrations are customarily used for tea making
purposes [11,12]. The mixture was allowed to stand for 30 min at room temperature,
filtered (Whatman NO.4), freeze-dried and stored in airtight containers at -20 DC.Two
different tea solutions (5 and 10% (w/v)) were prepared from the freeze-dried extracts in
distilled water, centrifuged at 300 rpm and the supernatant sterilized through 0.45 and
0.22 Ilm filters. A methanol extract of unfermented rooibos tea was also prepared
following excessive chloroform extraction. Thereafter, the solvent was evaporated at 48
DC in vacuo. The protective effect of the methanol extract (5 and 10% (w/v) in DMSO)
was also monitored against the different mutagens.
Soluble solid and polyphenol determination. The soluble solid content of each tea
preparation (2 and 4% for rooibos and honeybush tea, respectively) was determined
gravimetrically after drying 1 ml aliquots at 110 DCfor 12 h. Five determinations for each
tea preparation were done. The scaled-down Folin-Ciocalteau assay was used to
determine the total phenolic content [31] of the tea extracts (performed in triplicate),
while non-f1avonoids were determined after precipitation of f1avonoids [32].
Statistical analysis. Analysis of variance (ANOVA) was performed using the statistical
analysis system (SAS) programme. The Tukey T-test was used to determine whether
the means of the control and positive control groups differed significantly. The Dunnett
test was used to determine whether the means of the tea treatments differed
significantly from the positive mutagenic control treatments. Sonferroni pairwise
adjustment was used to compare the soluble solids, total polyphenols, f1avonoids and
non-f1avonoids of the fermented and the unfermented tea preparations.
RESULTS
Analytical data. The soluble solids, total polyphenol, flavonoid and non-flavonoid
content of the different tea extracts used in this study are summarized in Table 1.
Changes in the total polyphenol and f1avanoid content of the two teas during processing
are clearly noted, as they were significantly (P < 0.001) reduced during the fermentation
process. The soluble solids were significantly higher in the honeybush tea extract, which
is in agreement with the larger amount of the tea used in the preparation of the extract.
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Table 1 Soluble solid matter and total polyp heno Is in the different tea
• a
preparations
Tea extracts Total Flavonoids Non-fJavonoids Solid matter
polyphenols (%j" (%j" (%j" (mg/ml)"
Unfermented rooibos tea 41.15 :!:0.25ad 28.06 :!:0.25ad 13.10:!: 0.04ad 4.21 :!:0.44ad
(2% w/v)
Fermented rooibos tea 29.74:t O.36Ad 18.8:t 0.35Ad 10.94 :t 0.05Ad 3.42 :t 0.22ad
(2% w/v)
Unfermented honey bush 35.52:t 0.03b 27.10:t 0.02b 8.42 :t 0.05b 11.99:t 1.09b
tea (4% w/v)
Fermented honeybush tea 19.80:t 0268 9.86:t 0.188 9.94 :t 0.088 5.26 :t 0.37c
(4% w/v)
;;
Values :t SO are the mean of triplicate determinations. Statistical comparisons were made within a
group. Means in columns followed by the same letter do not differ significantly. If the letters differ then
P< 0.01. When the cases differ then P< 0.001. "Soluble solid matter (g per 100 g). CAqueous tea
extracts. 'Indicates significant differences between the two tea groups (i.e. unfermented rooibos vs.
unfermented honey bush and fermented rocibos vs. fermented honeybush).
Antimutagenicity of tea extracts. The protective effect of the different tea extracts on
the mutagenicity of the various chemical mutagens and carcinogens using the plate
incorporation assay are summarized in Table 2. Data on the protective effect of the
different tea extracts against the mutagenicity of the various compounds utilizing the
double layer technique are presented in Table 3. For data analyses the values of the
two separate experiments were combined, as it did not differ statistically.
Mutagens requiring metabolic activation
2-Acetylaminofluorene. Addition of fermented and unfermented rooibos and
honeybush tea significantly (P < 0.001) reduced 2-AAF-induced mutagenesis. A clear
dose response effect was noticed with the 10% (w/v) extract exhibiting the highest
protective effect with both teas. A similar protective effect was obtained with the
methanol extract of the unfermented rooibos tea at both concentrations, almost
completely inhibiting 2-AAF-induced mutagenesis. At the 5% concentration level the
fermented rooibos tea exhibited a higher protective effect than the unfermented
counterpart. However, at the 10% concentration level there was no significant difference
between the unfermented and fermented rooibos preparations. The unfermented
honeybush tea preparation exhibited a significantly higher protective effect than the
fermented tea at both concentration levels. When compared with fermented honeybush,
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the fermented rooibos tea exhibited a higher protective effect, whereas unfermented
honeybush tea (5%) exhibited a higher protective activity than its rooibos counterpart.
The total polyphenolic content related well to the protective effect exhibited by the
different tea preparations as a higher total polyphenolic concentration is associated with
a higher protective effect (Table 2).
Aflatoxin B1. As described for 2-AAF the addition of both the 5 and 10%
fermented and unfermented rooibos tea, significantly (P < 0.001) reduced the number of
revertants induced by AFB, with the unfermented tea exhibiting a higher protective
activity (Table 2). A similar protective effect (with no significant difference between
fermented and unfermented) was obtained with honeybush tea at both concentration
levels. No dose response effects were noticed with either rooibos or honeybush tea. In
contrast to the effect on 2-AAF-induced mutagenesis, no difference could be detected
between the protective effect of fermented and unfermented rooibos and honeybush
tea. The methanol extract again showed a similar protective effect when compared with
the unfermented rooibos tea preparations lacking any dose response effects. In the
case of AFB1-induced mutagenicity the higher total polyphenolic content did not relate
with the higher protective effect.
Direct acting mutagens
Cumolhydroperoxide. Only fermented rooibos tea (10%) and unfermented
honeybush tea (10%) preparations showed a significant (P < 0.05) decrease in the
CHP-induced mutagenesis (Table 2). The methanol extract and the unfermented
rooibos (10%) also slightly reduced the mutagenic response, but the reduction was not
significant. Fermented honeybush tea (5%) tended to increase the number of revertant
colonies in the presence of CHP, although not significantly. Only the unfermented
honeybush tea preparation showed a higher protective effect associated with a dosage
increase from 5 to 10%, which related well to the higher total polyphenolic content.
Hydrogen peroxide. Preparations of fermented (10%) and unfermented (10%)
rooibos tea and the methanol extract (10%) showed significant decreases (P < 0.05 and
P < 0.001) in the number of histidine revertants (Table 2). The total polyphenolic content
of the rooibos tea preparations were in relation with the protective effect as the 5%
rooibos tea preparation showed a far less inhibitory effect. No protective effect was
noticed with fermented and unfermented honeybush tea although the 10% (w/v)
http://scholar.sun.ac.za
Chapter 3
unfermented honeybush tea also showed a slight (non-significant) protective effect.
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Methyl methanesulfonate. No protective effect was noticed with the different
tea extracts, while the methanol extract of unfermented rooibos tea (5%) significantly (P
< 0.05) reduced MMS-induced mutagenesis. On the other hand, unfermented rooibos
tea (10%) significantly (P < 0.001) enhanced the revertant counts.
The double layer technique
When utilizing the double layer technique (P = MMS in lower layer of top agar, with the
tea preparation and TA 102 in the top layer) the methanol extract markedly and
significantly reduced the number of MMS-induced revertants when incorporated at 5 (P
< 0.05) and 10% (P < 0,001), respectively. In contrast to the plate incorporation assay,
both the unfermented rooibos (P < 0.001) and honeybush (P < 0.05) tea (10%)
significantly reduced the revertant counts (Table 3), respectively. No significant
protective effect was noticed with the fermented counterparts. With respect to CHP no
significant differences between the two variations of the double layer technique (a =
CHP and tea in bottom layer and TA 102 in top layer and P = CHP in bottom layer and
tea and TA 102 in top layer) were noticed. When compared with the standard plate
incorporation assay the methanol extract (P < 0.05) and both the fermented rooibos
preparations (5 and 10%) (P < 0.001) and the unfermented honeybush (10%) (P < 0.05)
showed significant reductions in the revertant counts induced by CHP (Table 3).
In the case of the metabolically activated carcinogen, 2-AAF, both tea
preparations significantly (P< 0.001) reduced the revertant colonies in both variations of
the test. However, the a-method resulted in a significantly (P<0.001) higher protection
against mutagenesis than the p-method (Table 3).
Control tea treatment plates. No toxicity or mutagenic activity of the different tea
extracts was detected in the presence of metabolic activation at the levels used in the
Salmonella test (data not shown). The spontaneous revertant counts of the different
strains in the presence and absence of DMSO were in the range of published values
[29].
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Table 2 Protective effects of aqueous rooibos and honeybush tea extracts on mutagenicity of a variety of
carcinogens used in the Salmonella assay"
Treatments Total Revertants per plate
polyphenols
Carcinogen (mg per plate)b TA 98 TA 100 TA 102
2.AAF AFB, CHP H,O, MMS
5 fIg per plate 10 ng per plate 400 fIg per plate 1.81 mg per plate (10 flM per plate
Control (-) 32 :t 5 120 :t 6 176:t 18 317:t22 183:t 16
Control (+) 513:t14a 309 :t 22a 870:t 144a 950 :t 122a 535 :t 34a
RBf (5%) 1.49 150:t29B 158:t21B 784 :t 66a 1028 :t 63a 592 :t 66a
RBf(10%) 2.97 88:t 12C 145 :t 6B 614 :t 67b 712:t81b 577 :t 53a
RBu (5%) 2.06 272:t 300 128 :t 6CO 850:t 100a 858:t 146a 635 :t 62a
RBu (10%) 4.12 43:t 6C 113:t 11CO 702 :t 37a 697:t 91B 676:t 46B
Me (5%) NO 40 :t 4C 115:t 6C 702 :t 68a 805:t 116a 442 :t 77b
Me (10%) NO 30 :t 7C 109:t 10C 706 :t 62a 650:t 145b 522 :t 44a
HBf (5%) 0.99 318:t260 157:t6B 926 :t 79a 968:t 131a 602 :t 64a
HBf (10%) 1.98 182:!: 28E 131 :!: 16BO 832 :t 68a 945:!: 59a 616:t 43a
HBu (5%) 1.78 143:t16B 139:t13BO 854:t 116a 1012:t33a 562 :t 34a
HBu (10%) 355 68:!: 12C 125:!: 14BO 674:!: 62b 805:!: 155a 606 :t 63a
,
Values are mean:!: So. of five replications. Means in columns followed by different letters then P < 0.05, when the cases differ then P <
0.001. RBf, rooibos fermented tea; RBu, rooibos unfermented tea; HBf, honeybush fermented tea; HBu, honeybush unfermented tea; Me,
b
methanol extract of rooibos unfermented tea (OMSO as solvent); NO, not determined. Calculated from the mean total polyphenol content of
the respective tea preparations presented in Table 1.
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Table 3 Effect of aqueous rooibos and honeybush tea extracts on mutagenicity of
a
a variety of carcinogens in the double layer Salmonella assay
MMS (10 flM per plate) CHP (400 flg per plate) 2-AAF (5 flg per plate)
Treatments TA 102 Treatments TA 102 Treatments TA 98
revertants/plate (10%) revertants/plate (10%) revertants/plate
Control (-) 170:l: 16 Control (-) 214 :l: 21 Control (-) 28:l: 3
Control (+) 522:!: 39a Control (+) 1065:!: 134a Control (+) 450:!: 29a
RBf (5% Il) 507:!: 58a RBf-a 702:!: 83A RBf-a 119:!:18Ab
RBf (10% Il) 443:!: 30a RBf-1l 730:!: 174A RBf-1l 190:!: 32A
RBu (5% Il) 453:!: 44a RBu-a 960:!: 108a RBu-a 40:!: 6Ab
RBu (10% Il) 395:!: 60A RBu-1l 752:!: 167a RBu-1l 67:!: 8A
Me (5% Il) 442:!: 77a Me-a 787:!: 77b Me-a NO
Me (10% Il) 406:!: 17A Me-Il 725:!: 73b Me-Il NO
HBf (5% Il) 498:!: 45a HBf-a 1295:!: 48a HBf-a 32:!: 2Ab
HBf (10% Il) 489:!: 47a HBf-1l 1195:!: 149a HBf-1l 69:!: 12A
HBu (5% Il) 502:!: 24a HBu-a 940:!: 42a HBu-a 32:!: 4Ab
HBu (10% Il) 423:!: 38b HBu-1l 813:!:32b HBu-1l 79:!: 6A
'Values are the means of five determinations :l: 5.0.: a, carcinogen and/or 59 and tea extract in bottom
layer, bacterial strain in top layer; Il, carcinogen and/or 59 in bcttom layer, bacterial strain and tea extract in
top layer. Means in columns followed by different letters then P < 0.05, when case differ then P < 0.001.
RBf, rooibcs fermented tea; RBu, rooibcs unfermented tea; HBf, honeybush fermented tea; HBu,
honey bush unfermented tea; Me, methanol extract of unfermented rooibcs tea (OM50 as solvent); MM5,
methyl methanesulfonate; CHP, cumolhydroperoxide; 2-AAF, 2-acetylaminofluorene; NO, not determined.
'p < 0.001 (differences between a and Il variations).
DISCUSSION
Five different mutagens with diverse chemical structures and mode of action were used
to determine the protective effect of two South African herbal teas against their
mutagenicity. Aqueous extracts of unfermented rooibos and honeybush teas displayed a
strong antimutagenic effect against both of the metabolically activated carcinogens, 2-
AAF and AFB,. In general the fermented tea preparations showed a high level of
protection, but not as effective as their unfermented counterparts with the exception of
5% fermented rooibos tea, which exhibited a higher protective effect against 2-AAF-
induced mutagenesis. In the case of 2-AAF, the fermented and unfermented rooibos
(10%) tea preparations exhibited a higher inhibition potential than the corresponding
honeybush tea preparations. When comparing the protection of the two herbal teas
against AFB,.induced mutagenicity, they showed a very similar protective effect despite
the fact that no dose response effects were noticed, suggesting that a threshold was
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reached with the 5% tea preparation. As discussed above, the unfermented rooibos tea
extract exhibited a higher protective effect than the fermented counterpart, whereas no
such effect was noticed with the different honeybush tea preparations.
When considering the protective potency of the teas against mutagens that require
metabolic activation, cognizance has to be taken of the fact that the different tea
preparations were tested on the same weight basis. The total polyphenol content of the
extracts is clearly more relevant for comparative purposes. The unfermented teas contain
higher concentrations of polyphenolic compounds, which are significantly reduced during
the fermentation process, due to oxidation [33]. In the case of 2-AAF, these oxidized
compounds could either have a lower antimutagenic potential or have lost their
antimutagenic potential, as the total polyphenol content of the various tea preparations
corresponded well with protection against mutagenesis. No relation with the polyphenol
content was noticed when comparing the protective effect of unfermented and fermented
rooibos at the 5% level. When AFB1 was used as the mutagen, unfermented rooibos tea
exhibited a higher protective effect than the fermented tea, which again related well with
the higher polyphenol content. However, both the unfermented and fermented
honeybush tea exhibited a similar effect indicating that the oxidation of compounds
during fermentation does not reduce the protective effect. Furthermore, fermented
rooibos and honeybush tea exhibited similar protective effects whilst the unfermented
rooibos tea exhibited a higher level of protection than honeybush tea. These data
suggest that, when metabolic activation is required, differences exist in the degree of
protection that not only depend on the type of tea and/or polyphenol content but also on
the specific mutagen used.
The role of antioxidants has attracted much interest with respect to their protective
role against free radical damage that may be the cause of many diseases including
cancer [34]. The antioxidative effect of green tea is mainly due to the phenolic
components, such as the f1avonoids [35]. Some flavonoid and non-flavonoid phenolic
compounds have been reported to also show alkylperoxyl radical scavenging activity thus
reducing radical-mediated pathogenesis, e.g. carcinogenesis [36]. In the present study
only a weak relation exists between the polyphenolic content of the herbal teas and the
antimutagenic effect when using the oxidative mutagens, H202, and CHP and the direct
acting mutagen MMS. Other investigators [18,37,38] have also noted this failure and/or
weak protective effect against direct acting mutagens. Constable et 81. [37] reported that
the major polyphenols are not the only compounds responsible for the protective effects
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of the green and black teas seen in the bacterial mutagenicity assay. As a reduction of
the catechin content in fermented and instant teas did not correlate with the
antimutagenic effects observed in the assay, other compounds formed during the
processing conditions may be involved. This may well be the case for the SA herbal teas
where the high oxidative properties of the fermented and unfermented teas did not
correspond well with the low protective effect against the various oxidative mutagens
used in the present study.
As discussed for the metabolically activated mutagens, differences exist with
respect to the protective effect of the tea preparations and specific mutagen used. No
protective effect was noticed against MMS, whereas with H202 fermented and
unfermented rooibos tea (10%), and with CHP, fermented rooibos and unfermented
honeybush (10%) tea, showed a protective effect. Only a weak relationship exists with
respect to the polyphenolic content of the teas and the protective effect against the direct
acting mutagens. Both the fermented and unfermented rooibos tea preparations (10%
w/v) showed a similar inhibition when using H202 as direct-acting mutagen despite the
fact that the total polyphenols was significantly lower in the fermented tea preparation.
With CHP only the highest concentrations of the fermented rooibos and unfermented
honeybush tea exhibited a protective effect. In some cases (CHP and H202), the
addition of the tea preparations (except the methanol extract) resulted in a marked (non-
significant) increase in the mutagen-induced response. One possible explanation for this
weak/lack of protection against the direct acting mutagens could be that the in vivo
induction of antioxidative enzymes is required to protect against oxidative-like mutations.
Another aspect that needs to be considered is the polarity of the mutagen used
compared with that of the protective principles in the aqueous tea preparations. The
relatively polar constituents (including some polyphenols) of the aqueous extracts could
be responsible for the low protective properties against direct acting mutagens. Due to
the differences in polarity, molecules can be restricted to either hydrophilic or
hydrophobic environments that will minimize their possible interaction. For example, the
polar constituents of the aqueous extract will be associated with the polar constituents in
the medium whilst the non-polar mutagens, MMS and CHP, are likely to be associated
with the bacterial cellular matrixes. This became evident as a higher protective effect of
the tea was obtained when incubating the fermented rooibos tea and the methanol
extract with TA 102 (top layer) and the mutagen (CHP) in the bottom layer, which
increased the possibility of the tea constituents to interact with the direct acting mutagen.
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With respect to the mutagens that required metabolic activation, the results
obtained from the double layer assay provided insight into the possible mechanisms
involved in the antimutagenic effects of the tea extracts. A higher degree of protection is
obtained when 2-AAF, the 89 mixture and the different tea preparations are incubated in
the bottom soft agar layer and TA98 in the top agar layer (a-method) than when the tea is
incubated with the bacterium (lJ-method). In both cases, the activated metabolite has to
diffuse from the bottom to the top agar layer to interact with the bacterium. To be
mutagenic, 2-AAF, has to be metabolically activated by the cytochrome P450 enzyme
system located in a hydrophobic pocket in the microsomes [39]. When the tea extracts
are incubated with the bacterium the protective effect could be ascribed to a direct
interaction of the activated mutagenic metabolite that diffuses from the bottom layer.
However, when the tea is incubated with the enzyme preparation in the bottom layer, the
inhibitory effect on 2-AAF mutagenesis can result from an interaction between the
different components of the tea extracts and the enzyme system catalyzing the metabolic
activation of the various promutagens (inhibiting cytochrome P450-mediated activation of
the carcinogen) and thus impeding the production of genotoxic intermediates. Tea
polyphenols can serve as such electron acceptors directing the flow of electrons from
NADPH away from cytochrome P450, the terminal component in the electron-transport
chain [38]. The structure of f1avanols (also referred to as catechins), the major polyphenol
in green and black tea, provide strong nucleophilic centres which enables them to react
with electrophilic carcinogens to form f1avanol-carcinogen adducts that may result in the
prevention of tumorigenesis [40,41]. This ability of aqueous green tea extracts to function
as nucleophiles is supported by Bu-Abbas et a/. [38]. Rooibos tea contains 4.4% tannins
[13] consisting of f1avanol chain extending units [42]. Unlike green and black tea, rooibos
tea also contains other polyphenols like f1avonols (iso-quercitrin), f1avones (orientin, iso-
orientin, luteolin) and dihydrochalcones (aspalathin, nothofagin) [33]. Honeybush tea has
been shown to contain f1avones (Iuteolin) and f1avanones (hesperidin, hesperetin,
naringenin, eriodictyol) [8]. The electron-rich aromatic B-ring system of the f1avones can
supply electrons that are required for the reduction of the active oxygen species [33].
These phenolic compounds presumably contribute towards the scavenging ability of the
herbal teas. Presently, it is unknown whether all these different polyphenols may playa
role in the antimutagenic activity of rooibos and honeybush tea. Apart from the
interference with the metabolic activating system, the tea components could also directly
interact with the genotoxic reactive intermediates that may result in the prevention of
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mutagenesis as discussed for the difference in protection obtained with b-method.
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The antimutagenic effects of the different rooibos and honeybush tea preparations
reported in this study could, in the case of 2-AAF that required metabolic activation, be
related to the action of the different polyphenols. Studies are in progress to elucidate the
mechanisms of antimutagenicity and to characterize the protective principles produced
by these indigenous teas. It is known that different causative factors (e.g. carcinogens)
are involved in the development of different cancers suggesting different mechanisms,
which is organ specific. The present study indicated that the mechanism of protection
obtained with the herbal teas differs not only when using direct-acting mutagens but also
differs between mutagens that require metabolic activation. It can be argued that the
herbal teas could protect against the activity of diverse mutagenic and possible
carcinogenic compounds in vivo and their effectiveness, as potential chemopreventive
drugs will depend on the mechanism of cancer development in a specific organ. In
conclusion, it would appear that the herbal teas may not only be a good dietary source of
natural antioxidants to counteract the damaging effects of free hydroxyl, superoxide and
peroxyl radicals in vitro [31,43], but may also protect against mutagenesis.
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ABSTRACT
Rooibos and honeybush teas significantly (P < 0.05) enhanced the activity of cytosolic
glutathione S-transferase alpha. A significant (P < 0.05) to marginal (P < 0.1) increase
in the activity of the microsomal UDP-glucuronosyl transferase was obtained with
unprocessed rooibos and honeybush teas, respectively. Oxidized glutathione (GSSG)
levels were significantly (P < 0.05) reduced in the liver of all tea treated rats while
reduced glutathione (GSH) was markedly increased in the liver of the herbal tea treated
rats. These changes resulted in a significant (P < 0.05) increase in the GSH/GSSG ratio
by the unprocessed, processed rooibos and unprocessed honeybush teas. Green and
black teas markedly to significantly decreased the oxygen radical absorbance capacity
in liver homogenates, respectively. Modulation of phase II drug metabolizing enzymes
and oxidative status in the liver may be important events in the protection against
adverse effects related to mutagenesis and oxidative damage.
KEYWORDS: Rooibos (Aspalathus linearis) tea; honeybush (Cyclopia intermedia) tea;
glutathione S-transferases; UPD-glucuronosyl transferases; glutathione; ORAC; rat liver
ABBREVIATIONS USED
CONS, 1-chloro-2,4-dinitrobenzene; DCNS, 3,4-dichloro-nitrobenzene: GSH, reduced glutathione: GSSG,
oxidized glutathione; UDP-GT, uridine 5'-diphospho-glucuronosyl-transferase; GST, glutathione S-
transferase; M2VP, 1-methyl-2-vinyl-pyridinium trifluoromethane sulfonate: DTNS, 5,5'-dithiobis-2-
nitrobenzoic acid; AAPH, 2,2'-azobis(2-amidinopropane) dihydrochloride: IJ-PE, p-phycoerythrin; DRAC,
oxygen radical abs()rbancElcapacity: DPPH, 1,1-diphenyl-2-picrylhydrazyl
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The protective role of tea (Camellia sinensis) against mutagenesis and carcinogenesis
has been well established in the literature (1-5). Similar information regarding the
protective role of the South African herbal teas, Aspalathus Iinearis (rooibos tea) and
Cyclopia species (honeybush tea), is being established (6). These herbal teas, prepared
from the indigenous Cape "fynbos" plants are consumed both locally and abroad with
global consumption of rooibos composing more than 50% of its annual production of
7500 tons (http://www.emg.org.za/documents/rooibos.pdf). while 90% of honeybush
annual production of 150 tons is exported (http://www.wesgro.org.za/
uploads/ssnatural.products.0800.pdf). The honeybush industry is only in a
developmental stage and consists mainly of processed Cyclopia intermedia harvested
from natural plant populations. Apart from these traditional processed herbal teas where
production includes an oxidation stepl"fermentation" (7, 8), the manufacture of
unprocessed ("green") rooibos and honeybush teas has recently commenced. During
this process, oxidation of the polyphenols is minimized to obtain a product with
enhanced antioxidant and antimutagenic activity (9, 10).
Several health-promoting properties have been associated with the consumption
of these herbal teas, but evidence is mostly anecdotal (11). Limited research has been
conducted regarding the biological effects of these teas. Extracts of rooibos tea
exhibited antimutagenic activity in Chinese hamster ovary (CHO) cells and in male ICR
mice (12). Recent studies in the Salmonella mutagenicity assay showed that aqueous
extracts of unprocessed ("unfermented") and processed ("fermented") rooibos and
honeybush teas prevent mutagenesis induced by 2-acetylaminofluorene (2-AAF) and
aflatoxin B1 [AFB1] (6). Several mechanisms have been proposed for the protective
effect against mutagenesis in vitro. These include the reduction in the formation of the
ultimate genotoxic intermediate by interfering with the cytochrome P450-mediated
metabolic activation of mutagens and/or the direct interaction of nucleophilic tea
components with the genotoxic intermediates, thereby preventing mutagenesis.
Aqueous extracts of rooibos and honeybush teas have been shown to possess
antioxidant activities in vitro (13, 14).
Unlike green or black teas, rooibos and honeybush teas contain no caffeine (11,
15) and have low tannin content (11, 16). The herbal teas also contain phenolic
compounds that differ from each other and from green and black teas. Rooibos
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flavonoids predominantly consist of dihydrochalcones, flavonols, and flavones. Its
flavonoid composition is unique in that it contains aspalathin, which to date has only
been isolated from rooibos (17), and nothofagin, another rare B-hydroxydihydro-
chalcone (18). On the other hand, honeybush tea contains mainly xanthones,
flavanones, and coumestans, with the xanthone, mangiferin, and the flavanone
hesperidin constituting the major phenolic compounds (19-21). Processing results in a
significant decrease in aspalathin and nothofagin in rooibos and mangiferin,
isomangiferin, and hesperidin in honeybush (10, 18). At present, very little is known
about the oxidized products present in the processed teas. In contrast, green tea mainly
contains flavanols, while black tea contains their oxidized products, theaflavins and
thearubigins (22, 23)
Although the herbal teas exhibit antimutagenic properties (6, 12) no information
is available regarding the possible protective effects against carcinogen metabolism in
vivo. It is known that the balance between the phase I (carcinogen activating) and the
phase II (carcinogen detoxifying) enzymes is critical in the subsequent production of
putative carcinogenic or mutagenic metabolites that are ultimately available to interact
with the cell. The level and/or activity of these enzymes have been suggested to play an
important role in the susceptibility of an individual for developing cancer (24). Several
compounds that selectively enhance the activity of the phase II enzymes have been
identified to impede the production of putative genotoxic metabolites and the formation
of preneoplastic lesions and tumors (25-28). An increase in phase II detoxifying
enzymes in rat liver treated by oltipraz [5-(2-pyrazinyl)-4 methyl-1,2 dithiole-3-thione]
has been shown (29, 30) and postulated to be essential for effective chemoprotection
against AFB,-induced hepatocarcinogenesis in rats (25). In a clinical trial conducted in
residents of Qidong, a high incidence liver cancer area in China, oltipraz was shown to
significantly reduce serum albumin DNA adducts of AFB1 (31).
The present study investigates the modulation of drug metabolizing enzymes in
the liver of rats by rooibos and honeybush teas as compared to green and black teas.
The antioxidant status as reflected by the redox state of glutathione and the oxygen
radical absorbance capacity (ORAC) in liver of rats exposed to the various tea
preparations was also determined.
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MATERIALS AND METHODS
Chemicals. The 1-chloro-2,4-dinitrobenzene (CDNB) [97-00-7] and 3,4-dichloro-
nitrobenzene (DCNB) [6306-39-4] were purchased from Merck. Reduced [70-18-8] and
oxidized [27025-41-8] glutathione were purchased from Roche. BDH laboratories were
the suppliers of sodium dithionite [7775-14-6], dimethyl sulfoxide (DMSO) [67-68-5] and
ethanol (96%). UDP-glucuronic acid [63700-19-6], p-nitrophenol [100-02-7], glutathione
reductase, perchloric acid [7601-90-3], 1-methyl-2-vinyl-pyridinium trifluoromethane
sulfonate (M2VP), EDTA [60-00-4], and 5,5'-dithiobis-2-nitrobenzoic acid (DTNB) [69-
78-3] were purchased from Sigma Chemical Co. Phycoerytherin W-PE) was purchased
from ProZyme, and 2,2'-azobis(2-amidinopropane) dihydrochloride (MPH) [2997-92-4]
and Trolox [53188-07-1] were obtained from Aldrich Chemical Co.
Plant Material. Individual batches of processed and unprocessed rooibos and
honeybush (C. intermedia) teas of the highest quality were a gift from Dr E. Joubert,
(ARC Infruitec-Nietvoorbij, South Africa). The black tea (C. sinensis var. assamica) is a
blend of locally produced African tea and Sri Lankan teas (htlp:l/www.five-
roses.com/about-us/default.htm) and was obtained from a commercial retail outlet in
Cape Town, South Africa. The green tea (C. sinensis var. sinensis) imported from
China, was a gift from Vital Health Foods, Kuilsriver, South Africa.
Preparation of Aqueous Tea Extracts. Aqueous extracts were prepared by the
addition of freshly boiled tap water to the tea leaves and stems to a concentration of 2
g/100 mL for processed and unprocessed rooibos and black and green teas, while 4
g/100 mL was used for processed and unprocessed honeybush tea. These concentra-
tions are customarily used for tea making purposes (7, 8). The mixture was allowed to
stand for 30 min at room temperature, filtered (Whatman no. 4), and after cooling,
dispensed into water bottles.
Treatment of Animals. Male Fischer 344 rats, 150 g, were obtained from the Primate
Unit of the Diabetic Research Group of the Medical Research Council of South Africa.
They were individually housed in stainless steel wire-bottomed cages fitled with
Perspex houses in a closed environment (24-25 °C), with a 12 h light-dark cycle and
50% humidity. The rats were divided into seven groups consisting of 10 rats per group.
The experimental groups each received the various aqueous tea extracts for 10 weeks
as their sole source of drinking fluid, while the control group received tap water. Fresh
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tea was prepared every second day. The rats were fed ad libitum rat cubes (Epol Ltd,
Johannesburg, South Africa), and the fluid intake monitored on a daily basis. Body
weights were monitored on a weekly basis.
Total Phenolic, Flavonoid Content and Soluble Solid Determinations. The soluble
solid content of each tea preparation was determined gravimetrically (sixteen
repetitions) during the course of the study after drying 1-mL aliquots at 110°C for 12 h.
The scaled-down Folin-Ciocalteau method with gallic acid as standard was used to
determine the total phenolic content (32) of the different tea extracts The phenolic
content of the extracts was determined before and after precipitation of the flavonoids to
yield the nonflavonoid content, and by difference, the flavonoid content of the tea
extracts. Precipitation of the flavonoids was done according to Kramling and Singleton
(33).
Chemical Pathology. The animals were fasted (16 h) and sacrificed under
pentobarbital anesthesia after 10 weeks, and blood was collected from the abdominal
aorta. Serum samples were prepared for the determination of clinical biochemical
parameters including creatinine, total cholesterol, total iron, aspartate transaminase
(AST), alanine transaminase (ALT), alkaline phosphatase (ALP), total bilirubin (T.Bili),
unconjugated bilirubin (D.Bili), and total protein. Serum analyses were conducted on a
Technicon RA 1000 automated analyzer.
Preparation of Microsomal and Cytosolic Liver Fractions. Upon sacrifice, the liver
was excised immediately, weighed, frozen in liquid nitrogen, and stored at -80°C until
analyzed. For the preparation of the subcellular fractions, a sample was homogenized in
3 volumes of ice-cold 0.15 M KCI solution for 1 min, using a Thomas homogenizer. The
homogenates were filtered through double layer cheesecloth and homogenized with a
glass dounce (10 strokes) using a loose pestle. The homogenates were centrifuged at
9000g for 10 min, and the cytosolic and microsomal preparations were collected after
centrifugation of the supernatant at 100000g for 1 h. The microsomes were
resuspended In 0 15 M KCI using a glass dounce, centrifuged at 100000g for 1 h,
resuspended in 0.15 M KCI, and stored with the cytosolic fractions at -80°C. All
procedures were performed at 4°C. Microsomal and cytosolic proteins were determined
by the method of Bradford (34) using BSA as standard protein.
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Glutathione S-Transferase Assay. The GST-a activity was measured
according to the method of Habig et al. (35), using CDNB as substrate. The reaction
mixture contained 0.1 M potassium phosphate buffer (pH 6.5), 30 mM GSH, and 30 mM
CDNB. The reaction was initiated by the addition of cytosol (10 mg proteinf mL), and the
increase in absorbance at 340 nm due to the formation of CDNB-GSH conjugates was
recorded for 3 min at 25°C. The specific activity (pmolfminfmg protein) was calculated
using a millimolar extinction coefficient of 9.6 for CDNB-GSH. The activity of GST-fJ was
measured using 60 mM DCNB as substrate (35). The reaction mixture contained 0.1 M
potassium phosphate buffer (pH 7.5), 86.1 mM GSH, and 60 mM DCNB as substrate
cytosolic protein (0.3 mgfmL). Absorbance was measured at 344 nm for 3 min at 25°C.
The specific activity was expressed as pmolfminfmg protein using a millimolar extinction
coefficient of 8.5 for the DCNB-GSH conjugate.
UDP-Glucuronosyltransferase Assay. The activity of microsomal UDP-GT was
determined spectrophotometrically using p-nitrophenol and UDP-glucuronic acid as
substrates (36). Liver microsomes (1 mg of proteinfmL), activated with 0.25% (wfv)
Triton X-100, were incubated with 0.1 M Tris-HCI (pH 7.4), 50 mM MgCI2, and 5 mM p-
nitrophenol for 2 min at 37°C. The reaction was initiated by addition of UDP-glucuronic
acid (30 mM) and was terminated after 10 min by the addition of 5% (wfv) trichloroacetic
acid (TCA). After centrifugation (3000g), 2 M NaOH was added to the supernatant, and
the absorbance was determined at 405 nm. The specific activity was expressed as
nmolfminfmg protein using the millimolar extinction coefficient of 18.1.
GSH Analysis. Total glutathione (GSH and GSSG) was measured according to
a modified method of Tietze (37). Liver cytosolic preparations were treated on ice with
6% (vfv) perchloric acid (PCA) containing freshly prepared 3 mM M2VP and 1 mM
EDTA for GSSG and with ice-cold 15% (wfv) TCA for GSH determinations on ice. After
centrifugation at 1OOOOg for 10 min, 50 fJL of the supernatant was added to glutathione
reductase (1U) and 75 fJM DTNB. The reaction was initiated by addition of 0.25 mM
NADPH to a final volume of 200 fJL. The change in absorbance was monitored at 410
nm for 5 min, and GSH and GSSG levels were calculated using pure GSH and GSSG
as standards.
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Oxygen Radical Absorbance Capacity (ORAC). The ORAC assay was based
on the procedure described by Cao and Prior (38). Free radicals were produced by
MPH, and the oxidation of the fluorescent indicator protein B-PE was measured. Both
reagents were prepared in 75 mM phosphate buffer (pH 7.0), and 50 pM Trolox was
used as standard. The liver samples were homogenized in 4 volumes of the phosphate
buffer in a Thomas homogenizer (10 strokes) and centrifuged at 12 OOOg for 10 min at 4
°C. The supernatant was deproteinized using 0.25 M PCA and centrifuged at 16 OOOg
for 15 min. The resultant supernatants were then stored at -80°C prior to analysis. The
reaction was performed in 96 well microtiter plates and consisted of 170 pLof B-PE (80
pg/mL) and 10 pL of diluted (1: 1) sample incubated at 37°C for 15 min. The reaction
was initiated by the addition of 20 pL of MPH (240 mM), and the fluorescence
(emission 590 nm, excitation 530 nm) was recorded every 5 min until reading had
declined to less than 5% of initial reading. The ORAC values were calculated and
expressed as pM Trolox equivalents/mg wet liver weight.
Statistical Analysis. Data were analyzed by two-way ANOVA using the generalized
linear model procedure, and Tukey's Studentized range test was used to determine
whether the means differed statistically. When data showed unequal variances, the
nonparametric Tukey-type test was used. Values were considered significant if P <
0.05. Bonferroni pairwise adjustment was used to compare GSH, GSSG, and UDP-GT
values.
RESULTS
Body Weight and Relative Liver Weight Gains, No significant differences (P > 0.05)
in the daily tea intake between the various groups were noted. No differences were
noted in the body weight gain and relative liver weight (percentage of bodyweights) as a
result of the tea treatment (Table 1).
Liver and Kidney Function Indicators and Serum Iron and Cholesterol Levels. The
effect of the different tea treatments on the liver function enzymes of the experimental
animals is summarized in Table 1. No significant differences were noted in the activities
of the liver function enzymes AST, ALT, and ALP. The level of total bilirubin,
unconjugated bilirubin, and total protein was also not significantly different between the
tea treated and control rats (results not shown). Similarly, the levels of creatinine, a
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Soluble Solid, Total Phenolic, Flavonoid Content and Total Phenolic Intake. The
soluble solids were significantly higher (P < 0.001) in the honeybush extracts than in the
rooibos extracts, which is in agreement with the larger amount of tea used for the
preparation of the honeybush extracts (Table 2). The soluble solids obtained from the
processed tea extracts constituted approximately 50% of the unprocessed herbal tea
extracts. The soluble solids of the black tea were significantly higher (P < 0.05) when
compared to the green, unprocessed rooibos and the processed herbal teas.
The total phenol content of the processed rooibos tea's soluble solids did not
differ significantly from its unprocessed counterpart, but processed honeybush tea had
a significantly lower (P < 0.001) phenol content when compared to the soluble solids of
unprocessed honeybush tea. Green and black teas had a similar phenolic content
(Table 2). The total phenolic content of unprocessed rooibos and green tea's soluble
solids was significantly higher than that of unprocessed honeybush tea. Black tea
soluble solids exhibited phenolic levels very similar to those of processed rooibos and
were significantly higher than those of the processed honeybush tea. The flavonoid
content of the green and black teas was approximately 20 and 30% higher when
compared with that of the processed and unprocessed herbal teas, respectively (Table
2). There were no significant differences in the phenolic intake of the rats that received
the unprocessed rooibos, green, and black tea, while rats that consumed the
unprocessed honeybush tea had the highest phenolic intake (P < 0.05). Rats that
received the processed herbal teas ingested the lowest amount of total phenols when
compared with the unprocessed herbal teas and green and black teas. When
considering the flavonoid intake, rats receiving the unprocessed honeybush tea, green,
and black teas had a significantly (P < 0.001) higher intake when compared to the rats
consuming the unprocessed rooibos tea. The flavonoid intake of the rats receiving the
processed herbal teas was significantly (P < 0.001) less when compared with their
processed counterparts.
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Table 1 Effect of tea treatments on the body weight gain, relative liver weight, and selected blood clinical chemical
parameters related to liver and kidney function •
Treatment Body weight Relative AST (UlL) ALT (U/L)
ALP (UlL) Creatinine Cholesterol Total iron
gain (g) liver
(1JITl 0 1/L) (mmoI/L) (pmoI/L)
weight (g)
Control (water) 109.3:1: 17.7a 7.26:1: 0.97a 333.6 :I:68.2a 179.4 :I:64.33a
134.8 :I: 10.2a 82:1: 6.7a 1.31:1:0.19a 15.10:l:1.54a
Rooibos tea 112.0:l:15a 7.00:1: 0.80a 351,5:1: 55a 123.9:1: 24,5a
144,6 :I:22.4a 88,5:1: 6.5a 1.64:1: 0.19a 16.45 :I:2.65a
processed
Rooibos tea 115.4:1: 18,8a 6.96:1: 1.2a 391.8:1: 66.9a 146.8:1: 47.7a
127.7:1: 36.7a 88:1: 6.2a 1,54:1: 0.23a 13.9:1:1.6a
unprocessed
Honeybush tea 117,8:1: 19.3a 6,72:1: 096a 320.6 :I:56.7a 145.4 :I:91.6a
133.1 :I:25.3a 86.1 :I:3.5a 1.55:1: 0.28a 13,8:1:2.1a
processed
Honeybushtea 106.1:1: 15.4a 7.53:1: O.77a 311,7:1: 39.1a 132.1 :I:30,3a
144,5:1: 30,5a 85.7:1: 4.35a 1.58:1: 0.27a 16.75 :I:4.23a
unprocessed
Black tea 127.8:1: 18.2a 6,53:1: 0.65a 356.2 :I: 100. 7a 182,3 :I:94.3a
132.6 :I: 12.9a 76.1 :I:5.22a 1.46 :I:0.25a 14.48:1: 2.19a
Green tea 121.3 :I:10,6a 7.04:1: 0.85a 386,7:1: 63.2a 143.1:1:67.4a
133,7:1: 18,9a 82.5:1:7.1a 1.53:1: 0.1a 14,26 :I:2.83a
a Values in columns are means :t STD of 10 rats per group. Means followed by the same letter are not significantly different.
136
http://scholar.sun.ac.za
ChapteT4---------------------~ 137
Cytosolic Glutathione S.Transferases. Exposure of rats to various aqueous tea
extracts did not significantly affect the activity of GST-{l (mu). However, there was a
significant increase (P < 0.001) in the activity of GST-o: (alpha) in the livers of rats fed
the South African herbal teas when compared to the control and green and black tea
treated groups (Table 3).
Microsomal glucuronosyl transferases. A significant increase (P < 0.001) in the
UDP-GT activity was evident following treatment of the animals with unprocessed
rooibos tea, while unprocessed honeybush tea also marginally (P = 0.06) increased the
activity of the enzyme. Animals receiving green, black, or processed herbal teas did not
significantly alter the activity of the enzyme (Table 3).
Glutathione levels. The concentration of GSH in the livers of the experimental animals
was not significantly affected by any of the teas, although the South African herbal teas
tended to increase the level (non-significantly) when compared with the control and
black and green tea groups (Table 4). A significant decrease (P < 0.05) in GSSG levels
was noted in the liver of rats exposed to the various tea preparations. Processed and
unprocessed rooibos tea also caused a significantly lower (P < 0.05) GSSG level in the
liver when compared to rats drinking the processed and unprocessed honeybush and
green and black teas.
Due to the changes in the GSH and GSSG levels, the GSH/GSSG ratio
significantly increased (P < 0.05) in the liver of the rats drinking the unprocessed and
processed rooibos and unprocessed honeybush teas, while processed honeybush tea
marginally (P = 0.06) increased the ratio (Table 4). Although green and black teas
markedly increased the GSH/GSSG ratio when compared to the control group, this
increase was not statistically significant.
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Table 2 Different intake parameters of male Fischer 344 rats fed various tea preparations over a period of 10
weeks.
Treatment' Soluble solids Total phenolic Liquid intake/ Total phenolic intake Flavonoids Total flavonoid
(mg/mL) content (mg Gallic day/100 9 BW (mg Gallic acid (% of total intake (mg Quer-
acid equivalents/ (mL) equivalents/ day/100 phenolic cetin equivalents/
mg soluble solids) 9 BW)' content)
..
day/100 9 BW)
Control None None 9.7:1: 1.45a None None
(water)
Rp tea 2.59 :!:0.44a 0.32:!: 007a 7.90:!: 1.01a 6.40:!: 0.08a 63.13:!: 1.69a 2.94:!: 0.89a
Rg tea 536 :t 0.81 b 0.36 :t 0.06a 829:t 0.74a 16.12:t 0.18b 76.02 :t 2.29b 11.97 :t 1.76b
Hp tea 5.96:!: 0.78b 0.15:t 005b 8.10 :t 0.85a 7.29:t019a 63.09:t 3.09a 3.73:t 104a
Hg tea 11.78:t 1.18c 0.23 :t 0.04ab 8.58:t 0.92a 22.90 :t 0.36c 7486:t 1.39b 19.07:t 237c
Black tea 837 :t 0.66c 0.26 :t 0.03a 8.03:!: 0.52a 17.30:t O.llb 92.9:t 2.35c 15.14:t 2.09c
Green tea 7.21 :t 0.82b 0.30:t 0.04a 7.92 :t 0.35a 17.02:t 0.06b 92.89 :t 0.7c 16.48:t 191c
Parameters of tea intake are mean of 16 determinations. Values in columns are means:t STD of ten rats per group. Means followed by the same
letter are not significantly different. If the leiters differ then P<O.OOl. 'Aqueous solutions (2%) were prepared of rooibos processed (Rp),
unprocessed (Rg), green and black teas and 4% (w/v) of honeybush processed (Hp) and unprocessed (Hg). 'Calculation of the total phenolic
intake was based on the soluble solids intake obtained from the average liquid intake/day. "Flavonoids were determined after subtracting the non-
flavonoid content from the total phenolic content (Materials and Methods)
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Table 3 Effect of unprocessed and processed herbal and green and black teas
on the activities of the cytosolic glutathione S-transferases and the microsomal
UDP-glucuronosyl transferases in livers of rats exposed to the various teas for
10 weeks.
Treatment
Water
Rooibos processed
tea
Rooibos
unprocessed tea
Honeybush
processed tea
Honeybush
unprocessed tea
Black tea
Green tea
GST-~.(mul GST-o.(alph<)l UDP-GT
(pmol/min/mg (pmol/min/mg (nmol/min/mg
prot) prot) prot)
2.41 :t 0.39a 2.39 :t 0.40a 31.55:t 3.97a
2.96:t O.77a 4.60:t1.10b 29.32 :t 3.09a
3.04 :t 0.64a 4.34 :t 1.03b 4509 :t 4.49b
2.50 :t 0.43a 3.87 :t 0.63b 37.7:t 5.88ab
2.43 :t 0.74a 3.45:t1.13b 40.81 :t 656(b)
2.15:t 0.47a 2.39 :t 0.66a 33.09 :t 3.67a
1.96 :to.38a 2.06 :t 0.46a 24.55 :t 2.57aa
Valuesin columnsare means:t STOof ten rats pergroup.Meansfollowedby the same letterare not
significantlydifferent(P > 0.05).If lettersdiffer thenP < 0.05.Lettersin parenthesisthenP < 0.1.OCNS
wasusedas substratefor GST-mudeterminationandCONS.forGST-alpha,
Oxygen Radical Absorbance Capacity (ORAC). The ORAC values in the liver of the
rats were significantly (P < 0.001) and marginally lowered by the green and black teas,
respectively. No effect was noticed on the hepatic ORAC level in the rats treated with
the herbal teas (Table 4).
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Table 4 Effect of unprocessed and processed herbal and green and black tea
on reduced glutathione (GSH), oxidized glutathione (GSSG), the ratio
GSH/GSSG and oxidative capacity (ORAC) in livers of rats exposed to the
various teas for 10 weeks.
Treatment
Water
GSH
(JlM/mg protein)
9.35 t 2.00a
GSSG
(JlM/mg
protein)
1.23 t 0.32a
GSH:GSSG
Ratio
7.98 t 2.50a
ORAC
(JlM Trolox
equivalents/mg
protein)
10.49t1.91a
Rooibos
processed tea
15.06 t 5.38a 0.42 t 0.13b 38.89t 12.19b 11.47 t 1.11a
Rooibos 16.39 t 5.33a
unprocessed tea
Honeybush 13.6 t 2.67a
processed tea
0.40 t 0.13b
0.70 t 0.16c
42.1t 9.66b
20.99 t
7.01(b)
1074 t 1.98a
11.28 t 1.84a
Honeybush 18.56 t 6.2a
unprocessed tea
0.51 t 0.18c 43.73t 12.73b 10.10t 1.20a
Black tea
Green tea
10.67 t 2.91a
9.2t2.12a
0.87 t 0.29c
0.76tO.15c
12.9t4.11a
13.3tl.77a
7.99 t 0.83b
8.72 t 1.96ab
Valuesin columnsaremeans:t STO of ten ratspergroup.Meansfollowedby thesameletterdo not
differ significantly(P > 0.05). If lettersdiffer then P < 0.05.Lettersin parenthesisindicatemarginal
effects(P < 0.1).
DISCUSSION
Certain dietary constituents may influence the incidence of diseases (e.g. cancer) by
modulating the enzyme systems responsible for the metabolic activation/detoxifying of
chemical carcinogens in the cell (39). In this regard, the popularity of herbal teas has
increased during the past twenty years (40) following advances made in our knowledge
on the anticancer properties of green and black teas (3, 41, 42). Because the phenolic
constituents of the two South African herbal teas differ from green and black teas, it is
imperative to investigate the possible protective mechanisms of rooibos and honeybush
teas against the adverse effects of xenobiotics in vivo.
Consumption of aqueous extracts of rooibos and honeybush teas, as sole
substitutes for drinking water, did not cause any adverse effects in the liver and kidney
of the rats. The total serum iron levels were not altered, indicating that none of the teas,
irrespective of the difference in phenolic composition, interfered with iron uptake in the
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present study. A study by Hesseling (43) showed that rooibos tea did not affect iron
absorption in a human population; however, conflicting findings have been reported with
respect to the effect of black and green teas on iron uptake in humans (44, 45).
Antioxidant activity has been demonstrated for rooibos (9) and honeybush tea
extracts (46) in various in vitro systems (e.g., scavenging of 1,1-diphenyl-2-
picrylhydrazyl radical (DPPH) and superoxide anion radicals). These studies showed
that honeybush tea exhibited a significantly lower antioxidant activity than rooibos tea.
This could be attributed not only to the difference in the phenolic profile but also to the
lower phenolic content of honeybush soluble solids. In the present study, the low levels
were compensated for by the increased amount of tea used in preparation of these
extracts. The latter did not negatively impact the consumption and/or the body weight
gain and liver function of the rats. The phenolic intake of animals receiving green and
black teas was similar or equal to the intake of animals receiving the unprocessed
rooibos tea and 3-4 times higher when compared to the processed honeybush and
processed rooibos tea. In a comparative study, it was demonstrated that aqueous
extracts of green tea exhibit higher antioxidant potency than those of black tea, while
unprocessed rooibos is comparable to black tea. Processed rooibos tea extracts exhibit
the lowest antioxidant activity (47). When using the ORAC assay, the total antioxidant
capacity of green and black tea compares favorably to other drinks prepared from fruit
and vegetables (48). In the present study, however, green and black tea marginally (P <
0.1) to significantly (P < 0.05) reduced the hepatic ORAC level, respectively, while no
effect was noticed with the herbal teas. It is not known whether a relationship exists
between the reduced hepatic ORAC and the total phenolic intake of the rats fed the
green and black teas under the present experimental conditions.
Reduced glutathione, a powerful intracellular antioxidant that plays an important
role in stabilizing many enzymes (49), could also be considered as a good marker for
the antioxidative capacity in tissue (50, 51). Several clinical conditions are associated
with a decrease in the GSH level in the cell that may result in a lowered cellular redox
potential (52). Van Acker et al. (51) showed that GSH has the ability to regenerate a-
tocopherol from its radical, maintaining the levels of a-tocopherol at a level to protect
the cell membranes against lipid peroxidation. In this regard, flavonoids mimic the
antioxidant activity of R-tocopherol, suggesting an interaction between flavonoids and
GSH. Nanjo et al. (53) showed that the addition of green tea catechins to diets high in
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palm and perilla oil prevented a decrease in the plasma a-tocopherol concentration in
rats. Rooibos and honeybush teas significantly decreased the level of GSSG in the liver
resulting in an increase of the GSH/GSSG ratio, presumably by stabilizing GSH. The
level of GSH was markedly (not significantly) higher in the liver of the herbal-tea-treated
rats. Green and black teas significantly (P < 0.05) reduced GSSG, while the GSH level
was not affected. Changes in the GSH and GSSG levels resulted in a significant
increase in the GSH/GSSG ratio in the liver of the rats fed the herbal teas, while it was
markedly (not significantly) increased with the green and black teas. Sohn et al. (54)
also showed that neither the black nor the green tea affected the liver concentrations of
GSH in male F344 rats when treated with 2% aqueous extracts of green and black teas
for 6 weeks. The GSH/GSSG ratios were not reported. Despite the differences in the
type of flavonoids, the unprocessed herbal teas exhibited a similar effect on the
GSH/GSSG ratio while there was an approximate 50% reduction in the case of the
processed honeybush tea. The significant increase in the GSH/GSSG ratio in the liver
of the herbal-tea-treated rats may be indicative of a reduced oxidative stress or an
increased antioxidant capacity in the cell, thereby lowering the susceptibility to oxidative
damage. The marked increase obtained with the green and black tea suggests that, in
the present study, the phenolic components of the herbal teas were more effective in
increasing the antioxidant status in the liver.
Stabilization of GSH in the liver may also result in an increase in the endogenous
detoxification capacity, as glutathione is known to, either directly or via the glutathione
S-transferases, interact with reactive genotoxic metabolites, thereby reducing the
likelihood of damage to cellular DNA (28, 55). With respect to metabolism, the
carcinogenicity of compounds (e.g. the mycotoxin AFB1 and 2-AAF) is modulated by the
interaction with the phase I activating or the phase II detoxifying enzymes (27, 28, 56,
57). Studies by Siess et al. (28) in Wistar rats suggest that dietary flavonoids inhibit
AFB1 carcinogenesis by decreasing the covalent binding of AFB1 to liver DNA as a
result of the production of conjugated AFB1 metabolites via the induction of phase II
enzymes GST-a and UDP-GT. Rats treated with coumarin, a natural benzopyrone,
were protected from developing hepatic AFB1-induced preneoplastic lesions (27). The
induction of class GST-A5, a subunit of GST-a, was implied to play an important
protective role. In the present study, the activity of GST-a was increased in the livers of
rats fed the processed and unprocessed rooibos and honeybush teas. The black and
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green teas showed no effect when compared to the control group, which is in
accordance with studies conducted by Bu-Abbas et al. (58) and Sohn et al. (54) using
male Wistar and Fischer rats, respectively. However, an increase in the activities of
GST-a and GST-J.1 when using aqueous extracts of black tea in human Chang liver cells
has been reported (1). Another study also showed a significant induction of GST by
green tea leaves when fed to Wistar rats at various concentrations between 4 and 63
weeks (59).
Similar discrepancies seem to exist with respect to the induction of UDP-GT by
green and black teas. Under the present experimental conditions, no induction of UDP-
GT activity was found in male Fischer rats treated with 2% tea in their drinking water for
10 weeks. The induction of UDP-GT activity in the microsomes has been suggested as
a major mechanism of tea as a chemopreventive agent (60). Unprocessed rooibos tea
significantly increased the activity of the microsomal UDP-GT in the liver, while
unprocessed honeybush tea only showed a marginal significant (P < 0.1) increase. The
increase in the glucuronidation capacity was suggested to facilitate the metabolism of
chemical carcinogens into inactive, readily excretable products, thereby reducing their
possible interaction with cellular DNA (58). The lack of induction of UDP-GT activity in
processed rooibos and honeybush tea could be due to the change in phenolic
composition during processing of these teas (9, 10, 21). The present study showed no
difference in the induction of the activity of the enzyme by the green and black teas. In
contrast, several studies indicated that aqueous extracts of black tea and to a lesser
extent green tea induced the activity of UDP-GT using p-nitrophenol and 2-aminophenol
as substrates for the enzyme (54, 56, 60, 61). However, when using 4-methyl-
umbelliferone as a substrate none of the teas increased the activity of the enzyme.
Decaffeinated black tea also failed to enhance the activity of the enzyme.
It would appear that many variables exist that could determine the induction of
the activity of phase II enzymes by green and black tea. These include the rat species
used (58), the amount of tea used, duration of treatment and route of administration
(59), and the substrate used in the enzyme assay (58, 61). Some of these parameters
could have contributed to the apparent lack of the induction of enzyme activity by green
and black tea reported in the present study.
A preliminary report by Marnewick et al. (62) indicated that the mutagenicity of
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AFB1 and 2-AAF decreased with the addition of liver cytosolic fractions from male
Fischer rats that consumed the South African herbal teas for 10 weeks when compared
with controls given water. The present study indicates that enhanced activities of the
important phase II enzymes, GST-a and UDP-GT, as well as the increased oxidative
status in the liver, may account for this protective effect in the mutagenicity assay. Apart
from the induction of phase II enzymes by rooibos and honeybush teas, other
mechanisms of antimutagenicity may playa role. Nucleophilic tea components may also
directly interact with the genotoxic reactive intermediates of mutagens to reduce their
mutagenic potential. However, this may vary with the type of mutagen and needs further
investigation (6, 63). Because the phenolic constituents of the two South African herbal
teas differ from those of green and black teas, the mechanisms involved in protection
against DNA damage could also differ. The induction of phase II hepatic drug
metabolizing enzymes and the increased antioxidant status of the liver by these herbal
teas may represent a promising tool for chemoprevention against cancer in humans as
they are consumed on a regular basis locally and are becoming increasingly important
as a nutraceutical product globally.
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ABSTRACT
Male Fischer rats were given unprocessed (not oxidized) and processed (oxidized) rooibos
and honeybush teas as well as green and black teas as a sole source of drinking fluid for
10 weeks, and sub cellular liver fractions were prepared. Cytosolic fractions of rats
consuming the unprocessed herbal teas, green and black teas significantly (P < 0.05)
protected against 2-acetylaminofluorene (2-AAF)-induced mutagenesis in the Salmonella
mutagenicity test with strain TA 98, using Aroclor 1254-induced microsomes. A marginal or
no protection was obtained with the processed herbal teas. The mutagenic response of
aflatoxin B, (AFB,) against Salmonella strain TA 100 was significantly (P < 0.05) inhibited
by cytosolic fractions from rats treated with processed and unprocessed herbal teas, while
no effect was obtained with the green and black teas. Microsomal fractions prepared from
livers of rats treated with both the processed and unprocessed rooibos teas and the
unprocessed honeybush tea, significantly (P < 0.05) reduced the activation of AFB, while
no protection was observed against 2-AAF-induced mutagenesis. In contrast, microsomal
fractions from rats treated with the green, black and unprocessed honeybush teas
significantly (P < 0.05) enhanced the mutagenic response of 2-AAF. None of the tea
treatments significantly affected the concentration of the microsomal liver cytochrome
P450.
KEYWORDS: Aflatoxin B,; 2-Acetylaminofluorene; Mutagenesis; Ex vivo protection;
Rooibos; Honeybush
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Food borne mutagens and carcinogens are readily converted into reactive genotoxic
intermediates by phase I metabolizing enzymes. Following this metabolic step, the
detoxification pathways convert the potential genotoxins to less reactive metabolites,
which can be more readily excreted [1]. Studies in experimental animals revealed that
many food-derived and/or synthetic components inhibit the carcinogenic response of food
contaminants e.g. 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), a heterocyclic amine
produced during the cooking of protein-rich food, benzo[a]pyrene (B[a]P), a polycyclic
aromatic hydrocarbon from heating food materials and aflatoxin B, (AFB,), a mycotoxin
produced by Aspergillus f1avus [2,3]. Dietary constituents can selectively modulate the
drug-metabolizing enzymes thereby altering the metabolic fate of the carcinogen in the cell
[4-6J. This could lead to either a decrease or in some cases even an increase in the level
of the active carcinogenic metabolite(s) available to interact with DNA, which is known to
be an important determinant in the development of cancer.
Epidemiological studies indicated that the frequent intake of certain food
components plays an important role in reducing the risk for cancer development in humans
[7-10]. With growing scientific evidence of the beneficial health properties of green and
black teas [11-13] the health-promoting potential of two unique South African herbal teas,
rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia) are of interest. Rooibos
and honeybush teas have been used as herbal beverages and to a lesser extent as herbal
'medicines' in South Africa before the 1800s [14]. The popularity of these teas can be
ascribed to the low tannin content [15,16] and the absence of caffeine [15,17]. The
established pharmacological effects of rooibos tea and to a certain extent honey-bush tea
include anti-oxidative [18-20], anti-aging [21], anti-viral and anti-inflammatory [22]
properties, and anti-mutagenic activity in test systems in vitro [23,24]. Most of the
protective effects against mutagenesis of green and black teas were ascribed to the
polyphenolic compounds, the catechins. Rooibos and honeybush teas contain a wide
variety of phenolic compounds that not only differs from that of the green and black teas
but also from one another. Rooibos tea predominantly contains dihydrochalcones,
f1avonols and f1avones [25,26] and honeybush tea (C. intermedia) contains xanthones,
f1avanones, and coumestans [27,28]. In contrast, green tea mainly contains f1avanols while
black tea contains the oxidized polymeric compounds, the theaflavins and thearubigins
[29,30].
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Many studies focused on the inhibition of mutagenesis by tea and tea polyphenols
in vitro, but these modulating properties have not been fully elucidated in vivo [311.
Considering the potent anti-mutagenic activity of rooibos and honeybush teas in vitro
[18,24] very little information is available whether similar protective mechanisms exist in
vivo and what type of mechanism is involved. A study by Sasaki et al. [23] in hamster
ovary cells and male ICR mice showed that extracts of processed rooibos tea decreased
the number of chromosome aberrations and micronucleated reticulocytes, respectively,
after exposure to benzo[a]pyrene (B[a]P) and mitomycin C (MMC). The present study
investigated the ex vivo modulating effects of sub-cellular hepatic fractions of rats treated
with processed and unprocessed herbal teas as compared with green and black teas
against 2-acetylaminofluorene (2-AAF)-and AFB,-induced mutagenesis in the Salmonella
mutagenicity assay.
MATERIALS AND METHODS
Chemicals. 2-AAF [53-96-3] and AFB1 [1162-65-8], biotin [58-85-5], histidine [71-00-1 j,
nicotinamide adenine dinucleotide phosphate (NADP) [1184-16-3], glucose-6-phosphate
(G-6-P) [54010-71-8] and the enzyme, glucose-6-phosphate dehydrogenase (G-6-PDH)
[9001-40-5] were purchased from Sigma (SA). Dimethyl sulfoxide (OMSO) [67-68-5] was
obtained from BDH Laboratory Supplies (Poole, UK). Agar and Nutrient Broth NO.2 were
purchased from the Difco Laboratories (Detroit, USA) and Oxoid (Hampshire, UK),
respectively. All other solvents used were of analytical grade.
Tea preparations. Aqueous extracts of processed and unprocessed rooibos and
honeybush and of green and black teas were prepared by the addition of freshly boiled tap
water to the tea leaves and stems (2 g/100 ml) for processed and unprocessed rooibos,
and black and green teas and 4 g/100 ml for processed and unprocessed honeybush tea.
The herbal tea concentrations used are customary for tea making purposes [32,33] in
South Africa. The mixture was allowed to stand for 30 min at room temperature, filtered
(Whatman no. 4) and after cooling, dispensed into water bottles. Individual batches of
processed and unprocessed rooibos and honeybush leas of the highest quality were
supplied by Dr. E. Joubert. The black tea (Camellia sinensis var. assamica) was a blend of
locally produced African tea and Sri Lankan teas (http://www.five-roses.com/about-
us/default.htm) and was obtained from a commercial relail outlel in Cape Town, South
Africa. The green tea (C. sinensis var. sinensis), imported from China, was a gift from Vilal
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Treatment of animals. Seventy male Fischer 344 rats, weighing 150-190 g, were
obtained from the Primate Unit (Diabetic Research Group of the Medical Research Council
of South Africa), randomly divided into seven treatment groups consisting of ten rats per
group and housed individually in stainless steel wire-bottomed cages fitted with perspex
houses in a closed environment (24-25 °C), with a 12 h light-dark cycle and 50%
humidity. Rats had free access to the various aqueous tea extracts for 10 weeks as their
sole source of drinking fluid while the control group received tap water. The rats were fed
rat cubes (Epol Ltd., Johannesburg, South Africa) ad libitum and the fluid intake monitored
on a daily basis while the tea was freshly prepared every second day. The general
condition of the rats was monitored daily throughout the experiment while the body weights
were determined on a weekly basis.
Preparation of microsomal and cytosolic liver fractions. The animals were sacrificed
under pentobarbital anesthesia and blood was collected from the abdominal aorta and
subjected to clinical chemical analyses [34]. Livers were immediately excised, weighed
and a sub-sample was homogenized in three volumes of ice-cold 0.15 M KCI for 1 min
using a Thomas homogenizer. The homogenates were filtered through double-layer
cheesecloth, and homogenized in a glass tissue-grinder (10 strokes) using a loose
plunger. The homogenates were centrifuged at 9000g for 10 min and the cy1osolic and
microsomal preparations collected after centrifugation of the resultant 'S-9' supernatant at
1OO,OOOg for 1 h. The microsomes were collected in 0.15 M KCI, homogenized in a glass
tissue grinder using a loose plunger, centrifuged at 1OO,OOOg for 1 h, resuspended in 0.15
M KCI and stored with the cy1osolic fractions at -80°C. All procedures were performed
under sterile conditions at 4°C. Microsomal and cy1osolic proteins were determined by the
method of Bradford using bovine serum albumin as protein standard [35].
The S-9 homogenate used in the standard Salmonella mutagenicity assay was
prepared from Aroclor 1254-induced rats as described previously [36], aliquoted in sterile
vials and stored at -80°C. For the preparation of Aroclor-induced microsomes the
resultant S-9 homogenate was fractionated as described above.
Cytochrome P450 determination. The cytochrome P450 content of the S-9
homogenates and microsomal fractions was determined from the dithionite-reduced
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difference spectrum of carbon monoxide-saturated samples and expressed as nmol/mg
protein using a millimolar extinction coefficient of 91 [37].
Salmonella mutagenicity /anti-mutagenicity assay. The Salmonella mutagenicity assay
was conducted according to the method described by Maron and Ames [36] with minor
modifications. Two known mutagens, 2-AAF and AFB1, requiring metabolic activation,
were used against tester strains TA 98 and TA 100, respectively. The tester strains were
obtained from Dr. B.N. Ames (Berkeley, California, USA). Stock solutions of the different
carcinogens were freshly prepared on the day of the experiment using dimethyl sulfoxide
as solvent. The mutagenic response of 2-AAF and AFB1 in the standard assay was
conducted using S-9 fractions from Aroclor-1254 treated rats at a concentration of 2 mg
protein/ml S-9 mixture and cytochrome P450 (CYP450) at 0.6 nmol/mg protein. Five
replicate plates were included for each sample.
Cytosolic modulation assay. For the cytosolic modulation assay, the S-9
activation mixture consisted of phosphate buffer (0.1 M) pH 7.4, salt solution (0.03 M KCI;
8 mM MgCI2), glucose-6-phosphate (5.3 mM), NADP (0.03 M) and Aroclor-induced
microsomes (1 mg protein/ml; 2.8 nmollmg protein). The optimum cytosolic concentration
to compare the protective properties of the different cytosolic preparations was established
first. The various cytosolic preparations from the herbal tea-and water-treated rats (one rat
per group) were tested at two protein concentrations (0.25 and 1 mg protein/ml S-9
mixture) against strain TA 98, with 2-AAF as a mutagen. Subsequent experiments were
conducted using the different cytosolic preparations at a protein level of 0.25 mg/ml S-9
mixture, with 2.AAF (5 ,tg/plate) and AFB1 (15 ng/plate) as mutagens. The total protein
concentration (1.25 mg/ml) of the S-9 mixture used in the comparative study was below
that proposed for mutagenicity testing (1.6 mg protein/ml S.9 mixture) of potentially
mutagenic compounds when utilizing the plate-incorporation assay [36]. This would have
excluded the possible occurrence of certain artifacts induced by the different cytotosolic
fractions such as bacterial cytotoxicity and/or the inhibition of mutagenesis due to the high
level of protein added.
Microsomal activation assay. The mutagen-activating potential of microsomes
isolated from tea-treated rats was determined using the standard plate-incorporation assay
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[36]. The activation mixture consisted of 0.1 M phosphate buffer (pH 7.4), salt solution
(0.03 M KCI; 8 mM MgCI2), glucose-6-phosphate (5.3 mM), NADP (0.04 M) and glucose-
6-phosphate dehydrogenase (equivalent to 2 U/ml). The microsomes of the different tea-
treated rats were incorporated at a level of 1 mg protein/ml in the activation mixture, while
the mutagen concentrations used were 100 mg/plate for 2-AAF and 50 ng/plate for AFB1.
Control plates, containing only DMSO (used as solvent vehicle) were also included
to obtain spontaneous revertant counts. All plates were incubated at 37 DCfor 48 h and the
histidine revertants were counted using a Quebec Colony Counter (America Optical Corp.,
Buffalo, New York). All experiments were repeated twice and five replicates for each
sample were included.
Statistical analysis. Analysis of variance (ANOVA) was performed using the statistical
analysis system (SAS) programme. Data showing equal variances were analyzed using
the parametric Tukey T-test. When data showed unequal variances (Kruskal-Wallis test)
the non-parametric Tukey-type test was used.
RESULTS
Tea intake profiles and effect on rat body weight parameters. The various tea
treatments had no adverse effects on the body weight gain, relative liver weight, blood
clinical chemical changes and daily fiuid intake of the rats [34]. Tea intake profiles varied
between 8 and 9 ml/100 g body weight per day with no significant difference between the
various groups. The total flavonoid intake was significantly higher (P < 0.001) in the black,
green and unprocessed honeybush tea-treated rats as compared with the rats consuming
the processed and unprocessed rooibos and unprocessed honeybush teas (Table 1).
Cytosolic modulation assay
Pilot study. An increase in the mutagenic response of 2-AAF against strain TA 98
with Aroclor 1254-induced microsomes was noticed when the level of the cytosolic fraction
from the control rats was increased from 0.25 to 1 mg protein/ml of the S-9 mixture
(equivalent to 0.125 and 0.5 mg/plate) (Fig. 1). Significant (P < 0.05) protection was
obtained with the different cytosolic fractions from the herbal tea-treated rats at con-
centrations of 0.25 mg/ml of the S-9 mixture. A similar inhibition pattern was obtained with
the higher cytosolic content (1 mg/ml S-9) although a weaker protection was noticed with
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the processed and unprocessed honeybush teas. Based on these data a cy1osolic level of
0.25 mg/ml of the S-9 mixture was used in the study for the different cy1osolic fractions of
the tea-treated rats, including those given the green and black teas. For comparative
purposes, the subsequent studies with AFB, as a mutagen against strain TA 100, was also
conducted at the same cytosolic protein concentration.
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Fig. 1. Ex vivo protective effect of different cytosolic protein concentrations (0.25 and 1 mg/ml) on the
mutagenicity induced by 2-AAF in S. typhimurium TA 98. Rp: processed rooibos, Rg: unprocessed rooibos,
Hp: processed honeybush and Hg: unprocessed honeybush. Each value represents the mean and standard
deviation (n= 5). P < 0.05 when different cytosolic concentrations were compared with the control.
Microsomes (1 mg/ml activating mixture) of Aroclor-induced rats were used to induce metabolic activation of
2-AAF.
Tea-derived cytosolic liver fractions. The protective effects of the different
cy1osolic preparations obtained from liver homogenates of the tea and the water treated
rats against 2-AAF- and AFB,-induced mutagenesis are summarised in Table 1. When 2-
AAF was used as mutagen, only the cy1osolic fractions of the rats consuming the
unprocessed herbal teas, and the green and black teas significantly (P < 0.001) decreased
the mutagenicity as compared with the cytosolic fractions prepared from the water-treated
control rats. The cy1osolic fraction of the rats receiving the processed honeybush tea
showed a marginal (P = 0.053) protective effect. When AFB1 was used as mutagen, the
cytosolic fractions from the rats treated with both processed and unprocessed rooibos and
honeybush teas resulted in a significant (P < 0.001) protective effect as compared to the
control. No significant protective effect was noted with the cy1osolic fractions of the rats
given the green and black teas at the specific concentration tested.
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Microsomal activation assay. None of the microsomal preparations of the tea-
treated rats caused a decrease in the mutagenicity of 2-AAF when compared to the
control (Table 2). However, a significant (P < 0.05) increase in the number of histidine
revertants was obtained with the liver microsomal fractions of the rats treated with the
unprocessed honeybush, black and green teas. A marked but not significant increase in
the number of histidine revertants was noticed with the microsomal fractions obtained
from the rats treated with the processed honeybush tea and the processed and
unprocessed rooibos teas.
When AFB1 was used as mutagen, the microsomal preparations of the rats treated
with processed and unprocessed rooibos and unprocessed honeybush teas showed a
significant (P < 0.05) decrease in the number of histidine revertants. No effect was
obtained with the microsomal fractions of the rats treated with the green or black teas, or
with the processed honeybush teas. The concentration of microsomal cytochrome P450
(nmol/mg protein) of the different microsomal preparations did not differ significantly as a
result of the different tea treatments (Table 2). However, the levels tended to be higher
(not significantly) in the microsomes prepared from rats that had received the unprocessed
honeybush tea and the black tea.
Spontaneous revertant counts. The spontaneous revertant counts of strains TA
98 and TA 100 were in the range (30-50 and 120-200, respectively) of published values
[36].
DISCUSSION
Several mechanisms for the modulating role of black and green tea extracts or purified
phenolic compounds on the in vitro mutagenic response against various metabolically
activated mutagens have been suggested. These include the inhibition of CYP450-
dependent bio-activation of the pro-mutagens and/or a prevention of DNA damage by the
interaction of tea components with the ultimate carcinogens [12,38-42]. With respect to
rooibos and honeybush teas, similar in vitro protective mechanisms against 2-AAF-and
AFB,-induced mutagenesis in the Salmonella mutagenicity assay were suggested
previously [24]. In that study, the anti-mutagenic activity of the aqueous toxic effect to the
Salmonella bacteria used.
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green and black teas against mutagenicity of 2-AAF and AFB, in
Salmonella assay
rats
and
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Tea treatments Total flavonoid intake Revertants per plate
(mg gallic acid TA 98 2-AAF (5 TA 100 AFB, (10
equivalents per day/100 9 fig/plate) ng/plate)
BW)'
Control (tap water) - 220.3 :t 32.5 a 385.0 :t 42.0 a
Processed rooibos tea 2.94 :t 0.89 a 206.7 :t 36.0 a 304.9:t 41.4 b
Unprocessed rooibos tea 11.97:t 1.76 b 151.2:t 30.1 b 303.3 :t 32.8 b
Processed honeybush tea 3.73:t 1.04 a 191.1 :t 37.6 (b) 306.1 :t 43.9 b
Unprocessed honeybush 19.07:t 2.37 c 161.3 :t 30.3 b 303.2 :t 45.1 b
tea
Black tea 15.14:t209c 116.2:t 27.3 b 359.8 :t 34.8 a
Green tea 16.48:t 191 c 111.6:t 25.8 b 345.8 :t 50.0 a
Spontaneous revertants - 30.3:t 37 131.5:t 11.9
Positive controlb - 487.7:t 74.3 519.7:t 31.2
Values in columns are means :t S.D.of 10 rats per group. Means followed by the same letter do not
differ significantly. If letters differ then P < 0.05. Letter in parentheses indicates a marginal effect (P <
0.1). Cytosolic preparations from different tea-treated and water-treated rats were incorporated at 0.25
mg/ml activation mixture. Aroclor-activated microsomes (1 mg/ml) were added to the activation
mixture. aData from Marnewick et al. [34J. bA S-9 preparation (2 mg protein/ml S-9 mix) from Aroclor-
induced rats was used.
Table 2 Activation potential of hepatic microsomal fractions isolated from rats
consuming the different teas on 2-AAF-and AFB,.induced mutagenesis
Tea treatments CYP450 Revertants per plate
(nmollmg protein) TA 98 2-AAF TA 100 AFB,
(100 fig/plate) (50 ng/plate)
Control (tap water) 0.35 :t 0.14 a 351.9:t 80.0 a 1115.4:t 167.1 a
Processed rooibos tea (2%) 0.31 :t 0.06 a 527.0:t 197.5 a 878.4 :t 178.0 b
Unprocessed rooibos tea (2%) 0.38:t 0.04 a 536.3:t 114.0 a 907.9:t91.1 b
Processed honeybush tea (4%) 0.31 :t 0.06 a 492.1 :t 101.0 a 1102.7:t 209.5 a
Unprocessed honey bush tea (4%) 0.45:t 0.11 a 617.7:t 75.9 b 941.2:t 154.3 b
Biack tea (2%) 0.41 :t 0.09 a 803.8:t 132.0 c 1150.7:t 244.3 a
Green tea (2%) 0.37 :t 0.03 a 818.0:t 149.7 c 1375.2 :t 350.6 a
Values in columns are means :t S.D. of 10 rats per group. Means followed by the same letter do not
differ significantly. If letters differ then P < 0.05. Microsomes from different tea-treated and control rats
were incorporated at a level of 1 mg/ml activation mixture. unprocessed rooibos and honeybush teas
resulted in a significant (P < 0.001) protective effect as compared to the control. No significant
protective effect was noted with the cytosolic fractions of the rats given the green and black teas at the
specific concentration tested.
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The present study was conducted to establish whether these protective mechanisms
would also prevail in vivo by monitoring the ex vivo anti-mutagenic activity of the cytosolic
fractions of tea-treated rats. Rats exposed to the various tea preparations (2 and 4% in
their drinking-water) exhibited no hepatotoxic effects when monitoring the serum levels of
enzymes indicative of liver function [34]. No cytotoxic effects were observed when
incorporating the different cytosolic fractions (0.25 mg protein/ml 8-9 activation mixture) in
the presence of Aroclor-induced microsomes (1 mg protein/ml 8-9 activation mixture). In
this regard, no reduction in the spontaneous mutation rate or any cytotoxic effects to the
tester strains were monitored when using the Aroclor-induced 8-9 containing a higher
protein content (2 mg protein/ml 8-9 mixture).
When considering the metabolic fate of AFB1 and 2-AAF, chemopreventive agents
have been characterised that selectively reduce their carcinogenic effects. With respect to
AFB1, studies focused on the fate of the reactive mutagenic metabolite, the AFBl-8,9-
epoxide, by either inhibiting its CYP450-dependent activation and/or enhancing its
detoxification via conjugation with glutathione (G8H) catalyzed by the cytosolic
glutathione-S-transferases (G8Ts) [43-45]. With respect to the aromatic amines (2-AF, 2-
AAF), two different mechanisms exist in the production of the active genotoxic metabolites,
one involving the rat liver microsomes and the other both the microsomal and cytosolic
cellular compartments [45,47]. In both cases the initial step involves N-hydroxylation with
the subsequent addition of either an acetyl group by the microsomal N,O-
acetyltransferases or a sulfate via the sulfotransferases in the cytosol [48]. Modulation of
the formation of active mutagenic metabolite(s) derived from these aromatic amines could
therefore occur at different levels involving both the cytosolic and microsomal
compartments [1].
In the present study, liver cytosolic fractions from rats that had received processed
and unprocessed rooibos and honeybush tea protected against AFB1-induced
mutagenicity ex vivo, while green and black tea showed no cytosolic protection.
Unprocessed herbal teas, and green and black teas showed a significant and processed
honeybush tea a marginal (P < 0.053) cytosolic protective effect against 2-AAF-induced
mutagenesis, while processed rooibos tea showed no protection. It is not known whether a
protective effect could have been obtained at higher cytosolic levels (>0.25 mg protein/ml
8-9 fraction). However, in the case of 2-AAF a lower protective effect was observed at the
higher cytosolic concentration (1 mg/ml) in the pilot study. In this regard the presence of
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the cytosolic sulfotransferases would have increased the mutagenic response of 2-AAF
and, as discussed above, could have decreased the protective effect of the cytosol.
Microsomal fractions obtained from rats treated with the herbal teas, except
processed honeybush tea, also showed a decreased metabolic conversion of AFB1 to its
reactive mutagenic intermediate, while the processed honeybush tea and the green and
black teas did not significantly alter the activation of AFB1. In contrast to AFB1
mutagenesis, none of the herbal, green and black teas decreased the microsomal
activation of 2-AAF. Instead, 2-AAF mutagenesis was increased markedly to significantly
when utilizing microsomal preparations of the different teas.
The present study provides evidence that active components involved in the ex vivo
modulation of 2-AAF and AFB1 metabolism are absorbed from the gut to exhibit their
protective effect. Therefore, oral administration of rooibos and honeybush teas is likely to
reduce the liver microsomal activation of AFB1 significantly, while cytosolic component(s)
would further reduce the availability of the active mutagenic metabolite to interact with
DNA. In contrast, only the cytosolic components are likely to protect against 2-AAF-
induced effects and the balance between enhanced microsomal activation versus cytosolic
protection could determine the biological outcome in vivo.
Differences in the ex vivo modulation of mutagenesis induced by 2-AAF could be
ascribed, as mentioned above, to differences in the metabolic pathways resulting in the
formation of the active metabolite. Whether induction of the microsomal N,O-
acetyltransferases could also contribute to enhanced activation of 2-AAF is not known at
present.
The exact mechanisms involved in the ex vivo protection of the different tea
preparations against AFB1-and 2-AAF-induced mutagenesis are presently unknown.
However, a recent study by Marnewick et a/. [34] indicated that the herbal teas significantly
enhance the activity of the microsomal UDP-glucuronosyl transferases, and the cytosolic
glutathione-S-transferase alpha (GST-a), which could be important in explaining the
protective effects of the different sub-cellular liver fractions. The herbal teas also stabilize
the level of reduced glutathione (GSH) that may result in an increased antioxidant capacity
in the cell. In the present study these parameters could play an important role in the ex
vivo protection of the cytosolic fractions against AFB1 and 2-AAF-induced mutagenesis.
The protective activity of green and black teas against 2-AAF appears not to proceed the
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modulation of GST-a or UDP-GT as they failed to induce the activity of these enzymes
under the present conditions [34]. In this regard the stabilization of GSH by the green and
black tea seems to be involved. It is not known whether the activity of the sulfotransferases
is modulated by green and black teas, thereby reducing the cytosolic activation component
of 2-AAF. However, other cytosolic components such as the tea phenols could also be
involved in the direct scavenging of reactive AFB, and 2-AAF metabolites under the
present experimental conditions.
Differences in the microsomal conversion of AFB1 and 2-AAF could be related
either to the induction of specific CYP450 isoforms involved in their metabolism or to direct
metabolic competition between the f1avonoids and the carcinogens. Various f1avonoids are
metabolized by certain CYP450 isoforms, e.g. CYP1A2, and they may competitively
reduce the CYP1A2-mediated activation of AFB1, thereby inhibiting its mutagenic activity
[4]. Different f1avonoids have also been shown to selectively induce the activity of enzymes
of the CYP family [49] e.g. the f1avanones induce CYP2B1/2 and the f1avones CYP1A and
2B isozymes [50]. Differences in the induction pattern of these isozymes could therefore
play an important role in the metabolic fate of a potential mutagen or carcinogen in vivo.
Treatment of rats with green and black tea from 4 to 6 weeks significantly induced different
isoforms of CYP450 including CYP1A1, 1A2, 2B, 4A1 [51-53]. In the present study the
total daily flavonoid intake was shown to be significantly (P < 0.05) higher in rats fed the
black, green and unprocessed honeybush teas, suggesting that the induction of the
CYP450 isoforms could have enhanced 2-AAF metabolism yielding the active mutagenic
metabolite. With respect to the protective effect of the herbal teas against AFB,
metabolism it would appear that the phenolic constituents of the herbal teas selectively
induce different isoforms of CYP450 that could direct the metabolism away from the
formation of the active mutagenic metabolite.
Various phenolic tea constituents exhibit different protective mechanisms in vitro
depending on the chemical nature and metabolic fate of the carcinogen [12]. Variation in
the protective effects of the herbal, green and black teas might also be ascribed to the
difference in phenolic constituents and their selective effects on the drug-metabolizing
enzymes. The present study confirms that the in vitro anti-mutagenic activity of the South
African herbal teas against AFB1 and 2-AAF-induced mutagenesis is likely to be active
under in vivo conditions as well, although the mechanisms may differ. This is the first
report on the ex vivo protective effects of rooibos and honeybush teas and it provides
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valuable information regarding their possible health-promoting properties.
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Abstract
A rat liver carcinogenesis model using diethylnitrosamine (DEN) as initiator was utilized
to investigate the chemoprotective properties of unprocessed and processed rooibos
(Aspalathus linearis) and honeybush (Cyclopia intermedia) herbal teas and green and
black teas against fumonisin B1 (FB1) promotion. The mean FB1 and tea intake profiles
over the three week promotion treatment were similar between the different groups,
although weekly differences were noted. The total body weight gain of the rats
consuming the various teas did not differ from the DEN-FB group, but inter-group
differences among the tea treated-rats were noted. Consumption of processed and
unprocessed rooibos teas variably decreased the relative liver weights when compared
to the DEN-FB1 control and other tea treated rats. Unprocessed rooibos tea significantly
(P < 0.05) and, to some extent, unprocessed honeybush increased FB1-induced liver
function enzymes. The honeybush and black teas decreased the FB1-induced elevation
of serum creatinine while the honeybush teas as well as green tea decreased serum
cholesterol. Green tea also significantly (P < 0.05) further reduced the oxygen radical
absorbance capacity (ORAC) effected by FB1 in the liver while unprocessed rooibos,
processed rooibos and processed honeybush exhibited a stabilizing effect. The
processed herbal teas and unprocessed honeybush tea significantly (P < 0.05)
decreased TBARS levels while the unprocessed rooibos, black and green teas showed
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no effect. Although the total iron levels in the serum were not altered by the various teas
when compared to the DEN-FB1 control, both honeybush teas significantly (P < 0.05)
and green tea marginally (P < 0.1) increased the levels when compared to the rooibos
teas. Unprocessed rooibos tea significantly (P < 0.05) decreased the hepatic reduced
glutathione (GSH) to oxidized glutathione (GSSG) ratio due to a decreased level of
GSH. The decrease GSH:GSSG ratio obtained with green and black tea was related to
an enhanced GSSG level suggesting an increased hepatic stress. All the tea extracts
significantly (P < 0.05) increased the relative amount of mini foci (5-10 ~m) when
expressed as a percentage of the total, whilst reducing the relative focal size of 11-20
~m, thereby delaying focal development. The relative amount of the larger foci was
significantly to marginally reduce by the unprocessed herbal and black teas while a
marginal increase was noticed with green tea. Unprocessed rooibos tea significantly (P
< 0.05) and unprocessed honeybush tea marginally (P < 0.1) reduced the total number
of foci (>10 ~m) of each size category, respectively. The major polyphenolic
components, which differ among the teas, may be responsible for the inhibitory effect of
the teas on cancer promotion of FB, in rat liver.
KEYWORDS: rooibos, honeybush, fumonisin B" cancer promotion, rat liver
INTRODUCTION
The popularity of two indigenous herbal teas, rooibos (Aspa/athus Iinearis) and
honeybush (Cyclopia intermedia), is rapidly increasing as health beverages in South
Africa, as well as abroad. Some of the contributing factors to this popularity include the
low tannin content, antioxidant properties and natural absence of caffeine (1-6). The
main phenolic constituents of rooibos and honeybush teas not only differ from one
another but also from those of green and black teas (7-11). The antioxidant (4,5,12-15),
antimutagenic and anticlastogenic (16-19) properties of rooibos and honeybush teas are
known but little information is available about their cancer modulating properties in vivo.
Based on the studies with green and black teas, the use of tea polyphenolic
components has been considered as potential chemopreventive nutraceuticals (20,21).
Regarding carcinogenesis, tea polyphenols are known to modulate the metabolic fate of
carcinogens in several ways rendering them less active/potent thus protecting the target
tissue against their adverse effects (22-25). A recent study indicated that the
consumption of rooibos and honeybush teas enhanced the activity of phase II
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detoxifying enzymes as well as modulated the oxidative status in the liver of rats (26).
Cytosolic liver fractions of the herbal tea-treated rats protect against mutagenesis of
aflatoxin B1 (AFB1) and 2-acetylaminofluorene (2-AAF) while the microsomal mediated
activation of AFB1 was reduced indicating the potential of the tea components to
modulate their metabolic fate ex vivo (19). These findings suggest that aqueous extracts
of rooibos and honeybush teas are likely to modulate the carcinogenic potency of
carcinogens in vivo.
Several studies in animals showed a reduced cancer incidence after
consumption of black and green teas (27,28). The consumption of tea polyphenols and
tea pigments comprising of the oxidized products, the theaflavins and thearubigins,
significantly reduced the number as well as the average area of GSTP+ foci in the liver
(29,30). An aqueous extract of green tea inhibited both cancer initiation and promotion
of AFB1-induced hepatocarcinogenesis in male Fischer rats (31). The fumonisin B (FB1)
mycotoxins were recently characterized as potent liver cancer promoters that occur in
maize and showed to synergistically interact with AFB1 in the induction of liver nodules
in a short-term carcinogenesis model (32). As these mycotoxins co-occur naturally the
modulation of their carcinogenic properties is of importance (33,34). Numerous studies
reported on the modulation of the carcinogenic properties of AFB1 by natural occurring
dietary constituents (23,35,36) while no studies, as yet, have been conducted on the
modulation of the carcinogenic properties of the fumonisins.
The present study investigated the chemoprotective properties of aqueous
extracts of processed and unprocessed herbal teas as well as green and black teas
against the cancer promoting activity of FB1 in rat liver utilizing diethylnitrosamine (DEN)
as initiator with the induction of hepatic preneoplastic foci as endpoint.
MATERIALS AND METHODS
Chemicals Diethylnitrosamine (DEN) was purchased from Sigma Chemical Co (Cape
Town, South Africa) and prepared in dimethylsulfoxide (DMSO). The FB1-containing diet
for the rats was prepared by evaporating FB1, dissolved in methanol (37), on a sub-
sample (200 g) of Epol rat mash diet and mixing it with the control diet (Epol rat mash)
to obtain the desired dietary level of 250 mg/kg diet. The diet was then stored under
nitrogen at 4 aC. The FB1 was purified according to the method of Cawood et at. (38) at
the PROMEC Unit (Medical Research Council, Tygerberg, South Africa) to a purity of
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93-95%. Glutathione-S-transferase placental form (GSTP) antibody was obtained from
OAKO. Reduced (GSH) and oxidized (GSSG) glutathione were purchased from Roche
(Cape Town, South Africa). Glutathione reductase, perchloric acid (PCA), tricholoro
acetic acid (TCA) 1-methyl-2-vinyl-pyridinium trifluoromethane sulfonate (M2VP), 5,5'-
dithiobis-2-nitrobenzoic acid (OTNB), NAOPH, EOTA, gallic acid, (+)-catechin,
quercetin, mangiferin, rutin were purchased from Sigma Chemical Co (Cape Town,
South Africa). Phycoerytherin (B-PE) were purchased from ProZyme and 2,2'-Azobis(2-
amidinopropane) dihydrochloride (AAPH), Trolox, hesperidin and hesperetin were
obtained from Aldrich Chemical Company (Cape Town, South Africa). Aspalathin and
nothofagin, with >95% purity were supplied by Ms P Snijman (PROMEC Unit, MRC,
South Africa), while iso-vitexin, vitexin, iso-quercitrin and orientin, iso-orientin were
purchased from Extrasynthese (Genay, France). All other chemicals used were of
analytical grade.
Plant material and preparation. Black tea (C. sinensis var. assamica), a blend of
locally produced African and Sri Lankan teas was bought from a retail outlet in Cape
Town while green tea (C. sinensis var. sinensis), imported from China, was a gift from
Vital Health Foods (Kuilsriver, South Africa). Processed ("oxidized") and unprocessed
(green "unoxidized") rooibos and honeybush (C. intermedia) teas were obtained from Dr
Joubert from the Agriculture Research Council (ARC), Infruitec-Nietvoorbij, South
Africa. All the tea extracts were prepared at concentrations customarily used for tea
making purposes (39,40). Freshly boiled tap water was added to the plant material at
concentrations of 2 g/100 mL for processed and unprocessed rooibos tea, green and
black teas and at 4 g/100mL for processed and unprocessed honeybush tea. The
aqueous extracts were allowed to cool to room temperature before these were
dispensed into the water bottles. Fresh tea was prepared every second day.
HPLC quantification of the major flavonoids of the rooibos and honeybush tea
aqueous extracts. Freeze-dried samples of rooibos and honeybush aqueous extracts
were diluted in deionised reverse osmosis water (Modulab Water Purification System
from Continental Water System Corporation) to a concentration of - 0.38%, filtered
(Nylon, 0.45 ,1m) and analyzed on a LiChrospher 100 RP-18 (5 pm, 250 x 4 mm)
column with a C18 guard column, using a Merck/Hitachi LaChrom2000 system
comprising of a L-7400 detector, L-7100 pump, Rheodyne 7725i injection valve, 0-7000
HPLC system manager and interface module. Polyp henoIs were quantified at 280 nm
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according to the method of Joubert (41) with a modification to the initial gradient.
Calibration curves were constructed for each flavonoid. Rutin co-eluted with iso-
quercitrin and the quantification was expressed as quercetin equivalents.
Treatment of animals. Ninety male Fischer rats, obtained from the Primate Unit, MRC
(Tygerberg, South Africa) had free access to rat mash (Epol Ltd, Johannesburg, South
Africa). They were housed in wired top and bottom cages fitted with Perspex ™ houses
and kept in a controlled environment of 23-24°C, 50% humidity and a 12 hr light cycle.
Rats, weighing between 150-170 g, were randomly divided into nine groups of ten rats
each and caged individually. Initiation was effected by a single i.p. dose of
diethylnitrosamine (DEN; 200 mg/kg body weight). Tea feeding, as the sole source of
drinking fluid, commenced one week after initiation until the end of the experiment, while
promotion commenced three weeks after initiation by feeding the FB1-diet (250 mg/kg)
for 21 days (Figure 1), The positive control rats received the DEN initiation and FB1
promotion treatments (DEN-FB1) in the absence of the tea with tap water being the sole
source of drinking fluid. Other control groups received either DEN or DMSO (carrier
solvent) treatments with the normal rat diet and tap water as drinking fluid. All the rats
were average fed during the FB1 promotion treatment period according to the daily feed
intake of the DEN-FB1 group receiving tap water. The body weights of the rats were
monitored on a weekly basis. The average weekly feed and FB1 intake was calculated
using mean daily rat feed intake as a function of the body weight and expressed as g
feed or mg FB1 per 100 g body weight. At termination, animals were fasted (16 hr),
euthanazed by i.p. injection of sodium pentobarbital (0.15 ml /100 g bw) and blood
collected from the abdominal aorta. Livers were excised, weighed and sections
processed in buffered formalin for histological examination. The remaining liver tissue
were immediately frozen in liquid nitrogen and stored at -80°C for biochemical
analyses.
Clinical parameters. The clinical biochemical parameters including serum creatinine,
total cholesterol, total iron, aspartate transaminase (AST), alanine transaminase (ALT),
and alkaline phosphatase (ALP) were measured on a Technicon RA 1000 automated
analyzer.
Determination of TSARS. The thiobarbituric acid reacting substances (TBARS) were
determined according to a modified method described by Esterbauer et al. (42). Sub-
samples of the excised livers were homogenized on ice in 19 volumes of 0.01 M
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phosphate buffer (pH 7.4) and incubated with 15 11MFeS04 for one hour at 3rC. The
incubated homogenate (1 mL) was mixed with 2 mL of cold trichloro acetic acid (TCA)
reagent (10% TCA, 0.01% BHT). The samples were centrifuged (3000 rpm) and 2 mL of
the resultant supernatant was combined with 2 mL of 0.67% TBA solution and
incubated at 90°C for 20 min. The mixture was allowed to cool to room temperature
and the absorbance was measured at 532 nm, Lipid peroxidation was expressed as
nmol malondialdehyde (MDA) per mg protein using a molar extinction coefficient of 1.56
X 105 (43). Non-specific lipid peroxidation was prevented by the incorporation of EDTA
in the phosphate buffer and BHT in the reaction solution for the TBARS assay,
DMSO Ctrl
DEN Clrl
DMSO Water GIrldiet I n=10
I I I 5
DEN W t r Ctrl diet I n=10I a e I
I 5
DEN Water FBI + Ctrl diet I
DEN-FB, Clrl I I I n=10
5
DEN Aqueous tea
DEN-FB1 I extracts FB, + Ctrl diet I
Tea extracts I I n=10
5
I I I I1 week 2 weeks 3 weeks
o Time period (weeks) 6
Fig. 1. Experimental design for the liver carcinogenesis model (for details see Materials
and Methods). DEN = intra peritoneal initiation regime (200 mg/kg body weight); FB1 +
Ctrl diet = Rat mash containing FB1 (250 mg/kg diet) as promotion regime; s = sacrificed
animals; n = animals per group; ctrl = control.
Oxygen radical absorbance capacity (ORAC). Sub-samples of the stored livers were
homogenized in 4 volumes of phosphate buffer (75 mM, pH 7.0) in a Thomas
homogenizer (10 strokes) and centrifuged at 12 000 g for 10 min at 4°C, The
supernatant was deproteinized using 0.25 M perchloric acid (PCA) and again
centrifuged at 16 000 g for 15 min. The resultant supernatants were then stored at -80
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DCprior to analysis. The ORAC assay, based on the procedure by Cao and Prior (44)
were done in 96 well microtiter plates and consisted of 170 III of poPE (80 ~lg/mL) and
10 III of diluted sample (1:1) incubated at 37 DCfor 15 min. The reaction was initiated by
the addition of 20 III AAPH (240 mM) and the fluorescence (emission 590 nm, excitation
530 nm) recorded every 5 min until the reading had declined to less than 5% of the
initial reading. The ORAC values were calculated as described by Cao and Prior (44)
and expressed as ~IMTrolox equivalents/mg wet liver weight.
Glutathione analysis. The total glutathione (GSH and GSSG) was measured
according to a modified method of Tietze (45). Liver samples were homogenized (1 :10)
in 15% (w/v) TCA containing 1 mM EDTA for GSH determination and in 6% (v/v) PCA
containing freshly prepared 3 mM M2VP and 1 mM EDTA for GSSG determination on
ice. After centrifugation at 100 000 g for 10 min, 50 III of supernatant was added to
glutathione reductase (1 U) and 75 ~IM DTNB. The reaction was initiated by addition of
0.25 mM NADPH to a final volume of 200 Ill. The change in absorbance was monitored
at 410 nm for 5 min and levels calculated using pure GSH and GSSG as standards.
GST.Pi immunohistochemical assay. Histochemical staining for the placental form of
glutathione-S-transferase (GSTP) was conducted on dewaxed liver sections using a
three-stage indirect strepavidin-biotin technique to identify GSTp. stained hepatocytes
(46). The enzyme-altered foci were quantified microscopically (10 X magnification),
according to their number and size (internal diameter) and categorized according to the
following sizes, 5-10 (mini foci), 11-20, 21-30, >30 IJm and expressed as number of
foci/cm2 of the liver section, the area of which was determined by image analyses. The
relative amount of each focal size category was expressed as a % of the total GSTp.
foci (>5 IJm).
Statistical analysis
Data were tested for normality using the Kolmogorov-Smirnof Test and Levene's Test
for Equality of variances. One-way ANOVA's were used to test for significant group
differences followed by Tukey-Cramer multiple comparison tests in order to establish
which groups differed significantly. The Kruskal-Wallis Test which is a non-paramatric
analogue to the one-way ANOVA was used to test for group differences when the data
was not normally distributed. Statistical significance was at the 5% level (p < 0.05).
Statistical comparisons were conducted between 1) the DEN-FB1 treated rats with the
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DEN and DMSO control as well as the tea treated groups and 2) among the tea-treated
groups.
RESULTS
Intake of selective herbal tea flavonoids. Aspalathin was the major flavonoid
consumed by the rats when fed the unprocessed rooibos tea, followed by its flavone
counterparts, orientin and iso-orientin, and the flavonol glycosides, rutin/isoquercitrin.
Nothofagin and its flavone counterparts, vitexin and iso-vitexin constitute some of the
minor flavonoids consumed (Table I). In the aqueous extract of processed rooibos,
aspalathin and nothofagin were reduced and the flavones increased, resulting in an
increased intake of iso-orientin and orientin relatively to aspalathin. The xanthone
mangiferin and the flavanone hesperidin, were the major flavonoid constituents
consumed by the rats treated with the unprocessed and processed honeybush teas,
while trace amounts of hesperetin were detected. Mangiferin and hesperidin were
markedly less in the processed honeybush tea.
Feed, FB1, tea intake profiles and body weight gains. During the first week of
promotion there were no significant differences in the average weekly feed intake
between the different groups (Table II), resulting in a similar intake of FB1. However,
during the second week the DEN-FB1 treated rats, with and without the different teas
significantly (P < 0.05) consumed less feed than the DEN and DMSO control groups.
The FB1 intake did not differ among the groups though. During the third week, rats
consuming processed and unprocessed rooibos and processed honeybush teas
showed a significant (P < 0.05) increase in feed intake when compared to the DEN,
DMSO and the DEN-FB1 control groups. The feed and FB1 intake was also significantly
(P < 0.05) higher than in the black and green tea treated rats. However, the average
FB1 intake during the FB1-treatment period did not differ significantly between the
groups while the total amount of FB1 consumed was similar.
When considering the mean weekly body weight gain (BWG) during the FB1
promotion, rats consuming black tea significantly (P < 0.05) increased the BWG when
compared to processed rooibos tea treated rats during the first week. During the second
week, consumption of the unprocessed honeybush and black teas significantly (P <
0.05) reduced the BWG as compared to the processed rooibos tea and the DEN-FB1
control group. Marked reductions were also noticed with unprocessed rooibos and
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green teas. No significant differences were noticed in the BWG between the different
groups during the third week.
Table I Flavonoid quantification of aqueous extracts of rooibos and honeybush teas
consumed by rats prior to the FB1 promoting treatment
Rooibos Tea Processed Unprocessed
Soluble solids (mg/mL) 2.59:t 0.44 5.36 :t 0.81
Phenolic compounds % of soluble solids Daily intake
(mg/100 9 BWr-
% of soluble solids Daily intake (mg/100 9
BW)
Aspalathin 1.05 :t 0.04 0.30 16.9:t 2.76 9.88
Nothofagin 0.09 :t 0.03 0.03 0.72:t 0.26 0.42
Orientin 0.93 :t 002 0.27 1.31 :t 0.36 0.77
lso-orientin 1.32 :t 0.08 0.38 1.61 :t 0.36 0.94
Vitexin 0.29 :t 0.01 0.08 0.26:t 0.04 0.15
lso-vitexin 0.37 :t 0.06 0.11 0.49 :t 0.15 0.29
Rulin/lso-quercitrin 0.91 :t 0.05 026 1.20:t 0.20 0.70
--
Honeybush tea Processed Unprocessed
-
Soluble solids (mg/mL) 5.96:t 0.78b 11.78 :t 1.18c
Phenolic compounds % of soluble solids Daily intake o . Daily intake
(mgt100 9 BW) Vo of soluble solids (mgt100 9 BW)
Mangiferin 1.11 :to.15 082 6.68 :t 0.84 9.02
Hesperidin 0.37 :t 008 0.27 2.63:t 0.16 3.55
Hesperetin trace trace
All samples used were aqueous extracts prepared as described in the methods. The values in columns
represent the mean :t standard deviation of 2-3 repeals of each sample. -Data from Marnewick et al., 2003. BW
= body weighl. --Mean daily tea intake of the 2-week pre FB, period (Table III) was used for determining of daily
intake of poly phenolic compounds.
http://scholar.sun.ac.za
~~apter 6 177
Table II Feed, FB1, tea intake and body weight gain parameters of the various treatment groups during the three week FB1 cancer
promoting treatment
Period Feeding Control treatments DEN-FB, treatment
(week) parameters
and BWG DMSO DEN Water Rp Rg Hp Hg BI Gr
1 Feed intake
530:t 144a 5.73:t 1.32a 5.15:tl.83a 5.71 :t 143a 540:t 1.61a 541.1.37a 6.07:t 1.56a(g/100g BW) 7.38.0.70a 7.12 :t 0.21a
FB, intake
0.97 :t 002a 1.14 :t 0.29a 0.83 :t 0.19a 1.06:t 0.14a 0.96 :t 0.23a 1.06.0.23a 1.17:t 0.35a(g/100g BW) - -
BWG (g) 10.9 :t 62a nd
11.0:t74a 8.3.4.1a 10.5 :t 44a 134:t5.1a 15.9.86a 20.2 :t 6.7b 17.7:t7.10a
Feed intake
6.92 :t 0.29b 7.16:t O.17b 622 :t 0.39a 6.14.0.83a 6.10 :t 0.89a 6.17 :t 0.82a 5.92 :t 0.84a 5.87 :t 0 79a 5.91 .082a(g/100g BW)
2 FB
, intake
1.62 :t 0.07a 1.63.0.06a 1.64 :t 0.05a 1.64:t 0.06a 1.58.0.06a 1.55 :t 0.06a 1.57 :t 0.06a(g/100g BW) - -
BWG (g) 14.7.6.1a nd -5.0:t 144bc -5.8 :t 5.9bc -194.10.1b -7.6 f 5.3b -21.3:t 14.6bd -22.8 f 5.2bd -13.7:t 6.3b
Feed intake
6.65:t 0.14a 7.65 f 0.26a 6.63:t 0.35a 7.02 f 0.08b 7.03 :t 0.06b 705 :t 0.08b 6.78 :t 0.29ab 6.70 :t 003a 6.83 :t 0.04a(g/100g BW)
3
FB, intake
1.67 :t O.lOa 1.77:t 0.02b 1.75 :t 0.02bc 1.76 • 0.02bc 1.69 :t 0.03ab(c) 1.68.0.01a 1.70 :t O.Ola(mg/l00g BW)
BWG (g)
68:t4.1a nd 49 :t 5.7a 10.3 :t 3.3a 108:t 7.7a 8.1 :t 3.6a 9.6.6.7a 7.0:t 58a 4.3 :t 3.5a
Ave
FB, mg/l00g BW - - 1.51 :t 026a 1.57.026a 1.51 :t 0.35a 1.26 :t 0.27a 1.50.0.29a 149 :t 026a 1.56 :t 0.27a
intake
Total
FB, mg/l00g BW - - 30.11 31.31 3024 3137 29.99 29.80 3120
intake
Mean
G 300:t 8.7b 29.6:t 16.5b 10.9:t 15.8a 12.8 :t 6.2a 1.2 :t 8.9a 14.0 :t 6.3a 4.3 f 9.2a 4.3:t 10.5a 8.3.67aBWG
Abbreviations Rp = processed rooibos, Rg = unprocessedrgreen" rooibos, Hp = processed honeybush and Hg = unprocessedl"green" honeybush tea extracts, BI = black and Gr= green tea,
BWG = body weight gain. nd = not determined. Values in the rows represent the mean of ten rats per group :t STD. Values followed by the same letters do not differ significantly. If letters differ
then P<0.05 while letters in parenthesis then P<O.l.
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When considering the mean BWG over the FB, treatment period, the unprocessed
herbal and black teas caused the lowest increase although changes were not
significant.
The mean daily water consumption was approximately 10 mL/1 00 g body weight.
Rats consumed significantly (P < 0.05) less unprocessed rooibos and black teas during
the pre-FB, treatment period when compared to the honeybush teas (Table III). During
the first week of FB1 treatment, the rats consumed significantly (P < 0.05) less black tea
as compared to the other tea treatments. The tea intake was significantly (P < 0.05)
reduced during the second week in all the tea treated rats. The black tea intake was
significantly (P < 0.05) and marginally (P < 0.1) lower when compared to the
unprocessed honeybush and rooibos teas, respectively. No differences in the tea intake
profiles were noticed during the third week.
Table III Tea intake profiles of the various treatment groups before FB1 feeding and during
the three week FB1 cancer promoting treatment
Fluid intake (m1/1 00 9 BW) in DEN-FB, treated rats
Period
(weeks) I Water Rp Rg Hp Hg BI Gr
Pre-FB,
intake 110.1:!:1.8a 12.3 :!:2.2ab 107:!:2.1a 12.7 :!:2.9b 12.9:!: 2.3ab 10.5:!: 2.6a 12.3:!:1.9ab
(2 weeks)
1 nd 11.3:!: 09a 11.9:!:1.8a 14.8:!: 1.5a 130:!: 20a 10.1:!:1.9b 12.5:!:1.7a
2 nd 9.3:!: 1.2a 8.8:!: 1.6(b) 10.2:!: 2.2a 8.6:!: 1.9a 6.2:!: 0.7b 8.9:!: 1.7ab
3 I nd 12.4:!:2.0a 12.0:!: 1.2a 12.1 :!: 1.2a 128:!:11a 10.9:!: 0.8a 11.5:!:2.5a
Abbreviations: Rp = processed rcoibas, Rg = unprocessedl"green" rcoibos, Hp = processed honeybush and Hg =
unprocessedl"green"honeybushtea extracts,BI = blackand Gr= green tea, BW= bodyweight, nd = not detennined.Values in the
rows representthe meanof ten rats per group :t STD.Valuesfollowed by the same lettersdo not differ significantly.If lettersdiffer
then P<O.05.Letters in parenthesisthen P<O.1.
Effect of FB! and various tea treatments on total body weight gain and relative
liver weight. The total BWG of the rats, during the entire experimental period, was
significantly (P < 0.05) reduced in the DEN-FB1 compared to the DMSO and DEN
control groups consuming water (Table IV). No significant differences were noticed
between DEN-FB1 control group and those receiving the various tea treatments.
However, among the different tea treated groups, the total BWG of the rats consuming
the unprocessed rooibos was significantly lower when compared to the processed
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rooibos and green tea. The DEN-FB1 treatment significantly (P < 0.05) reduced the
relative liver weights when compared to the DMSO and DEN control groups. The DEN-
FB1 treated rats consuming processed rooibos and honeybush teas showed a marginal
(P < 0.1) decrease and significant increase (P < 0.05) in the relative liver weights,
respectively. The relative liver weights of rats consuming the processed and
unprocessed rooibos was significantly (P < 0.05) decreased when compared to the
other tea treated rats. A marginal (P < 0.1) decrease in the relative liver weight was
affected by unprocessed rooibos tea when compared to unprocessed honeybush tea.
Clinical chemistry. Serum levels of AST, ALT, ALP, creatinine and cholesterol were
significantly (P < 0.05) increased in the DEN-FB1 control group as compared to the
DMSO and DEN control groups (Table IV). Processed and unprocessed rooibos teas
markedly to significantly (P < 0.05) further increased serum AST levels, respectively.
When comparing the different tea treated groups with one another the rooibos teas
significantly (P < 0.05) increased AST as compared to black and green tea and
marginally (P < 0.1) to processed honeybush. Unprocessed rooibos and honeybush
teas significantly (P < 0.05) enhanced the FB1-induced serum ALT levels while a
marked increase was also noticed with processed rooibos. Among the different teas,
unprocessed rooibos tea significantly (P < 0.05) enhanced ALT when compared to
processed honeybush, black and green teas. Rats consuming the different teas did not
alter the FB1-induced increased serum ALP levels although processed honeybush teas
markedly elevated the level. Within the different tea treated rats, processed honeybush
marginally (P < 0.1) increased ALP when compared to processed rooibos and
significantly (P < 0.05) to black tea. Unprocessed rooibos tea also marginally (P < 0.1)
increased ALP as compared to black tea.
Black tea and processed honeybush teas significantly (P < 0.05) decreased the
serum creatinine levels when compared to the DEN-FB1 control rats while a marginal (P
< 0.1) reduction was obtained with unprocessed honeybush tea. A similar trend was
noticed when the creatinine level was compared among the different tea consuming
groups. With respect to the FB1-induced increase of serum cholesterol, processed and
unprocessed honeybush and green teas significantly (P < 0.05) and black tea
marginally (P < 0.1) decreased the level. Among the different teas, processed and
unprocessed honeybush and green teas significantly (P < 0.05) lower the cholesterol
levels.
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Table IV Effect of DEN-FB1 and various tea treatments on the total body weight gain, relative liver weight and clinical chemistry
Groups Body weight Relative liver AST ALT ALP Creatinine Cholesterol Total Iron
gain (g)' weight (g)' (U/L) (U/L) (U/L) (umol/L) (mmoIlL) (~lmol/L)
DMSO 86.9 :t 8.2a 29:t 0.35a 88.1 :t 16.8a 53.7 :t 7.3a 168.9 :t 32.8a 69.0 :t 6.0a 1.6 :t 0.2a 23.1 :t 5.8a
DEN 777:t25.1a 3.51 :t 027c 102.8 :t 15Aa 96.7:t 11.5c 27204 :t 69.1 c 67.3:t 3.7a 104 :t 0.3a 25.9 :t 2.6a
DEN-FB, 39.8 :t 13.8b 250:t 0.16b 258 7 :t 60.2b 211.6 :t 48.0b 28204 :t 82.0b 85.8 :t 4.7b 3.5 :t DAb 2404 :t 7Aa
DEN-FB,-Rp 44.0 :t 6.8bc 2.36 :t 0.12(b)d 320.6 :t 78.1 bd 296.6 :t 113Abe 28304 :t 61.3bd 85.3 :t 4Abd 3.3 :t OAbc 21.9:t 2.3ab
DEN-FB,-Rg 296:t 9.6bd 2044 :t 0.09bdf 341.1 :t 50.Oed 321.3:t 75Adef 325.3 :t 86.8bde 83.5:t 5.8bd 2.9 :t 1.0bce 22.6 :t 4Aab
DEN-FB,-Hp 37.9:t 12.7b 2.79 :t 0.05ae 242.9:t 54.3b(d) 236.3 :t 639beg 355.3:t 77.8b(d)ef 77.2 :t 3.8cef 2.3 :t 0.8ade 27.5 :t 2.2acd
DEN-FB,-Hg 36.1 :t 16Ab 2.58 :t 0 19be(f) 283.2:t 52.1 b 2809:t 71.7de 314.3:t 57.9bde 808 :t 5.8(b)df 2.1 :t 0.3ad 28.3 :t 4.9acd
DEN-FB,-BI 40.2 :t 19.8b 2.58 :t 0.13be 207.1 :t 56.3be 216.0:t 90.5beg 245.0:t 58Abd(e)g 7804 :t 2.2c(d)f 30 :t 0.6(b)cef 24.1 :t 6.3abd
DEN-FB,-Gr 48.3:t 13.3bc 2.59 :t 0.11 be 22604 :t 22.5be 229.3 :t 41 Abeg 2968 :t 62.1 bde 83.6 :t 3.0bd 204 :t 0.5ade(f) 27.1 :t 4Aa(b)d
Values in columns represent the mean t STD dev. 'relative liver weights equal liver weight/body weight. Abbreviations: Rp = processed rooibos, Rg = unprocessedl"green
rooibos, Hp = processed honeybush and Hg = unprocessedl"green" honeybush tea extracts, BI = black and Gr = green tea. Values followed by the same letters do not dille
significantly. When letters differ then P<0.05. Letters in parenthesis then P<0.1. 'Including DEN, Pre-FB, tea treatment and FB, treatment regimens. n= 7-10 rats per group.
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The total iron levels were not significantly altered by the teas as compared to the DEN-
FB, control group. However, both unprocessed and processed honeybush teas
significantly (P < 0.05) and green tea marginally (P < 0.1) increased the total iron levels
as compare to the unprocessed and processed rooibos teas.
Table V Effect of unprocessed and processed herbal, green and black teas on reduced
glutathione (GSH), oxidized glutathione (GSSG), the ratio GSH:GSSG, oxidative capacity
(DRAC) and lipid peroxidation in livers of rats
Groups ORAC GSH GSSG GSH:GSSG TBARS (nmol
(uM Trolox eq/mg (uM/mg protein) (uM/mg protein) Ratio MDA/mg
protein) protein)
DMSO 15.5:t 2.4a 3.2 :t 0.69a o 21 :t 0.03a 15.1 :t2.3a 0.08 :t 0.01a
DEN 12.8 :t 2.2b 3.0:t 0.76a 0.26 :t O.06(a) 12.1:t 3.8a 0.07:t 0.01 a
DEN-FB, 13.6:t 0.7b 4.6:t 0.87b 0.22 :t 0.03a 21.6 :t 4.7b 0.32 :t 0.08b
DENFB,-Rp 14.5:t 1.5b 3.2 :t 0.91 ac 0.20:t 006ac 17.0:t 4.4(b)c 0.21 :t 0.07a
DEN-FB,-Rg 14.7:t 1.3(b) 2.9 :t 0.91 ad 0.26:t O.04bde 11.1:t3.5ad 0.30 :t O.04b
DEN-FB,-Hp 14.4:t1.1b 4.7 :t 0.28b 0.22 :t 0.06ace 22.9 :t 7.4bc 0.16 :t O.04ac
DEN-FB,-Hg 13.2:t 1.1b 4.7:t1.1b 0.26 :t O.06(a)(c)eg 19.3:t 7.6bc 0.26 :t 0.06ad
DEN-FB,-BI 13.6:t1.1b 5.1 :t 2.2b(c)(d) 0.32 :t 0.05bd(c)g 15.8:t 6.1(b)c(d) 0.35:t 0.0700
DEN-FB,-Gr 10.0:t 0.88c 4.5:t 1.2b(c) 0.36:t 0.09bdf(g) 13.4 :t 5.2ac 0.31 :t 0.09bd
Values in columns represent average of 5 to 8 values per group :t STD. Means followed by the same letter do not
differ significantly, when letters differ then P<0.05. Letters in parenthesis then P<0.1. Abbreviations: Rp = processed
rooibos, Rg = unprocessedf'green" rooibos, Hp = processed honeybush and Hg = unprocessedf'green" honey bush
tea extracts, BI = black and Gr = green tea.
Effect on hepatic oxidative status
(i) Oxygen Radical Absorbance Capacity (ORAC). Both the DEN-FB, and DEN
treatments significantly lowered the hepatic ORAC status when compared to the DMSO
control group (Table V). Green tea further decreased (P < 0.05) the hepatic ORAG
values while unprocessed rooibos tea marginally (P < 0.1) increased the ORAG, No
significant changes were noticed in the ORAG levels with the other teas although
processed rooibos and honeybush teas markedly (not significantly) increased the level
when compared to the DEN-FB, control rats.
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(ii) Hepatic glutathione. Rats receiving the DEN-FB, dietary treatment significantly (P <
0.05) elevated the GSH levels in the liver when compared to the DMSO and DEN
control groups (Table V). Consumption of processed and unprocessed rooibos teas
resulted in a significant (P < 0.05) reduction in hepatic GSH levels. A similar effect was
noticed when the GSH level was compared among the different tea-treated rats. When
considering the GSSG levels, rats treated with DEN-FB, exhibited no significant
changes when compared to the DMSO control group, while a marginal (P < 0.1)
increase was noticed in the DEN control group. However, hepatic GSSG levels were
significantly (P < 0.05) elevated with green, black and unprocessed rooibos teas and
marginally (P < 0.1) with the unprocessed honeybush tea. Green and black teas
significantly (P < 0.05) and marginally (P < 0.1) increased GSSG, respectively, among
the different teas. Unprocessed rooibos and honeybush teas significantly (P < 0.05) to
marginally (P < 0.1) increased GSSG, respectively, as compared to their processed
counterparts. DEN-FB, treatment significantly (P < 0.05) increased the GSH:GSSG ratio
in the liver when compared to the DMSO and DEN control groups. Rats consuming
unprocessed rooibos and green teas significantly (P < 0.05) decreased the GSH:GSSG
ratio, while a marginal (P < 0.1) decrease was noticed with processed rooibos and black
teas. Among the different teas, unprocessed rooibos significantly (P < 0.05) decreased
the ratio.
Lipid peroxidation. The TBARS levels were significantly (P < 0.05) increased in the
liver of the DEN-FB, treated rats (Table V) when compared to the DMSO and DEN
groups. The DEN-FB, treated rats consuming processed rooibos, processed and
unprocessed honeybush teas showed a significant (P < 0.05) decrease in the hepatic
TBARS levels when compared to the DEN-FB, control rats. Consumption of
unprocessed rooibos, black and green teas showed no effect on the FB,-induced lipid
peroxidation, although black tea markedly enhanced the level. Among the different teas,
processed rooibos and honeybush teas significantly decreased lipid peroxidation when
compared to their unprocessed counterparts. Unprocessed honeybush significantly (P <
0.05) reduced lipid peroxidation when compared to black tea.
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Table VI Effect of various tea treatments on the induction of GSTP+ foci by combined treatment of DEN and FB1•
GSTP' liver Foci
Treatment
groups No foci/em' % of Total No foci/em' % of Total No foci/em' % of Total No foci/em' % of Total Total no of foci
5-10 flm 11-20 flm 21-30 flm >30 f1m/cm' (>5 f1m)
DMSO Nd nd nd Nd nd nd nd nd nd
DEN 4.7:t1.7a 587:t BAa 1.9:t 08a 32.9 :t 7.6a 0.5 :t 0.8a 6.5:t 8.7a 0.14:t 0.34a 2.0 :t 4.0a 6.0 :t 2Aa
DEN-FB, 8.0:t 2.8b 23.7:t 7.5b 18.2:t 5.6b 50.2:t 8Ab 6.5 :t 1Ab 19.6 :t 5.0b 23:t1Ab 6.5 :t 3.9b 35.0:t11,1b
DEN-FB,-Rp 15.9 :t 8.7(b)d 39.2:t 14.3cd 15.5:t 5.7bd 391 :t 4.3ac 6.5:t 2.9b 16.1 :t 3.6bc 2.3:t 1.1bc 6.0 :t 3.2bc 40.1 :t 14.0bd
DEN-FB,.Rg 12.6:t 4.9cdf 53.9:t 17.1a(d) 10A:t 5.3c(d)e 36.0:t 9.0ace 3.1 :t 2Ac 103:t 6.6a(c)d 0.7:t1.1ad 1.9 :t 2.8ad 25A:t 10.3(b)el
DEN-FB,-Hp 17.9 :t 5Acd(f) 42.3:t 7.9ad 15.1 :t 6.3bde 33.9:t 4.6ade 7.6 :t 4.8bd 16A :t 7.0bc(d)e 3.5 :t 2.7bc 7.5:t4.1b 44.2 :t 16.3bg
DEN-FB,-Hg 197:t 8.5cd(f) 52.7:t 14.7a(d) 11.9 :t 5.9(b)deg 31.8:t 6.2ade 4.0:t 2.7c(d) 106:t 5.1a(c)d 0.9:t 1.7(b)(c)d 2.3 :t 4.1 (b)d 38.0:t 14.2b(f)
DEN-FB,- BI 30.0 :t 3.5ce 540:t 12.3a(d) 17.3:t 9.9bd(e) 27.9:t 15.8ace 7.7:t 3.0b 13.8:t 6.1(b)cde 2.5:t 1Abc(d) 43:t2.1bde 575:t 11.5cg
DEN-FB,.Gr 239:t 11.3cdg 37.8:t 13.3ad 18.2:t 6.2bdf(g) 33.3:t 4.6ade 10A:t 6.6b 17.5:t 8.8bc(d)e 5.9:t 5.2b(c)(d) 9.7:t 7.2(b)ce 61.8:t 14Ac(g)
Abbreviations: Rp = processed rooibos, Rg = unprocessedl"green" rooibos, Hp = processed honeybush and Hg = unprocessedl"green" honeybush tea extracts, BI = black and Gr
= green tea, nd = not detected. Values in columns represent the average of ten rats per group :t STD. Values followed by the same letter then no significance differences are
shown. When letters differ then P<0.05, while letters in parenthesis then P<0.1.
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GSTP liver foci
Differences between DEN-FB1 and various tea treatments. FB1 significantly (P <
0.05) increased the number of GSTP+ foci in all size categories as reflected in the
increased total number when compared to the DEN control rats. No GSTP+ foci were
detected in the liver of the DMSO control rats. (Table VI). All the tea preparations
significantly (P < 0.05) to marginally (P < 0.1) increased the number of mini foci (5-10
f1m) when compared to the DEN-FB1 treatment. A similar effect was noticed when
considering the relative number of foci, expressed as a % of the total. Of interest is that
the DEN control group, unprocessed rooibos and honeybush and black teas numerically
exhibited the highest % of mini foci. When considering the focal size 11 to 20 f1m,which
constitutes 50% of the total number of foci in the DEN-FB1 treated group, the
unprocessed rooibos and honeybush teas significantly (P < 0.05) and marginally (P <
0.1) decreased the number of foci, respectively. The relative amount was significantly (P
< 0.05) decreased by all the tea-treated groups. In the focal size category 21-30 f1m,
which constitutes approximately 20% of the total number of foci, the unprocessed herbal
teas again significantly (P < 0.05) decreased the number of foci while the relative
amount was significantly (P < 0.05) and marginally (P < 0.1) decreased by the
unprocessed herbal teas and black tea, respectively. When considering the focal size
greater than 30 f1m, constituting approximately 6% of the total amount of foci, the
unprocessed rooibos tea significantly (P < 0.05) and unprocessed honeybush tea
marginally (P < 0.1) decreased the number. A similar response was obtained when
considering the relative amount, although green tea showed a marginal (P < 0.1)
increase. Of the herbal tea treated groups unprocessed rooibos tea marginally (P < 0.1)
reduced the total number of GSTP+ foci (>5 ~m), while the green and black teas
showed a significant (P < 0.05) increase when compared to the DEN-FB, control group.
However, when omitting the mini-foci (5 to 10 ).1m), none of green and black teas
exhibited a significant increase while unprocessed rooibos and honeybush significantly
(P < 0.05) and marginally (P < 0.1) reduced the total number of foci, respectively (Figure
2)
Differences between tea treatment groups. Among the different tea treated groups,
black tea exhibited the highest number of mini foci while a marginal (P < 0.1) increase
was noticed for the honeybush teas. The relative amount of mini foci was marginally (P
< 0.1) increased by the unprocessed herbal teas as compared to the processed teas. In
contrast black tea marginally (P < 0.1) increased the relative amount of mini foci when
http://scholar.sun.ac.za
Chapter 6 185
compared to green tea. In the focal size category 11-20 IJm, the unprocessed rooibos
marginally (P < 0.1) decreased the number of foci as compared to the processed
rooibos and black teas and significantly (P < 0.05) when compared to green tea.
Unprocessed and processed honeybush also marginally (P < 0.1) to significantly (P <
0.05) decreased the number of foci as compared to black and green teas, respectively.
When considering the relative amount, the rooibos teas accounted for the highest
contribution to this size category. Unprocessed rooibos and honeybush significantly (P
< 0.05) reduced the number of foci in the size category of 21-30 IJmwhen compared to
their processed counteracts as well as the black and green teas. With respect to the
relative amount, the unprocessed herbal teas marginally (P < 0.1) lowered the level
when compared to their processed counterparts and green tea. A similar effect was
noted in the focal size >30 IJm, where the unprocessed rooibos tea significantly (P <
0.05) reduced the number as compared to the processed herbal teas. A marginal (P <
0.1) reduction was also noticed when compared to the green and black teas.
Unprocessed honeybush tea also marginally (P < 0.1) reduced the number of foci as
compared to the processed counterpart and green and black teas. Unprocessed rooibos
significantly (P < 0.05) reduced the relative amount, when compared to the processed
herbal tea and green teas. Unprocessed honeybush tea showed a significant (P < 0.05)
and marginal (P < 0.1) reduction when compared to green tea and processed
honeybush, respectively.
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Fig. 2. The total number of GSTp. foci (>10 ~Im) in liver sections of rats consuming the
different teas while fed a dietary level of 250 mg FB1/kg diet for 3 weeks. Values
represent the means :I: STO of 10 rats per group.
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The herbal teas significantly (P < 0.05) decreased the total amount of foci (>5I.Jm) as
compared to the black and green teas when the combined effects were considered
(Figure 3A). The separate effects of the different teas indicated that unprocessed
rooibos and honeybush significantly (P < 0.05) decreased the total number of foci when
compared to the green and black teas (Figure 3B). A similar effect was noticed with
processed herbal teas.
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Fig. 3. (A) Interactive plots illustrating the combined effects of the various tea treatments
on the induction of total number of hepatic GSTp. foci (>5 !-1m)by FB1 (.significant
difference from black and green tea). (B) Separate effects of the tea processing on the
induction of GSTp. foci (For statistical differences see Table VI).
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DISCUSSION
FB, has been characterized as a non-genotoxic liver cancer promoter (47) and
subsequently shown to be hepatocarcinogenic in mice (48) and rats (49) and
nephrocarcinogenic in rats (48). The mechanism of cancer induction is not known at
present but studies in rats indicate that FB1 could effect both cancer initiation and
promotion in the liver (37,50,51). The disruption of growth-stimulatory responses in
normal and altered initiated cells is suggested to be important in establishing a growth
differential whereby the preneoplastic cell populations are clonally expanded,
subsequently leading to hepatocarcinogenesis induced by FB1 (52,53). At a cellular
level, FB, also disrupts sphingolipid, phospholipid and fatty acid metabolism which have
been suggested to be the underlying mediators responsible for the growth differential
created in the liver (54-56).
The cancer promoting potential of different dietary levels of FB, in DEN-initiated
rats has been previously established (51). The present study confirms that, at the
dietary level used, FBI induced hepatotoxicity as indicated by a significant (P < 0.05)
increase in the liver function enzymes and cholesterol, with a resultant decrease in body
weight gain and the relative liver weight (51,57). Serum creatinine, a marker for kidney
damage effected by FBI (56), was also increased. Black and processed honeybush
teas significantly (P < 0.05) and unprocessed honeybush tea marginally (P < 0.1)
reduced the serum creatinine, suggesting a protective effect against FBrinduced
nephrotoxicity. The honeybush teas and green tea also effectively protected against
FB,-induced accumulation of serum cholesterol. The high level of hesperidin in
honeybush tea is of interest in this regard as hesperetin, the aglycone of hesperidin, is
known to reduce the level of plasma cholesterol in high cholesterol fed rats (58).
Consumption of unprocessed rooibos and to a certain extent, processed rooibos and
unprocessed honeybush teas, further increased the clinical chemical parameters for
liver damage induced by FB" suggesting an enhanced hepatotoxic effect. This resulted
in a reduction in the relative liver weight (P < 0.05) of the rats consuming the processed
and unprocessed rooibos teas when compared to the other teas. As the tea intake
profiles during the pre-FBI and FB, treatment periods were similar, except for the black
teas which tended to be lower, and total FB, intake during this period did not differ,
specific interactions between the tea constituents and FBI are likely to affect the
enhanced hepatotoxicity. The latter is further substantiated that consumption of the teas
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did not induce any hepatotoxic effects in the liver in the absence of FB1 under similar
experimental conditions (26),
One possibility for the enhanced hepatotoxicity of FB1 could be the mobilization
of iron in the liver, shown to be effected by FB1 (53), resulting in a possible prooxidant
effect when interacting with the herbal tea polyphenolic compounds, In the present
study the total plasma iron was significantly (P < 0,05) increased by the honeybush teas
and marginally (P < 0,1) by green tea when compared to the rooibos teas, This
observation was mainly due to a marked reduction in the total plasma iron in the rooibos
treated rats as compared to the DEN-FB1 group consuming water. This would imply that
the herbal teas, as well as the green tea, interfere with the iron mobilization effect
enhanced by FB1 in the liver and therefore could modulate the oxidative status in the
liver. With respect to oxidative damage, processed rooibos and unprocessed and
processed honeybush teas significantly (P < 0,05) reduced the FB1-induced lipid
peroxidation under the present experimental conditions, This finding is in agreement
with the antioxidant potency of these teas which is known to be less than that of
unprocessed rooibos, black and green teas (4,14) and therefore less likely to interact
with iron to induced a prooxidant effect. The current study supports this finding as the
processed herbal teas exhibited a significant (P < 0,05) lower inhibitory effect on lipid
peroxidation, Of interest was the significant (P < 0,05) increase in lipid peroxidation by
green and black tea as compared to the honeybush teas and unprocessed rooibos teas,
Another contributing factor is the ORAG, which was only marginally (P < 0,1)
increased by unprocessed rooibos and markedly by processed rooibos and honeybush
teas, suggesting an enhanced protective effect against oxidative damage, This apparent
contradictory finding with respect to the increased serum liver function enzymes and
enhanced protection against lipid peroxidation could be related to the stabilizing effect
of the herbal teas on the ORAG values as well as the hypothesis that lipid peroxidation
is a secondary event following FB1-induced cytotoxicity (59), Therefore, despite the
apparent increased cytotoxicity of FB1 the subsequent lipid peroxidation is prevented by
rooibos and honeybush teas, Although the herbal teas did not enhance the ORAG
levels in rats (26) it stabilized the levels during FB1 promotion in the present study,
which could explain the enhanced protective effects on lipid peroxidation, As rats
consuming the unprocessed rooibos tea are exposed to far higher levels of flavonoids,
possible interactions with iron prohibited any significant reduction in lipid peroxidation as
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compared to the processed tea. The lower antioxidant potency of unprocessed
honeybush tea (13,14), therefore, could explain the higher inhibitory effect on the FB,-
induced lipid peroxidation. No effect was obtained with black tea on the ORAC level and
FB,-induced lipid peroxidation while green tea, significantly (P < 0.05) further reduced
the ORAC level while lipid peroxidation was not effected. A possible interaction with the
green tea polyphenolic compounds and FB,-mobilized hepatic iron could be responsible
for the reduced ORAC level. A reduction of ORAC by green tea was also reported
previously when rats were consuming the tea over a period of 10 weeks (26). This
would suggest that, when considering ORAC, the FB, treated rats consuming green tea
were subjected to additional stress.
Apart from the ORAC, the GSH:GSSG ratio is also an important oxidative
parameter during promotion as the liver is subjected to a variety of stresses, some of
which may lead to a depletion of GSH levels. FB1 is known to increase oxidative stress
in the liver (59) and a recent study in glioblastoma cells showed that FB, reduced the
level of GSH (60). However, the decrease in GSH during stressed conditions is likely to
be counteracted by the development of gamma glutamyl-transpeptidase positive (GGT+)
foci. These altered hepatocytes are provided with amino acids necessary for GSH
synthesis by GGT, located on the outer surface, which primarily acts as a glutathionase
(61). The GGT+ cells will therefore be able to replenish glutathione providing the cell
with a selective growth advantage during promotion. A study, utilizing a DEN
carcinogenesis model, also reported on an increased GSH level in the liver of male
Wistar rats, which was ascribed to the induction of GGT+ adenomas (62). In the present
study, rats treated with DEN-FB, significantly increased the level of GSH in the liver,
presumably due to the increased number of preneoplastic foci, known to stain positive
for GGT (47,49), resulting in an increased GSH:GSSG ratio. However, the single DEN
treatment regimen did not increase the GSH level as only few enzyme altered foci were
induced in the absence of the FB1 promoting treatment. The increased level of GSH
was significantly (P < 0.05) lowered by processed and unprocessed rooibos teas,
resulting in a decreased GSH:GSSG ratio. Black and green teas marginally (P < 0.1) to
significantly (P < 0.05) decreased the ratio, respectively, mainly due to an increased
GSSG level. It is known that, under stressed conditions, this ratio tends to decrease
either due to increased GSSG or decreased GSH levels (63). The green tea probably
enhanced the oxidative stress in the liver of rats exposed to FB1 as the GSSG level was
significantly increased without affecting the GSH level, thereby decreasing the
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GSH:GSSG ratio. This hypothesis is further strengthened as green tea also reduced
ORAC in the liver of these rats. The unprocessed rooibos tea, however, decreased the
ratio as a result of the decrease in GSH, which could be explained, as discussed above,
by the reduced number of altered foci in the liver. An interesting relationship exists
between the GSSG status and the inhibition of lipid peroxidation. Teas exhibiting the
highest protective effect against lipid peroxidation were also associated with the lower
level of GSSG in the liver, suggesting that the accumulation thereof, as stated above, is
related to an increased oxidative stress.
Consumption of the different teas as a sole source of drinking fluid significantly
(P < 0.05) arrested the proliferation of GSTP+ altered cells in the presence of the cancer
promoter FB1. This was deduced from the finding that the relative number of foci (10-20
,1m) that constitutes approximately 50% of the total amount of foci, significantly (P <
0.05) decreased in liver of rats treated with the different teas. In contrast, the relative
number of mini foci (5-10 IJm) was significantly (P < 0.05) increased, suggesting that the
different teas interfere with the promoting of these lesions by FB1. Unprocessed rooibos
and honeybush teas also significantly reduced the relative number of the larger foci,
further suggesting an interference with cancer promotion. The green tea flavonol, (_)_
epigallocatechin-3-gallate (EGCG) was shown to inhibit the proliferation of a hepatoma
cell line through the induction of apoptosis and cell cycle arrest (64). Inhibition of cell
proliferation was suggested in a study where green tea constituents and polyp henoIs
inhibited the number and size of enzyme altered foci when administered to rats during
cancer promotion (31). In the present study all the teas delayed the development of
DEN-induced preneoplastic cells presumably due to the inhibition of cell proliferation.
However, the reduction of the number of foci, as was noticed with the unprocessed
rooibos tea and to a certain extent with the unprocessed honeybush tea, could be
related to the increased toxicity which could further enhance the apoptotic effects of FB1
in the liver and thereby inhibited the grow1h of preneoplastic lesions. It was previously
reported that apoptosis, induced by FB1, delayed cancer induction by removing initiated
cells from the liver (49,50).
The antioxidant activity of many plant phenolic components may play an
important role in maintaining the balance between cell grow1h and cell death in
preneoplastic lesions (65). In the present study, no conclusive evidence exists to show
the involvement of antioxidant activities of the different teas in the decreased number
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and/or delayed development of GSTP+ foci. However, processing of the herbal teas,
known to reduce the antioxidant status (14,66), also reduced the inhibitory effect on
FB1-induced cancer promotion. Varying effects on ORAC, GSH levels, and the inhibition
of lipid peroxidation were noticed which could be related to the differences in
polyphenolic constituents among the various teas and their specific interactions with
FB1 during cancer promotion. Therefore, the protection against FB,-induced cancer
promotion by the different teas may not be entirely related to their antioxidative
activities. Other features, e.g. their pro-oxidant activity and effect on cell regulatory
processes such apoptosis may also be involved and need to be investigated. Tea
polyphenols have been shown to exhibit pro-oxidant features and have been associated
with the induction of apoptosis in cultured cancer cells (67). The mechanisms involved
in the inhibitory effect against liver tumour promotion by the herbal teas are therefore of
interest and remain to be elucidated.
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Inhibition of tumour promotion in mouse skin by extracts of rooibos (Aspalathus
Iinearis) and honeybush (Cyclopia intermedia), unique South African herbal teas
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ABSTRACT
Ethanol/acetone (E/A) soluble fractions, prepared from methanolic extracts of
processed and unprocessed rooibos and honeybush as well as green tea, significantly
(P < 0.001) reduced tumour formation in mice skin initiated with 7,12-dimethyl-
benz[ajanthracene (DMBA) followed by 12-0-tetra-decanoylphorbol-13-acetate (TPA)
promotion. The green tea E/A fraction completely inhibited (100%) tumour formation
followed by fractions of unprocessed honeybush (90%), processed honeybush (84.2%),
processed rooibos (75%) and unprocessed rooibos (60%). No relationship exists
between the total polyphenol (TP) content of the herbal tea fractions, inhibition of
microsomal lipid peroxidation and the inhibition of skin tumour promotion. The green tea
fraction, with the highest flavanol/proanthocyanidin content, also exhibited the highest
protective activity against hepatic microsomal lipid peroxidation, and completely
inhibited skin tumour formation. The unprocessed rooibos tea fraction, with a similar TP
content exhibited the highest inhibition against lipid peroxidation of the herbal tea
fractions, but showed the weakest protection against tumour promotion. In contrast, the
unprocessed honeybush tea fraction with a similar TP content and inhibitory effect on
lipid peroxidation than the processed rooibos fraction, exhibited the highest protection
against tumour promotion. The flavanol/proanthocyanidin and flavonol/flavone contents
of the unprocessed honeybush tea fraction, expressed as a percentage of the TP, were
similar to that of the green tea and unprocessed rooibos fractions, respectively.
Differences in the f1avanol/proanthocyanidin and flavonol/flavone composition and/or
non-polyphenolic constituents are likely to be important determinants in the inhibition of
tumour promotion by the herbal tea E/A fractions in mouse skin.
KEYWOROS: Rooibos, Honeybush, TPA, Chemoprevention, Tumour promotion
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Chemical carcinogenesis in murine and possibly human skin is a multi-step process
including initiation, promotion and progression [1,2]. In mouse skin, a single topical
application of 7, 12-dimethylbenz[a]anthracene (DMBA) affects initiation while promotion
is accomplished by repeated topical applications of a promoter such as 12-0-
tetradecanoylphorbol-13-acetate (TPA) [3,4]. In contrast to initiation, which is
irreversible and possibly unavoidable because of continuous exposure to chemical and
physical carcinogenic agents, the process of promotion is reversible [4,5]. The
reversibility of tumour promotion therefore provides an opportunity to interrupt or delay
the development of altered lesions resulting in tumour formation.
A variety of plant and/or other phenolic compounds exhibit chemoprotective
properties by disrupting the different stages of multi step skin carcinogenesis, especially
tumour promotion [5-11]. The phenolic composition of green tea has been well
characterised and the major flavonoid constituents, the catechins, are known to be
inhibitors of cancer initiation and promotion in mouse skin [11-13]. The major phenolic
components of the unprocessed South African herbal teas are the dihydrochalcones,
aspalathin and nothofagin present in rooibos (Aspalathus linearis) and the xanthone,
mangiferin and flavanone, hesperidin in honeybush (Cyclopia intermedia) [14,15]. In the
processed herbal teas, aspalathin remains one of the major components in rooibos.
Although mangiferin and hesperedin decrease with processing, they also remain the
major monomeric polyphenols in processed honeybush. The polyphenolic composition
differs from that of green tea and their cancer protective properties are not known at
present.
Aqueous extracts of rooibos tea significantly decreased the number of
chromosomal aberrations in hamster ovary cells treated with benzo[a]pyrene in the
presence of liver homogenates [16]. An in vivo study in male ICR mice showed a
significant decrease in the number of micronucleated reticulocytes, induced by
mitomycin C, by aqueous extracts of rooibos tea [16]. Apart from these studies very little
is known about the modulation of the genotoxic effects of carcinogens by these herbal
teas. Recent investigations showed that aqueous extracts of honeybush and rooibos
exhibit antimutagenic properties against aflatoxin B1- and 2-acetylaminofluorene-
induced mutagenesis in vitro [17] and ex vivo [18]. Aqueous extracts of unprocessed
and processed rooibos as well as unprocessed honeybush significantly enhanced the
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antioxidant capacity in the liver of rats by stabilising glutathione (GSH) [19]. The activity
of hepatic phase II metabolising enzymes, glutathione-S transferase (GST-a) and UOP-
glucuronosyl transferase (UOP-GT) was also significantly enhanced in the liver by the
aqueous extracts of rooibos and honeybush teas. This would imply that these herbal
teas not only altered the metabolic fate of carcinogens but also the oxidative status of
cells that can protect against the adverse effects of oxidative damage induced by many
carcinogens. The present study investigated the modulating effect of ethanol/acetone
(E/A) soluble fractions prepared from methanol extracts of processed and unprocessed
rooibos and honeybush teas on tumour promotion in mouse skin, using green tea as
reference.
MATERIALS AND METHODS
Chemicals. 7,12-dimethylbenz[a]anthracene (OMBA) and 12-0-tetra-decanoylphorbol-
13-acetate (TPA), butylated hydroxytoluene (BHT), 2-thiobarbitric acid (TBA), ethylene
diamine tetra-acetic acid disodium salt (EOTA), gallic acid, (+)-catechin, quercetin,
mangiferin, rutin, p-dimethylaminocinnamaldehyde (OAC) and Folin's reagent, were
purchased from Sigma Chemical Co. (Cape Town, South Africa). Hesperidin and
hesperetin were obtained from Aldrich Chemical Co (Cape Town, South Africa).
Orientin, iso-orientin, vitexin, iso-vitexin, luteolin, chrysoeriol and iso-quercitrin were
purchased from Extrasynthese (Genay, France). Aspalathin and nothofagin, isolated
from unprocessedl"green" rooibos to a purity of >95%, were supplied by Ms P Snijman
(PROMEC Unit, MRC, South Africa). All other chemicals used were of analytical grade.
Animals. Six-week old female ICR mice were obtained from the Animal Unit, Medical
School, University of Cape Town (South Africa) and kept in the Animal Unit of the
University of Stellenbosch, (Tygerberg, South Africa) for at least one week prior to
commencement of the experiment. Mice had free access to pelleted murine chow (Epol
LTO, Johannesburg, South Africa) and water while kept on a 12 hr photoperiod with
optimum air changes per hour and a constant room temperature of 21 DC.
Plant material. Processed (oxidised) and unprocessed ("green"/unoxidised) rooibos
and honeybush teas, part of the indigenous "fynbos" flora in certain coastal and
mountainous regions of the South Western Cape Province (South Africa), were
obtained from ARC Infruitec-Nietvoorbij, (Agriculture Research Council), Stellenbosch,
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South Africa. The green tea (Camellia sinensis var. sinensis), imported from China, was
a gift from Vital Health Foods, Kuils River, South Africa.
Preparation of the ethanol/acetone soluble (E/A) extracts. Polyphenolic extracts of
both processed and unprocessed rooibos and honeybush and Chinese green teas were
prepared by extracting (3 times) grounded plant material with chloroform (3% m/v) by
vigorous stirring in an Erlenmeyer flask and filtering through Whatman no 3 filter paper.
The residual plant material was exhaustively extracted overnight with methanol as
described above, filtered, the solvent evaporated under reduced pressure at 40°C in a
Rotavapor and the residue stored in an airtight container at 4 °c in the dark. The E/A
(1:1 v/v) soluble fraction of the different tea preparations was prepared by reconstituting
30 mg of the methanol extract in 1 mL absolute ethanol and acetone (1 :1) mixture.
Soluble solids, total polyphenolic, f1avanol/proanthocyanidin and flavonollflavone
content of the E/A soluble fractions. The solid content of each E/A soluble tea
fraction was determined gravimetrically (4 repetitions) after drying 1 mL aliquots at 110
°c for 12 hr. The Folin-Ciocalteau method with gallic acid as standard was used to
determine the total polyphenol (TP) content [20]. The flavanol/proanthocyanindin and
flavonol/flavone contents were determined colorimetrically (640 nm) using OAC with (+)-
catechin as standard [21] and spectrophotometrically (360 nm) using quercetin as
standard [22], respectively. The results were expressed as mg catechin or mg quercetin
equivalents/mg soluble solids. The possible contributions of hesperidin, mangiferin and
aspalathin to the flavanol/proanthocyanidin content were also determined
spectrophotometrically using reactivity with OAC as a measure.
HPLC quantification of the major flavonoids in the E/A soluble herbal tea
fractions. Dried E/A fractions of rooibos and honeybush were dissolved in methanol
and filtered through a Magna Nylon 13 mm 0.45 pm filter prior to HPLC analysis. The
honeybush extracts were analysed for mangiferin, hesperidin and hesperetin according
to the method of Joubert et al. [15]. HPLC analysis were conducted on a LaChrom2000
system comprising of an L-7400 UV detector, L-7100 pump, Rheodyne 7725i injection
valve and 0-7000 HPLC system manager and interface using a Phenomenex Synergy
Max-RP C12 80A (4 pm, 150 x 4.6 mm 1.0.) column while quantification was done at
280 nm. The rooibos extracts were analysed for the dihydrochalcones, aspalathin and
nothofagin and the flavones, orientin, iso-orientin, vitexin, iso-vitexin, luteolin,
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chrysoeriol and flavonols quercetin, iso-quercitrin and rutin. Rutin co-eluted with iso-
quercitrin and the quantification was expressed as quercetin equivalents. A Waters LC
Module 1 Plus system, 2996 diode array detector and Millenium Version 3.2 for system
control and data acquisition were used. Separation was conducted on a Merck
Lichrosphere 100 RP-18 (5 ~lm, 250 x 4 mm 1.0.) column. Quantification was conducted
at 288 nm (dihydrochalcones) and 255 nm (flavones and flavonols) according to the
method of Joubert [23] with a modification to the initial gradient. A calibration curve for
each flavonoid was prepared.
Thiobarbituric acid reacting substances (TSARS) determinations. The formation of
TBARS, measured as malondialdehyde (MOA), was used to determine the protective
effect of the E/A soluble fractions (0.01% dissolved in OMSO) against lipid peroxidation
utilising a rat liver microsomal (1 mg protein/mL) preparation. Lipid peroxidation was
determined using a modified method of Yen and Hsieh [24] in the presence of Fe2+ and
absence of hydrogen peroxide. Results were expressed as nmol MOA per mg protein
using the millimolar extinction coefficient of 153 [25]. The microsomal fraction was
prepared from an S-9 liver homogenate by Sepharose 2B column chromatography in
Tris buffer (50 mM, pH 7.4) containing KCI (150 mM) as previously described [26]. The
microsomes were stored at -80 DC until used. Protein determination was performed
according to the method of Kaushal and Barnes [27] using bovine serum albumin as
standard.
Effect on tumour promotion. Eighty mice were randomly divided into 8 treatment
groups of 10 animals each and caged separately. Prior to the study the dorsal side of
the skin was treated with a depilatory cream (No Hair; Adcock Ingram, South Africa).
Mice were treated with a single topical application of OMBA (200 nmol) in acetone (100
uL) as tumour initiator followed by the cancer promoter, TPA (5 nmol; 100 uL), one
week later. The protective effect of the E/A tea fractions was monitored by topical
application (100 uL) 30 min prior to TPA treatment. Positive control (OMBAlTPA) mice
were treated with the carrier solvent in a similar manner (acetone/ethanol). Two
experimental control groups were included consisting of OMBAIacetone and
acetonelTPA treatments. The treatments were repeated twice weekly for 20 weeks and
the number of skin tumours was recorded weekly. The final tumour yield and tumour
volume, using tumour height and internal diameter measures, were determined upon
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termination by CO2 asphyxiation. Details of the experimental outlay are summarised in
figure 1. The experiment was repeated once.
Positive
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Acetone ~
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Fig. 1. Experimental protocol of the various treatment regimens used in the two-stage
mouse skin cancer model. Mice were treated with a single dose of DMBA (200 nmol) or
the control solvent (acetone). Modulation of cancer promotion was conducted by the
application of the tea ethanol/acetone (E/A) polyphenolic fractions 30 minutes prior to
TPA (5 nmol) twice weekly for 20 weeks.
Statistical analyses
An Analysis of Variance (ANOVA) was performed on the data using Proc GLM in SAS.
Where equal group variances were present, the F-test was used to test for group
differences, using the parametric Tukey-test to indicate which specific groups differed
significantly. Otherwise the Welch test was used where groups had unequal variances.
Student's T-test was used to test for pair wise group differences.
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RESULTS
No noticeable clinical signs of illness e.g. weight loss, diarrhoea, rhinitis, alopecia were
detected in any of the groups as a result of the topical application of the different
treatments.
Soluble solids, total polyphenolic and flavonoid content of the E/A soluble
fractions.
No significant (P > 0.05) differences were noticed in the soluble solid content of the
various fractions. The TP content of the E/A soluble fractions of the processed herbal
teas (13-24%) were significantly (P < 0.001) to marginally (P < 0.1) lower when
compared to their unprocessed counterparts (31-55%) as well as the green tea (56%)
(Table I). The green tea E/A fraction had a similar TP content to that of the unprocessed
rooibos. The E/A fractions of the unprocessed herbal teas had a similar
flavanol/proanthocyanidin content while their processed counterparts had a significantly
lower (P < 0.001) content, with the processed honeybush fraction containing the lowest
amount (P < 0.001). When expressed as a percentage of the TP content, the green tea
and unprocessed honeybush tea E/A fractions contain up to 90%
flavanols/proanthocyanidins, followed by unprocessed rooibos (47%), processed
rooibos (22%) and processed honeybush (14%). The flavonol/flavone content of the
processed and unprocessed rooibos E/A fraction was significantly (P < 0.001) higher
than the honeybush and green tea fractions. The unprocessed honeybush E/A fraction
contained a marginally (P < 0.1) higher flavonol/flavone content when compared with
green and processed honeybush fractions. When considering the flavonol/flavone
content as a percentage of the TP content the E/A fractions of the unprocessed herbal
teas (- 4.7%), exhibited the lowest amounts when compared to the processed
counterparts (10 -15 %) which were still significantly (P < 0.001) higher than the green
tea E/A fraction (1.8%).
None of the major flavonoid constituents of the E/A fractions prepared from
honeybush and rooibos, aspalathin, mangiferin and hesperidin showed a positive
reaction with DAC when the flavanols were determined.
Quantification of selective f1avonoids of herbal E/A fractions. Aspalathin and
nothofagin comprised the major flavonoids in the E/A fraction of the unprocessed
rooibos (Table II). The flavone oxidised products of aspalathin, orientin and iso-orientin
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and those derived from nothofagin, vitexin and iso-vitexin were also detected. Rutin and
isoquercitrin, that co-eluted, were present while only trace amounts of quercetin, luteolin
and chrysoeriol were detected. A similar pattern was noticed in the EtA fraction from the
processed rooibos with the exception that aspalathin and nothofagin were reduced
while their oxidised analogues were increased. Rutintisoquercitrin, quercetin, luteolin
and chrysoeriol could also be detected. Mangiferin and hesperidin were the major
flavonoid constituents detected in the unprocessed and processed honeybush EtA
fractions. As noticed for rooibos tea, the honeybush flavonoids were markedly reduced
as a result of tea processing.
Based on the volume of each fraction applied to mouse skin, aspalathin was the
major flavonoid in the unprocessed rooibos EtA fraction whilst iso-orientin, orientin and
aspalathin represented the major flavonoids when administering the processed rooibos
fraction. Mangiferin and hesperidin were the major compounds in both the unprocessed
and processed honeybush fractions (Table II).
Inhibition of microsomal lipid peroxidation. The unprocessed herbal tea fractions
exhibited a higher protective effect against lipid peroxidation when compared to their
processed counterparts (Table I). Of the herbal teas unprocessed rooibos exhibited the
highest protective effect while processed rooibos and unprocessed honeybush showed
a similar but lower protection. The processed honeybush fraction was the least effective
against the inhibition of lipid peroxidation with the green tea fraction exhibiting the
highest (P < 0.05) protective effect of all the teas fractions.
Inhibition of tumour promotion. None of the mice in the negative control groups
(DMBAlsolvent and solventITPA) developed skin tumours. The positive control mice
(DMBAfTPA) developed a mean number of 5.3 skin tumours per mouse (Fig. 2A) with a
tumour incidence of 88.3% (Fig. 2B). No tumours developed in the mice treated with the
green tea EtA fraction. Topical application of the various herbal tea EtA fractions
significantly (P < 0.001) protected against tumour promotion by TPA (Fig. 2A). The
mean number of tumours per mouse was significantly reduced by unprocessed rooibos
(1.1) followed by processed rooibos (0.7), unprocessed (0.3) and processed (0.2)
honeybush (Fig. 2B) fractions. Unprocessed honeybush exhibited the highest decrease
(90%) in the % tumour bearing mice, followed by processed honeybush (84.2%),
processed rooibos (75%) and unprocessed rooibos (60%) fractions.
http://scholar.sun.ac.za
Chapter 7 206
Table I. Soluble solids, total polyphenolic, f1avanol/proanthocyanidins and flavonol/flavone contents of the ethanol/acetone tea
extracts topically applied to mouse skin. The inhibitory effect on of lipid peroxidation was monitored in rat liver microsomes (1mg
protein/mL) in the present of Fe2+
Tea Soluble TP content (mg Flavanol/ Flavanol/ Flavonol/flavone Flavonol/flavone $TBARS (nmol
extracts solids Gallic acid proanthocyanidin proanthocyanidin content (mg Quercetin content (expressed MDAt mg
equivalents/mg content (mg content equivalents/mg soluble as a % of TP) protein)
(mg/l00uL) soluble solids)* Catechin (expressed as a % solids)"
equivalents/mg of TP)
soluble solids)**
Rp 2.24 i: 0.36a 0.24 i: 0.03a (24%) 0.05 i: O.OOla (5.4%) 21.90 i: 0.05a 0.037 i: 0.010a (3.7%) 15.07 i: 4.57a 1.40 i: 0.44a
Rg 229 i: 0.20a 0.55 i: 0.08b (55%) 0.26 i: 0.004b (26%) 46.46 i: 0.12b 0.026 i: 0.002a (2.6%) 4.68 i: 0.31b 0.37 :t 0.1Ob
Hp 2.16 i: 0.46a 0.13 i: 0.02(a) (13%) 0.02 i: 0001c (2%) 13.62 i: O.Olc 0.014 i: 0.008b (1.4%) 10.52 i: 6.37a 3.50 :t 0.43c
Hg 2.07:t 0.42a 0.31 :t 0.04a (31%) 0.28 :t 0.001 b (28%) 91.04 i: 0.09d 0.015:t 0.003 (b) (1.5%) 4.84:t1.12b 1.47:t 0.31a
Gr 257:t 0.41a 0.56 :t 0.05b (56%) 0.51 :t 0.002d (51%) 9150:t 0.16d 0.010 :t 0.002b (1%) 1.78:t O.4c 0.04:t 0.01b
Ctrl 4.01:t 0.10d
'TBARS assay conducted using 0.01% (wlv) of the E/A polyphenolic fraction dissolved in DMSO. Values are means:t STD of 17-20 determinations, except for soluble
solids (n=4). Means in columns followed by the same letter are not significantly different. If the letters differ then P<0.001. Letters in parenthesis then P<0.1. *, **, •
values expressed as a % of the soluble solids. Abbreviations: Rp = processed rooibos, Rg = unprocessed rooibos, Hp = processed honeybush, Hg = unprocessed
honeybush and Gr = green lea. TP = total polyphenols.
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Unprocessed
% soluble solids .,9/100.,1% soluble solids "9/100 .,1
Polyphenols
Table II. Quantitative amount of flavonoids applied to the mice skin using
processed and unprocessed herbal ethanol/acetone tea fractions
E/A fractions
Processed
Rooibos constituents
Aspalathin 2.12 :t 002 63.45:t 062 5.67:t 0.06 226.82 :t 2.31
Nothofagin 0.24 :t 0.01 7.36:t 003 0.81 :t 0.01 32.47:t 0.15
Orientin 2.43 :t 0.01 72.80 :t 0.09 0.54 :t 0.01 21.68:t 0.10
Iso-orientin 3.08 :t 0.01 92.33 :t 0.03 065 :t 0.01 2615:t0.03
Vitexin 0.37:t 001 11.24 :t 0.02 0.06 :t 0.01 2.49:t 004
Iso-vitexin 094:t 0.04 28.29 :t 0.12 0.27 :t 0.01 1076:t 0.04
Rutin/lso-quercitrin 074 :t 0.01 22.09 :t 0.17 0.31 :t 0.01 12.24 :t 0.07
Quercetin 0.13:t 0.01 3.83 :t 0.25 Trace Trace
Luteolin 0.11 :t 0.01 3.19:t 0.35 Trace trace
Chrysoeriol 0.10 :t 0.01 2.91 :t 0.002 Trace trace
Honeybush constituents
Mangiferin 3.74:t 0.01 112.19:t 0.52 5.61 :t 0.08 168.42 :t 2.37
Hesperidin 3.69 :t 031 110.69:t 9.32 4.14:t 0.15 124.26 :t 4.42
Hesperetin trace Trace 0.41 :t 0.01 12.24 :t 0.01
The values in columns represent the mean t standard deviation of 2-3 determinations.
When considering the mean tumour volume/mouse a similar trend was observed. The
DMBA-initiated mice receiving TPA promotion had a mean tumour volume (mm3) per
mouse of 80A :t 158.6, compared to 34.7 :t 130A for processed rooibos, 27 :t 55.6 for
unprocessed rooibos, 11.3 :t 35.7 for unprocessed honeybush and 1.8 :t 5.7 for
processed honeybush.
The herbal tea fractions not only decreased the tumour volume and the mean
number of tumours per mouse (Fig. 2A) but also delayed tumour development (Fig. 2A,
B). The first tumour in the DMBAITPA treated mice appeared at 4 weeks, 12 weeks
when treated with the processed and unprocessed rooibos and 16 weeks when treated
with the processed and unprocessed honeybush E/A fractions.
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Fig. 2. Inhibitory effect of topical application of various tea E/A polyphenolic fractions on
TPA-induced tumour promotion in mouse skin. The mean number of tumours per
mouse (A) and the percentage mice with tumours (8) is plotted as a function of the
treatment period (weeks). The fractions include Rp = processed rooibos, Rg =
unprocessed rooibos, Hp = processed honeybush, Hg = unprocessed honeybush and
Gr = green tea. The number of animals per group = 17-20. (Fig 2a insert - skin tumour
incidence in mice treated with the herbal teas extracts between 12 to 20 weeks).
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DISCUSSION
The mechanisms involved in mouse skin tumour promotion have not been fully
characterised but events such as hyperplasia, inflammation and production of reactive
oxygen species (ROS) amongst others, have been shown to be important [12,28,29].
Pre-treatment of murine skin with natural antioxidants suppressed the oxidative stress
activity of ornithine decarboxylase (ODC), cell proliferation and ultimately inhibited skin
tumour promotion [30,31]. Topical application of green and black tea polyphenols prior
to TPA administration protected against the onset and subsequent development of skin
tumours [7,13,32). Polyphenolic fractions of green tea exhibited antioxidant activity
towards hydrogen peroxide and superoxide anion radicals in mouse hepatocytes and
human keratinocytes [33,34). Thus, compounds exhibiting antioxidant and/or anti-
inflammatory activities are expected to be effective anti-tumour promoting agents (35).
The present study confirms that a polyphenolic fraction of green tea, containing
mainly flavanol/proanthocyanidin constituents, inhibits the formation of mouse skin
tumours. Evidence is also provided for the first time, that E/A soluble fractions prepared
from unprocessed and processed rooibos and honeybush methanol extracts protect
against TPA-induced tumour promotion in mouse skin. A significant (P < 0.05) decrease
in tumour incidence, a marked reduction in tumour volume and a delay in the onset of
tumour development were shown in the present study. Previous studies showed
aqueous extracts of the herbal teas reduce oxidative stress, as well as enhance the
antioxidant capacity in rat liver after chronic exposure [18,19). Aqueous extracts of
processed rooibos tea also significantly inhibited the activity of ODC in fibroblasts and
myoblasts in tissue culture which were ascribed to the potent radical scavenging activity
of rooibos tea extract [36). Data from these studies and the present study suggest that
the antioxidant activity of the different tea E/A fractions are likely to be involved in the
reduction of ROS induced by TPA thereby inhibiting tumour promotion.
The green tea fraction with the highest TP content, exhibited the best protection
against lipid peroxidation and tumour promotion. Inhibition of lipid peroxidation by the
herbal tea fractions are in accordance with previous data indicating a relationship
between the polyphenolic content of aqueous rooibos and honeybush tea extracts and
their antioxidant potency [37-41]. However, no relationship existed between the TP
content and the inhibition of lipid peroxidation and the protection against tumour
promotion in the present study. It seems that differences in and/or the relative
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concentrations of flavonoid subgroups constituting the TP of the herbal E/A fractions,
will determine their protective potency against tumour promotion.
When considering flavonoid subgroups, the flavanol/proanthocyanidin content,
expressed as a percentage of the TP content, both green tea and unprocessed
honeybush tea fractions exhibited similar levels (approximately 90%). This would imply
that the flavanol content as well as the type of flavanols and/or flavanol-like compounds,
such as the proanthocyanidins and polymeric tea tannins could also play an important
role in the inhibitory effect on tumour promotion. In this regard, the E/A fractions from
green and unprocessed honeybush showed the strongest reaction when utilising the
butanol/HCI method [42] to determine the presence of proanthocyanidins (unpublished
data). The proanthocyanidins, therefore, are likely to make a major contribution towards
the flavanol content of the green and unprocessed honeybush fractions when compared
to the other herbal tea E/A fractions. The proanthocyanidins from grape seed oil have
been shown to inhibit photo- and chemically- induced skin carcinogenesis in mice
[43,44]. Of interest is that the major flavonoids determined in the honeybush tea
fractions, hesperidin and mangiferin, did not contribute to the flavanol content. A
previous study also reported on the lack of hesperidin to react with DAC during the
colourimetric determination of flavanols [45].
The flavonol/flavone content of both the unprocessed honeybush and rooibos
fractions contained approximately 5% of the TP content. As the unprocessed
honeybush fraction exhibited the highest protective effect it would imply that the
flavonol/flavones play a secondary role to the flavanols/proanthocyanidins. This is
further supported by the fact that the E/A fraction of green tea exhibiting the highest
protective effect also contain the lowest flavonol/flavone content (-2%). A higher
flavonol/flavone and lower flavanol/proanthocyanidins content exhibited intermediate
effects against tumour promotion, as in the case of the processed rooibos and
honeybush fractions. As described for honeybush tea, the proanthocyanidins of rooibos
tea could also be involved, as tannins of unprocessed rooibos is comprised of
epicatechin and catechin-extending units [46].
The polyphenolic composition of the herbal teas differs from one another [47-50]
and from green and black teas [51,52]. Purified green tea flavanols, epigallocatechin
gallate (EGCG), epicatechin gallate (EGG), epigallocatechin (EGG) and epicatechin
(EG) inhibited TPA-induced inflammation of mouse ears [11]. The flavonol, quercetin,
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possessing reactive oxygen scavenging activity, also inhibits skin tumour promotion and
certain biochemical effects associated with skin tumour promotion [11,53]. The
antioxidant properties of the purified polyphenolic compounds from rooibos have been
well characterised in different in vitro radical scavenging and lipid peroxidation assays
[37-39,41,54]. Aspalathin exhibits a similar antioxidant activity to EGCG [55]. At present
no data is available on the inhibitory effects on cancer promotion of the rooibos
flavonoids aspalathin, nothofagain, orientin and iso-orientin, which constituted the major
flavanoids in the processed and unprocessed rooibos fractions, applied to the mouse
skin. Rutin, quercetin and luteolin, present to a far lesser extent in the processed
rooibos fraction are known to exhibit anti-inflammatory activity [56]. The honeybush
flavonoids, hesperidin and hesperetin also possess anti-inflammatory activity [57,58),
while mangiferin is the major antioxidant of honeybush [59]. Both the unprocessed and
processed honeybush fractions contained high amounts of hesperidin, which together
with mangiferin constitutes the major flavonoids applied to mouse skin. The better
protective effect by the unprocessed and processed honeybush E/A fractions against
tumour promotion, when compared to rooibos, could in part be attributed to the anti-
inflammatory activity of these compounds. However, the protective properties against
skin tumour promotion by hesperedin, mangiferin and other minor honeybush tea
flavonoids, including glycosylated flavonols, isoflavones, flavanones [50] and the
coumestans [49] still need to be elucidated.
As the polyphenolic content of the honeybush E/A fractions only constitute 13 to
23% of the soluble solids and 24 to 50% for rooibos, the non-flavonoid components
could also play a major contributing role in the inhibition of tumour promotion.
Subsequent studies need to be conducted to elucidate whether the herbal polyphenolic
fractions and/or specific flavonoids could modulate biological events involved during
TPA-induced tumour promotion in mouse skin.
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Summary
Theoretically cancer is a preventable disease, but in practice, prevention by avoiding
exposure cannot be achieved and additional approaches are needed. One such
approach is an increased intake of chemopreventive compounds that is expected to
interfere with the initiation, promotion or progression of carcinogenesis.
Chemopreventive compounds are largely categorized as enzyme modulators,
antioxidants, inhibitors of carcinogen-adduct formation, inhibitors of oncogene
activation, modulators of signaling cascades associated with carcinogenesis, to name a
few, Although considerable advances have been made in the field of chemoprevention,
more research is needed to establish this as an additional approach to alleviate the
burden of cancer. The past 10 years yielded important information from across the
world concerning the positive impact of non-nutritive components of plant origin like teas
on human health. Special attention has been paid to the development and availability of
laboratory methods and has led to an explosion in the neutraceutical industry utilizing
herbal plant extracts in combating human disease.
Studies with green and black teas have led the way in utilizing tea infusions as
possible chemopreventive agents against cancer development in humans. Considerable
work has been carried out on both green and black teas and their polyphenolic
components that provide valuable information regarding the possible protection against
carcinogenesis in vivo, The protective role of green tea against human cancers is
evident from the number of epidemiological studies, while the data on black tea are
limited. The antioxidant activities of green tea are well established, and the ability to
induce various antioxidant enzymes, inhibit of the metabolic activation of carcinogens,
induce certain P450s and phase II drug metabolizing enzymes, be antimutagenic in
various microbial systems and mammalian cells and inhibit tumour promotion in mouse
skin, lung, oesophagus, stomach, liver and colon have been previously reported, The
two most common South African herbal plants used for the preparation of traditional
health drinks are rooibos (Aspalathus linearis) and honeybush (Cyclopia species).
Having been used by local communities for centuries, anecdotal evidence provides
important information regarding their possible use against certain human ailments, The
herbal teas not only differ from one another but also from green and black teas with
respect to their polyphenolic constituents while they are naturally caffeine free with low
tannin content. The present study was conducted to investigate the possible cancer
modulating properties of the herbal teas and included short term in vitro
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antimutagenicity, ex vivo antimutagenicity, in vivo modulation of drug metabolizing
enzymes and oxidative status of cells, and tumour promotion in rodent models.
The in vitro antimutagenic activity of aqueous extracts of processed ("fermented")
and unprocessed ("unfermented") rooibos and honeybush teas, was evaluated in the
Salmonella strains TA 98, TA 100 and TA 102 using five different mutagens with diverse
chemical structures and mode of action, in the presence and absence of 89. All the
herbal tea extracts significantly inhibited the mutagenicity of the metabolic activated
mutagens, 2-AAF and AFB1. However, the inhibitory effect on the direct acting
mutagens, MM8, CHP and H202 using tester strain TA 102, designed to detect
oxidative damage, was far less pronounced. During tea processing ("oxidation"), the
polyphenolic content decreases substantially and in general this was reflected in a lower
antimutagenic activity dependant on the mutagen used. Variations of the double layer
Salmonella mutagenicity assay further elucidated the possible mechanisms of
protection involved in the antimutagenic activities of the herbal teas. With respect to the
metabolic activated mutagen, 2-AAF, a higher degree of protection was obtained when
the herbal teas were incubated with the mutagen and activating (89) mixture in a
separate layer to that of the bacterial strain, TA 98 as opposed to when the herbal teas
were incubated with the bacterial strain. These results suggested that two mechanisms
are involved in the in vitro antimutagenic activity of the herbal tea extracts against
carcinogens requiring metabolic activation. The tea components may (i) interfere with
the enzyme system (P450) catalysing the metabolic activation of the carcinogens and
thus impede the production of the activated intermediates and/or (ii) may directly
interact with the pro-carcinogen and/or reactive intermediate resulting in the prevention
of mutagenesis. The mild and/or lack of protection against mutagenesis induced by the
direct acting/or oxidative mutagens, suggested that an induction of antioxidant
protective mechanisms in vivo may be required to protect against these mutagens. Both
the processed as well as unprocessed rooibos tea extracts showed a similar inhibition
against H202-induced mutagenesis, despite the fact that the total polyphenols were
significantly lower in the processed herbal tea preparations. No relationship seems to
exist between the antioxidant activity of the herbal teas and the antimutagenic or lack of
antimutagenic activity against direct acting mutagens in vitro.
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Results from this study indicated that:
1. the mechanism of protection by the herbal teas against metabolic
activated and direct acting mutagens differs, while the type of mutagen
used also plays a role.
2. rooibos and honeybush teas may not only be a good dietary source of
antioxidants (as previously suggested in the literature) but also may
protect against mutagenesis in vivo.
The next study was conducted to determine the effect on hepatic drug
metabolizing enzymes and oxidative status by rooibos and honeybush teas in rats
consuming aqueous extracts at concentrations customarily used for human
consumption. The balance between phase I and phase II enzymes is critical in the
subsequent production of carcinogenic/mutagenic metabolites that will interact with the
cellular components. The level and/or activity of these enzymes plays an important role
in the susceptibility of an individual for developing cancer. Rooibos and honeybush teas
significantly enhanced the activity of the cytosolic phase II enzyme, GST-a, while the
unprocessed herbal teas also induced the activity of the microsomal phase II enzyme
UDP-GT. The induction of UDP-GT activity in microsomes has been suggested as a
major phase II carcinogen deactivating mechanism by green tea. None of the herbal
teas displayed any effect on the concentration of the phase I activating enzyme, P450.
The polyphenolic components of the herbal teas also modulated the cellular oxidative
status in the liver of rats. Both herbal teas significantly reduced the level of hepatic
GSSG, as well as markedly increasing the level of GSH, resulting in an increased
GSH:GSSG ratio. An increased ratio is indicative of a reduced oxidative stress or an
increased antioxidant capacity in the liver cells, thereby lowering the susceptibility to
undergo oxidative damage. The stabilization of GSH in the liver may result in an
increase in the endogenous detoxification capacity, as GSH is known to either bind
directly or enzymatically via GST to reactive genotoxic metabolites, thereby preventing
DNA damage. The induction of phase II hepatic drug metabolizing enzymes and the
increased antioxidant status of the liver by rooibos and honeybush teas provides a
promising tool for the protection against adverse effects related to mutagenesis and
oxidative damage. Rats also demonstrated no adverse effects on the body weight gain,
relative liver weights and serum enzymes related to liver and kidneys function. The lack
of toxicity confirms what has been noticed in man consuming the herbal teas for more
than 3 centuries.
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Following this study, it was imperative to establish whether consumption of the
herbal teas may protect against mutagenicity of 2-AAF and AFB1 in the Salmonella
assay conducted under ex vivo conditions. Hepatic cytosolic fractions of rats consuming
unprocessed herbal teas and to a certain extent the processed herbal teas, protected
against 2-AAF-induced mutagenesis using tester strain TA 98 and Aroclor 1254-induced
microsomes. Both processed as well as unprocessed herbal teas also protected against
the mutagenicity induced by AFB1 using tester strain TA 100. Hepatic microsomal
fractions prepared from the rats consuming the processed and unprocessed rooibos
and unprocessed honeybush teas reduced the activation of AFB1 while no protection
was observed against 2-AAF-induced mutagenesis. Thus, in the case of AFB1, oral
administration of rooibos and honeybush influenced both the microsomal activation as
well as the cytosolic protection against mutagenesis whereas with 2-AAF, only the
cytosolic components contributed to the protective effect. Differences in the ex vivo
modulation of mutagenesis by these carcinogens could be ascribed to differences in the
metabolic pathways resulting in the formation of the ultimate active metabolite. This
study confirmed that the in vitro antimutagenic activity of the herbal teas against AFB1-
and 2-AAF-induced mutagenesis is likely to prevail under in vivo conditions. These
results also provided the first evidence that components of rooibos and honeybush teas
involved in the ex vivo modulation of 2-AAF and AFB1 metabolism, are absorbed from
the gut and are available to exert their protective effects.
With the established in vitro and ex vivo antimutagenic properties, the in VIVO
modulation of drug metabolizing enzymes and oxidative status in the liver by the herbal
teas and the cancer modulating properties were investigated. As the role of dietary
intervention during the different stages of carcinogenesis, such as cancer promotion is
complex, short-term carcinogenesis models in experimental animals continue to play an
important role in identifying potential cancer modulating compounds and validating the
mechanisms involved. Numerous studies are being conducted to investigate the role of
chemopreventive agents as inhibitors of tumour promotion. The possible
chemoprotective properties of aqueous extracts of processed and unprocessed rooibos
and honeybush teas against the cancer promoting activity of FB1 in rat liver using DEN
as initiator and the induction of hepatic preneoplastic foci as endpoint, was therefore
elucidated. Consumption of the herbal teas arrested the proliferation of GSTP+ cells in
the presence of the cancer promoter, FB1, as the relative number of smaller foci was
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significantly increased while the larger foci was decreased, Consumption of the
unprocessed herbal teas also reduced the total number of GSTP+ foci presumably by
increasing the hepatic toxicity and the subsequent apoptotic effects of FB1 thereby
inhibiting the growth of the preneoplastic lesions, A possible mechanism involved in this
enhanced hepatotoxicity of FB1 could be the mobilization of iron in the liver, resulting in
a prooxidant effect when interacting with the polyphenolic compounds of the herbal
teas, In this regard the processed herbal teas, known to have a lower antioxidant
capacity, exhibited a higher protection against FB1-induced lipid peroxidation which was
also associated with a reduced accumulation of GSSG, an indicator of increased
hepatic stress, Unprocessed rooibos, green and black teas, known to have a high
antioxidant capacity are less effective in counteracting lipid peroxidation effected by
FB1, presumably due to prooxidant effects of their polyphenolic constituents, Due to the
complexity of these interactions no conclusive evidence with respect to the involvement
of antioxidant activities of the herbal teas and the decreased number and/or delayed
development of GSTP+ foci in the liver could be demonstrated, Varying effects on the
ORAC, GSH levels and the inhibition of lipid peroxidation were noticed which could be
ascribed to the differences in polyphenolic constituents among the teas and their
interaction with FB1-induced hepatotoxic effects, Other features, affecting cell regulatory
processes, may be involved and still need to be elucidated,
The chemopeventive properties of the herbal tea extracts were further
investigated by monitoring the protective effects of polyphenolic extracts in the two
stage skin carcinogenesis model. It is known that a variety of plant phenolic compounds
exhibit chemoprotective properties by disrupting the different stages of multi step skin
carcinogenesis, especially tumour promotion, The present study indicated that
polyphenolic fractions prepared from methanol extracts of processed and unprocessed
rooibos and honeybush teas effectively reduced tumour formation in mouse skin
initiated with DMBA by interfering with TPA promotion, The protected effect was shown
by a decrease in tumour incidence, a reduction in tumour volume as well as a delay in
the onset of tumour development. The processed herbal tea fractions exhibited a similar
inhibition while the unprocessed honeybush tea showed a higher inhibition potential
than the unprocessed rooibos fraction, Elucidation of the flavonoid sub groups of the
herbal teas, suggested that the flavanol content as well as the type of flavanol and/or
flavanol like compounds, such as the proanthocyanidins, could play an important role in
the inhibitory effect. This hypothesis was supported by the finding that green tea, with a
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high flavanol/proanthocyanidin content, was the most effective inhibitor of TPA-induced
tumour promotion. Fractions with a lower flavanol/proanthocyanidin content and higher
flavonol/flavone content, as found in the processed and unprocessed rooibos fractions,
exhibited an intermediate effect against cancer promotion. The higher protective effect
by the unprocessed and processed honeybush fractions when compared to the rooibos
fractions could in part be attributed to the anti-inflammatory activity of hesperedin, which
together with mangiferin, constitutes the major flavonoids in the honeybush fractions
applied to the skin. Chronic inflammation in mouse skin facilitates growth of initiated
cells and their subsequent progression into malignancy.
Quantification of the major flavonoids in the aqueous and methanolic extracts
showed that the dihydrochalcones, aspalathin and nothofagin comprised the main
flavonoids in the unprocessed rooibos extracts, while their flavone counterparts,
orientin, iso-orientin, vitexin and iso-vitexin and the flavonol glycosides,
rutin/isoquercitrin constituted the major flavonoids in the processed rooibos. Aspalathin
and nothofagin levels were reduced during processing, resulting in an increased
intake/application of iso-orientin and orientin relatively to aspalathin. The main
flavonoids detected in the unprocessed and processed honeybush tea extracts were the
xanthone, mangiferin and the flavanone, hesperidin, while small amounts of hesperetin,
the aglycoside, were also detected in the unprocessed tea. Further characterisation and
quantification of other flavonoids in honeybush tea extracts including the glycosylated
flavonols, isoflavones, flavanones and the coumestans is currently in progress
The antimutagenic and anticarcinogenic properties of green and black teas are
well known and were confirmed in the present study. Rooibos and honeybush teas
exhibit similar properties with respect to the modulation of drug metabolising enzymes
and the oxidative status than green and black teas in the liver. However, variables such
as the rat species, amount of tea consumed, duration of tea treatment, route of
administration, and substrates used in the enzymes assays should be taken into
account when comparing the different studies. In addition, the flavonoid constituents
and content of the tea preparations and the different mechanisms involved underlying
the complex processes of carcinogenesis could be responsible for the differences
noticed between the different teas in the present study. This becomes evident when
comparing the chemopreventive properties of the different teas with respect to their
effect on drug metabolizing enzymes and against tumour promotion in the liver and
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mouse skin. However, this study indicated that the herbal teas exhibit similar cancer
modulating properties than the green and black teas.
Conclusion
Humans are constantly seeking to advance their health and alleviate various ailments
with herbal remedies. An integrated approach using different in vitro test systems and
animal models is ideal in planning intervention trials in which advantage is taken of
information which may reflect the carcinogenic process in humans. The popularity of
rooibos and to a certain extent honeybush herbal teas has increased tremendously the
past few years both locally and abroad. In addition to being enjoyable, safe and
economical beverages, they provide a natural, rich source of compounds beneficial to
human health. Results from this study and others strongly suggest that the consumption
of rooibos and honeybush teas may playa role in improving the overall health that could
alleviate the cancer burden in humans.
Future directions
Future studies will be aimed at elucidating the possible mechanisms involved by which
rooibos and honeybush teas may affect the induction, growth and subsequent
progression of specific cancers. The establishment of biomarkers to be used in clinical
trials with relation to tea consumption will be important to evaluate the efficacy of human
intervention studies.
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"We must take science to the people. All of us are fond of quoting Pandit Jawaharlal
Nehru's famous words paying a tribute to your community - namely, that 'Scientists
are a minority in league with the future'. This is true. But let us also remember that a
bright future can be realized only when science is in league with the majority of our
society"
Shri Atal Bihari Vajpayee
(Prime Minister of India - 2003)
"Science and Technology (8&T) are essential components of the government's
strategy for creating the South Africa of the future. The importance of S&T is
recognised outside government as well, by other political parties, by business, the
higher education sector, the science councils, labour, NGOs and civil society."
B.S. Ngubane 1996
Minister of Arts, Culture, Science and Technology
1. Extract from White Paper on Science and Technology - Preparing for the
21sl Century
"Access to information is empowering, enabling people to monitor policy, lobby, learn,
collaborate, campaign and react to proposed legislation. It is also one of the most
powerful mechanisms through which social and economic progress can be achieved.
The democratization of society and elimination of poverty can only occur if people have
equal access to the services and resources they need to perform their productive tasks.
Democracy implies being aware of choices and making decisions. The extent to which
this is possible depends largely on how much information is available to the people and
how accessible it is. For the national system of innovation to become effective and
successful all South Africans should participate. This requires a society which
understands and values science, engineering and technology and their critical role in
ensuring national prosperity and a sustainable environment. This, in turn, requires that
8&T information be disseminated as widely as possible in ways that are understood and
appreciated by the general public.
Recent history has demonstrated the potential of technology to improve the
quality of people's lives. Yet disadvantaged populations in general and women in
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particular, especially those in rural areas, have little access to information about these
technologies. To date, a combination of factors have prevented them from gaining
equitable access to the information they need and have thus limited their ability to
participate more fully in the transformation process in South Africa.
A campaign to promote awareness and understanding of S&T and of its
importance will have two key elements, namely promoting S&T literacy on the one
hand, and promoting the power of S&T on the other. These programmes would include:
- increasing familiarity with the natural world
- promoting understanding of some of the key concepts and principles of S&T
- demonstrating that science, engineering and technology are social tools and
- fostering the ability to use S&T knowledge in ways that enhance personal, social,
economic and community development.
The deficiencies of the current system are multifaceted. The solution of this
problem requires an innovative approach in itself. All available SET institutions in South
Africa should be actively involved in such an initiative.
Government will institute via DACST the delivery of S&T public awareness
programmes in collaboration with consortia of institutions, including societies for the
advancement of science, professional associations, academies of science, science
museums and libraries, media (printed and electronic), educational institutions and
private business. (www.polity.org.za/html/govdocs/white_papers/scitech.html).
2. Contributions of this study towards PAUSET
The reporting of science in South Africa, and for that matter elsewhere in the world as
well, poses a challenge. The public and the tea industry should be aware of the
implications of current scientific research which may impose directly on their life and
quality of life. In order to accomplish this, efforts are made to ensure credible, factual,
balanced and relevant information transfer to the public. The current study allowed for
many opportunities and occasions to share our knowledge about the possible health
benefits of these two endemic herbal teas. Contributions were made in the following
areas:
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(i) Lay Publications
Two brochures entitled: "Rooibos Tea - A Unique South African Herbal Tea" (Fig. 1)
and "Honeybush Tea - A Healthy Beverage from the Cape Fynbos" (Fig. 2) were
compiled in conjunction with the Agriculture Research Council. These were specifically
designed for the layman. Countless enquiries from the public, herbal tea industry,
producers and distributors about the health benefits of these two herbal beverages
sparked the initiative. The brochures will continually be updated as the science around
rooibos and honeybush teas are elucidated. Distribution of the brochures among
healthcare workers, e.g. dieticians, school learners and teachers has proved to be very
successful in educations initiatives.
Numerous other lay "publications" in the form of news paper articles and radio
and television interviews have been produced and are summarised in Table 1.
(ii) Guest lectures
The following guest lectures were given, mainly as a result from requests from the
local herbal tea industry and/or herbal tea distributors:
2000: Health properties of South African herbal teas: Oral presentation at Boise
Centre on the Grove, Boise, Idaho, USA, 17 November 2000.
2001: Guest speaker at the opening ceremony of the Rooibos Association of Japan in
Tokyo, 18 October 2001.
2002: Presentation at Rooibos Ltd, Clanwilliam, South Africa re scientific research
done on rooibos (Aspa/afhus /inearis) at PROMEC Unit of the Medical Research
Council of South Africa, 13 November 2002.
2003: Workshop presented at the BOSS 2003 (Business Opportunities for
Singaporeans) entitled: "Health promoting properties of Rooibos - a Unique
South African herbal tea" held at the Singapore Expo Hall, Singapore, 30
August 2003.
Invited guest speaker at event launch of Roibo's rooibos tea held in the Raffles
Town Club, Singapore, 2 September 2003.
Invited guest speaker at the press launch of Roibo's rooibos tea held in the
Corus Hotel Ballroom, Kuala Lumpur, Malaysia, 4 September 2003.
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Table 1 Lay Publications
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Media
Printed
media
Television
Sources
MRC News, Vol 30, no 4, November
1999
Sunday Times, 20 February 2000
Fair Lady, 19 January 2000
Die Burger, 24 August 2000
South African Honeybush Tea
Association, Newsletter July 2003, no 8.
Information leaflet included in press
kit for launches of Roibo's rooibos in
Singapore and Malaysia September
2003.
HerbalGram, USA, entitled:
(www.herbalgram.org/herbalgram)
Interview by Daniel Lee, of the Seoul
Broadcasting System (South Korea),
16 May. The interview forms part of
a documentary film promoting South
Africa as a tourist destination.
Rooibos tea was included as it only
grows in South Africa and is popular
in Korea. The film crew spent more
than 3 hours filming activities in the
PROMEC Unit
Title
Anyone for tea? - Izelle
Theunissen (News Editor)
SA teas keep cancer at bay
- Laurice Tait (Health
reporter)
Down to a tea - Karene d
Plessis (Health Line
reporter)
Heningbostee se onskatbare
potensiaal nog grootliks
onontgin - Laetitia Watson
(reporter)
Honeubsh tea and cancer
prevention - E. Joubert, JL
Marnewick (scientists)
Health promoting Properties of
Rooibos - a Unique South
African Hebal Tea" - JL
Marnewick (scientist).
Rooibos: This herbal tea
serves a cupful of
antioxidants without caffeine
or tannin - Laurie Erickson
(health reporter
2004: Invited guest speaker at Royal Health Service's National Royal Health
Workshop for dietitians on the Health promoting properties of Rooibos tea. The
workshop was held at Panorama Medi Clinic, 20 January 2004.
(iii) Empowerment of school teachers and learners
A workshop was held at the MRC (7 March 2003) to accommodate twenty five science
teachers from schools in the Western Cape area. One of the sessions addressed the
question of "How a scientific investigation should be conducted", using the Rooibos
project as an example.
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The MRC's Events Management Community Liaison Office extended an
invitation to address the grade 10 to 12 learners from Bonteheuwel High School (17
March 2003) as well as Bernadino Heights High School, Kraaifontein (29 July 2003) on
the health promoting properties of rooibos tea.
A presentation on the "Health promoting properties of Rooibos and honeybush
teas" was given to 55 B Sc students at 2nd or 3'd year level from the Science Faculty of
The University of Zululand, 23 September 2003.
(iv) Capacity development
Since January 2000 to date, 15 students from both local and abroad universities and
colleges have been trained in the AMES assay, isolation of primary hepatocytes, tissue
culture techniques and execution of animals studies. These students were mostly post-
graduate students requiring practical experience for completion of their degreel
qualification.
In conclusion, when conducting a scientific investigation, sound basic research is
required but it is of utmost importance that the research findings have to be effectively
communicated not only to the scientific community, but also to the public. This aspect
was recently emphasized by Kenneth Olden, Director of the NIEHS, that the research
process should be a "two-way street - communication does not simply flow from the
ivory towers, but that people charged with setting research agendas should be
responsive to the needs and messages of the public they serve".
"Think like a wise man but communicate in the language of the people"
William Butler Yeats (1865-1939)
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Addendum A:
Liver sections of rats treated with DEN-FB1, DEN and DEN-FB1-unprocessed rooibos
tea, (Chapter 6) stained to detect GSTP altered hepatocytes .
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Addendum B:
Visual aspects of the two stage mouse skin carcinogenesis model performed in this
study (Chapter 7).
CHAPTER 7
Two stage mouse skin carcinogenesIs model
Experimental procedures
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